var title_f11_32_11776="Striate palmar xanthomata";
var content_f11_32_11776=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Palmar xanthomata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Striate xanthomata of the palmar creases in a patient with type III hyperlipoproteinemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Durrington, P. Dyslipidaemia. Lancet 2003; 362:717. Copyright &copy; 2003 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11776=[""].join("\n");
var outline_f11_32_11776=null;
var title_f11_32_11777="Scimitar syndrome III";
var content_f11_32_11777=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scimitar syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 306px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEyAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3GynMrjPHfrWpFKAc5A5xXE6XfksOfxz0rTh1H96+TgA8igDsrecN1Pbr61ejk4GfWuUtbstjAPtg1twz7go5AH60AaykEZHSlJwMmq32gJEWJJxzWZdapklcgKelAF27vvLOxcAn1rAvtbeF87wG6D3qS/ffayyBsOq/K45z7VwmsamkLESgor8LgZO6gDtm1eeeAiNwkh6DOaqHWZEkCM7Er90seD615/c3cmmEXVzceXCwwrMeeevHWuTl+I/9lSyrbqLqFCcPL1HvjsKAPonRrieZmjKkQHkEjG2ovE16LNmLSldyfKqjJNeMaL8VYdS8mJvMS44CqZAA3Ndz4nvP7W0Kz1HT23SQNiZSeMd8mgDd8P8AiOL7PibduZiF3dPeuh1K5kWGEQt++fBwB2/GvFbLV5ru9jt0jCSpKN0aN1B6EV6vIk8bW010pWOJB0OTkUAXvt0ssoWFhsQgyZ64xWbrOo3kNwk0DZtTzuU9PwqnJcS3F6yvIlvAWwue59/Wqmoxz2yqsUocH7wB4x2oA6XS9Z+0KvmLnPQjrWv50e1W3DaehrkdKnnMY3AonQgjgGt6xhlkCM5UqByQO/tQBqUVXW6jaRkj52cMe1WKACiiigAoopk2fKbHXFAHJ+N9ebR7GSZiVQDjb1zXhuqeJ5riSSRCwkYcDqc9q9O8fadd6orwxht46+mK8vvNNUy/PbMrx5BbB5x2xQBwreI72J7hbMzRTEY2tyW+lVrTW7s4W4nEVyq43D77D0NaeuTQ28UEjqkYYna2fmJz0ribmCV9UVEeQb2BZgO56UAdza62hsJGlkuBdBivm9CVx1612PhHVX12G0W4Mbz2zh1yo3MB6mvNtU0qSysdl1Pcl3cfIq4UD611PwqlNtf3quFgcoFDk5zQB2vinS7281Fr7SPOZ5V3GP7yIR1wc1Lpmi+ILDw1LqtzdI0sn/Lu33lA7Y7VZ0nUr7QLG7l1K4WUNKTCCAMoehrmIfE1/ezXXk3G9H+VlYjAJ/u4oA6LTdauDbAywBCjfMIfmByO4Heuk0q4e6DvGxCuQCMfdOOK81WS7sbGK40+7XJkKyRyMNyn3Peu58O69fS6bchhHJM4DIMAY9aAPQNPuDbrAiksCeW9fwrq0fdGrHC5GTXlmjanDdI0rEoV4bjBB9APSuwu70w6am1y2B85J/SgDoDcoDyQBnGc0+OVH+6wNefXeutIqMImC56KetXdN1feVUNzn05zQB29Ifrisu01IE7Zeh5B71dklI5JBVulADpZdoP86ge6TYc8e9Z13OSMAiqrXJEZyOKALct184Knp7025uuBzyaw7i5bfuUjbxj3pwumMfJPIoAZdXmZiFIJzRWLcTt5joc88UUActY34wpRgRjkGtG1vDvY5z82Oe1cdYXYQknJPoe1atncFnY5JAbj/GgDutPvQrI2ecdK6G2vOBg8n3rgbOVlxn0/Wt+zuCqbjwB3oA37vURGoVSM+9ZU10jMGjLZJ9eDWLqFw9xkqSByDXI6h4pTTbpliIYjAJJ4B9qAPRkuJvNlb5YlKHKeo9a43xXPJPZvc6fBEIUGQWYFwR2x6VjQ+LZHllufNRpd+1DnGV9BWbd31wUu7izVPJmz5oHzYHcigDldTk1G9ukvLm4MYI3orPz6Y9q5DXy8cDu6oqSN+7cHOT1wfWtrxJfxXqx2tg+BuJLOeh9jSw3EFvBFZX1vFOkoDKJBhRjg49/egDzuznmM7SR7iEOMtwBXqvw18QzWUk9vNdSNbXalHgVzjOOpFYGu+Gbe6/eaHNHCG4aAv+oP9K1PA2mx6H9vu7+a3jCJhS3Lbhyf8KAOq0h5/DHiuO+1BpPKQGSGIDIcYre0Tx5qWqeJHcSMunsxOwnO36+9cPfa5pd0v2vRrkzX0igMrMT5Rx2z0+lcx4Z1+4t9Qu4NucLvPHBIPf3oA+gPEetSSXkDWSkgKCyqOM+wq5az3t9C3mlzKGHA4yK808M+IdR1aVVUAuvKgLjB9a9I0m8u7K5iiu5R5s4GyIDcwJ7UAd7ocMs8UUW4EgfvGz0rX1S8FtD5EDBTjBP90f41jX+sW+iWS20bgXk3IXHr3qnayvLDIJ3UswHfk/WgC/ptyUfgnHB6810NtOXjz1965K0wsrc4Cn071uQzfucbskjGBQBoC4Y5I28HHParKOG6frWSJ9hznPPHFWI7hcnBG4dTQBoZpC3uM9qqyT7Rx1PWqr3OfUcgZoAfcQxSFwRnLdK838baTcRK9xpx2PtJ6Z4r0cSblPHP0rG1wBoG3YG4flQB8heITDHHfG8LNLneqFeQf6VxGmX+oXt21tYELg7y4PIA+te1fFPw2ZInuoYnSHPzsR26ZJrxjTNSs/DusyqyCZ+Y0lHI2nvjvQB2uv6gE0OwtLu9WZzEGk5+6c8VQ8N2C+Z5+lXW6TcCYy2SfpXFS6tA18+GWSInH7zPAqbSMrciazuxCwYY5xj3oA9x8Y2N7ZeE0utSDRqciPJz9K8esdUZDJGrFd7ZILdT7V63Nqtx4v8AAg025f8A0q3G0ux+/jofavGbm0jsr+SFw2U+6SOf/wBVAG1canLDp6iKR/8AWfMwYncT0rrdB8W6lZ/YPsh3qyN5jNz29K5e/wBBlfSbe4tpkdrgBlQHBx/WrdpHJDcWsBbayADJ6GgD37Q7qZNL09tTtRbzXJJZ43HHGa1Nf16Fbm3s7G/hUwgGQMwBOe2TXmdp4gSeyit5UIWE/u3Q856YrjdbleTVGlt2kcM+4AjkmgD3WTUZDdl/LzHnsRWpb6hbu7mEFHK5z1z614hoHiLUsm3jLPF6S8k4/lXceHtYhuGVHBguJBgHO4H29qAPR0vmiYlSSvHzetdJZ3pubcY7dya4GE3MUnA3IOuK3dNu0jUKCA2eQKANq4kbYwByCcj2rJN06lhJ1PbtU11OyliR8h96xrq4+Y8AfhQBLcXgaQKOMClWfAJJy3oKx5JyX6Ad6Q3Z3Ejnjr6UALqF0VlOAMn0orG1W4KDfnr3NFAHFWcvzDPPetvS58ysOduSOlc/aYI7EdRW9o6GSVlJyo5Jx0oA6qxIYAnOB+tXNRulit/mYqoGScfpVK2URj5vuqMnJ6DtXL+KtTa4UiKXaozn3oAoa14ulinZYiGt/wCIHqRXJXetRmTzkKId2CjJuXmq2pSptHllpJQc8dvas9IYJlZtwSRx8wx8oPr7UAa97b3Oo2kV1pzRYVtjiPjOfaum0nRdYtPC094VSOSN8osjcgD29/SuC0ieeD7XaKSsbYIYrnaM8kfhXX6p4ggm0u8FpeXIhiGyIyNxgDHNAGDq2mte2jX+liTHPmx4ACt6g1iS3ESWogmBlm254O7Yf8Kraf4nnF01pcAtbFSDhsE1hTPHpusxXVnJ/o5YsnmHOO2PegCdb25udRihRpSrOFKJnj1rvdXmsVgstP8AtsSpIAZECkkDp16VyWkTm0vI9QlURvsw2R1//XVzVPEdlfaVPJJZKL4HbEwXgLQBLo0Nlo/iBhcFBG24Iqjr/dNep+A30bV1mnutL8+5hJjl8tgpcD1HrXz7YzDV5bZbmVYLjcczMx6CvdvhHp7R2NzLEGbewDTnI3EDn8PegC7qF9pnh6VV0uAxT3Jx85yIs9BXY/Di5MOnXfiHXnHlQAxxM3fb1Ye/YVxuveDDqesWSpdGNruTYIxyQOpb8q6L4sXtvpWn6bosEv8Ao8aqZB97O3pn8eaALcd8ur6jNqlw4QyY8oPxtUdK6HRrsiTC4fcQ3HQ15b4clOqTDF6ZfKOcsu35T2Ar03wlYy26s7tyenORigDpkkRwGBwep5rRiuFRG4HHcnmqEaYyTwTwCKlBHtgevegC19oy3TiplnCAbQOOTVB2wVI69acZBsC/1oAvSXG7H3euaPPBAzt6EHmqqnK7j1x2qKSYBgBz+nFAGgswCZIz35NVLmeJz+8XJHGc5FVzKHBCvkn3/lUaxFhliCaAMDxVcWcmmzWl3Cn2eUbCDwDn1r5P+IPg2DTdU8yxnZ1zjYSDjv19K+uPEdrb31pLBPGHTGM/56V86+KNBu7LxKUhZTGSGV5D8v05oA8Ilj2uyMFjZScjPWut8CW8U9x5crQmMqTl+OlP8a+G5ra6mvUSNYJSWZUbd5bVn+GLI3EkqwEl0XzARwGA9P8ACgD1vwJfPbai1nO0bWyA4KqMhT0OfauL8Zz28uo7XjeKZXKxy8EEZ/iFS2WryaXdJeLDMr7fLbcMA59aZ42ure+sku7e2IHG/HOGAzQBW8P3l/A7o0oY25JQA5IPt7V09vqD65dttVYfITc1wy9c9c/SuUUxRafDfPGy+ZErud2N2a7TwZqcE2nv5mmsYZYnUH+9xzg0AOaeC10h7gMRLC5VAjYDcdawXvnt3S8tZHkdudknT3rqtNi0m48IXMmpma2mT5oYWQ7phnAANVF8LRajb/6BeEOzL8s4ChRj2oA5uPUJ5LkOcR/Nn5DwPeu08Ji4hne42u0akMMdCexpum+EYNFMd7e3EV1CG4SPncfoe1bkmsWq6kFgiCKQANoxsB7HFAHQWGrPYSbVkd/OYszM3B9sdq7HTb+K5j6bX9OtefFIoQZoQspJ+8vRfb61raWWRVlzkvkqM8fjQB36XG+HDHOPWsy8zk4xz0PvTNNvEm2xzHD9AelPujGiFZCF7D60AZFzKwJzjjuKiM3y5IJGO4p9wgEjBgfxqlKVH068UARX5EkYHXviiqlwdyZ6HpjPb8KKAOL02Rzjb0PUEc8+ldjpa7MKD8xPIx1rk9FgV2RT3OSc111gSrsQME9O+BQBd1a5MFl5anAK5J9a4i5uPMVipiEZ4+bk5xXR+JPmVG3EJjb+NcfLA8zOqNhTwcjgD1FAGXquY3iMQ2nGMZOM561AIkt5o57xljQ/MSozkehFXmnt7a0kgaRGYch2HC+1c1FfwvPPDe3BurdlyyKCAaAL8+pWTvNBZI/2eQYEqcnJ7H2rD1qC7h8PtGsbyRI3zFfT1p1xfiZMaQos3iO1YTyXHrmul8IXMeqXKWMihL0A78D5XoA8n0oTzah5aj5QGPzHoAOtalhbRXJitnLySqwJbHysM16T4r+HEmmWj6hbtH5sgKeQidM9xWF4G0qSFb2a6iCra4ADgjOaAGeJGt5UsILGJY2Bwxz8oA6VkeK7WOMRNASIyBlc/MDjnPtVfxrcmLVQ6T4iKAxhRx+OKztS1uSe2gWaMDC4Vv4iPegCxp1tbSWsRUlmjP8AqwvJJ96+lPAU0sfw4aaG28qYZVlb+Ljg18t6TPci2mERHk5DHHHPoa+n/hpbvB8OJDf3CtBdIX2q3K59fT6UAbXws068nubrV9UL7bVSIRkkFj94gfSvM/iRquo3epNmOMB5GOfLz9Mt2rrfF2tyeHvhAV0Sd4TdyGJZFYluT1z9BXicGrajE6wXk0sgY8gsfmPbNAHrXwxguZbqJbmwCKybmYDrzjNe82VtHBDGFUAYrxv4PfbJLfz7syKfuLvJOFHTFeyRsWjGT1HNAEz4PGeP5VEECnAJwe4pJcnAJwM96QvweuD/ACoAViVUYx060m/CYyo9hTHII78Hp2pjMOcLuHp6UAWBIRCeR7Cqb3BY5PfPAokk3HABAxQUKn5vTigCaCQbs7MknqPSllkOSq9DwM9adCpVgE+5STcjn7x6e1AFaZT5BAAcHsDjFfMvx0tdS+3TmKWdYzhggOFPvX1D8ixlRn1GD0rg/GXh6PU459wU71IUkdDjrQB8h6Vrd1BIsF3JmLoRIM8Vo6bKNM1lzbXAjgdsxOMA4PfPt6Vu+LPh/eWySzLCFiibmROgBrHsNJW6VLe5DHb3xgg+1AHTpNNOzwPHFcbQWYnkN7g1tfDTw2fFOo/2dcRPBG0m2R0OVKVy3hy+hs7/AOwX1jJPGJBtKsRx3r6i+Gmj6VpkS3ljbsizJkNIcsD6UAeI/FHwdBo3i230633S6MFA8vOCT3H4V0UvgJLPQ7WbTbkqluQ7AnPB7Vp/ECxutQ1G4lgXeGkLjHOB/Q1ynjTxfb6H4fhis5nNzNFjy8kqD0J9sUAch4j1i/a/jtop2kigyqlhlQvoM1WOq3N3aSCJWjkjAxt+XPvWbJrVzew5jgjG75g/J5qbRtZYO+9VZtpXCr3oA0LDU9RlQi4kL28bjJkPFdfoupaDfXCR29wbWcDBklPyZHGa4G81aCSxEUqf6SH3Njpg/TvUNlEGQFF+Rjt+X8+aAParWxuLMyS5LRuAQQwKNWxZyRTys1uXDjgr2BrzLw74hvdH0l0ifzLd5cBG74/lXoWganZavCgsW8uZeXhxg+/1FAGzZiVCPNf5geuODWzOfPiEmclQQR1zWai7CkbkngjitK1AWJl6r2oAzrkELk8Y7egrOmzt+VscVq3QTzSMY7VmTEbzk4HOaAM+VWMBOcA+tFOmIMTIuDu6UUAcjpLlWQ4GepFdhZEqHd8BVII965LR4hJIij0z1rpywSMiM/MTg8UAVdRuBcho5c4J69xXGeJNZjt4zb2MRQtw8hOc+mPStrxBfrBAYYWBk/iya4DUJN8wJfMj8kc4+lAGPf30k8nkuWLqv3ex96z1RnfdGSGZcH39q3TEJhIXj8mfZjG3hgP61Wjs5Z42EURBzglf4fwoAoTSyQ3kaoIoTHgFhzn/ABrp7e+nmiW5hkS0viRudRgzgHpjsc1ianNBplzDKIlkuQuCGAIH/wBeuZn1S6uroN5zI5IwQfu+woA+jrPxNPHoekprcWZ5SXd+AFz0J9uayvFFzLZJPLBHCN4II++pyODjoK5S3hs9d8FwrJdTLqduG3KX+QgdxjpxUPhzWJtW0g2cEikwfuyp6nA6570AedosstzMIWySzM0cg/lU1lo8ur3cMFsHW6dwArf54pt+Lm18QSRgkfNuOOla91rt9YiK8tF2XCthX2feAoA2dG+HmtaUn9oTpHPaIczKpypHcGvWvEML6R4SiktX+ywGNXCsOFBHcVzXwq8SXEEJj16JZLCVy4XryeScd66/4izpr+jI2lKJ7MTKrrGRjH+AoAwPjRHHD4V8MaZFMoOzzXw2AcKO31NcBoOlSai0MduGeaWUKcchB7+9d18frLdrOixMvlwJaHb83PUDpW98H/CrxXr3SmVdiAgOmN2e4oA9C8H6c9hocMMpBlVQN5HJA7GukjyItzZyOmaSJHyRtAAG0fL0qyF2xfOcgCgCMjAHJxjp1poC5J6AjrUmflyR29KhJAGCcE9KAGysFB+bj+v9az5ZnEx2txU9w6noT15PSqpUbs54NAF4IRGpXluvI7VYXOwZPA7ZqvGC0GQeQfXrUgRgmMnr69qAJISd+cH5eMHiiRwWAUj8aYhZV49e/elZQCSoyOnPFADySFxtGB3BrI1gO0JWIAuMnFa/IAUgbu/0rOu49zPnrjg0AcqLEzQMk4jZZM7o2XPFV/8AhD9FtZUu2so2fGCoPBH+PvXRxIqPhV+XGM56VBeSsq/uwCpOCMc0AedeM/h/ZC4ttW0yMwRW7iQouSCPevRtPuorPw3EoVUKgMowcEntmrlvDMmlmG6jLBlIx6+lU3sUEcbzMUt1O5kagDF1e4j07RZ7q4jHmSglBnAXtXzbr6SXVrJcTR7m80o4BztGe3tmvXPi34msYrGWL7WuT8oT+6PWvDNC1xJZLjTroNJBc5CY52k0AGkSiG4WDa7rIcHPaunu9Dl0+3kuZAY42+RAo559axLO3XQrl5b1t4HCgjnrXVy+KTd2ENpcQpIu7CyLwFHpQBxr2CRESTMSWPQHqa0r6RobKNIoHiDHIcCtC+0Yw3VvOS0kUo3AqMjFRahLJd7LZV2tExzg5z6UAQ2yTDTyZ3CgHKlj69z7V0eiXEsN1GUBRhyJIm71nXulkWsMkspUYwEU5JrUCXmliPy4UgjeMOueWZTxzQB63oWo/wBpQxibAukGAeiyf/XrctHwPLcEOeDmvPfCe+eFJEdlAUg4Pvxn0rtbG4FzGFc/vUHX1FAEt5FtmZl288DmsG73hmIPHat+6O5uOPpWRcMxDDAAHHvQBmTszMpAOevNFRSli/I7YPNFAHP6KGiiycZYcZ4wK1729FlBubb50nCe3HU1haezPIqp17H2qt4juWm1F4lXIQBR1oAytQIkkbJbPXH1rOuYYbVg7ydOOOtXmmFsSuAw6Njn8qpXXlyxl5H2wp/F0PtQA68mt5RHL9odoUGxpMAAd6zLjxhYI6WaWjwxocGdWy7fWsTV7v7WXtrXEaAZVD3I7msa3tY5Gb7TMoIH388596AOy1G0j1fTLq9gbc8Cjaq4BIPHSuJ8mVIy23YM8Dufc10Ols+nFbqzvt8n8SKuRj0INdlNo2neJdES9jjitLlWKy54Uen0oA5rQbuOHSp7ZwfMkUEuvSp/CGmyR3ovIEAgKt5wY4JI6ECtGHw62k2E9xc4dQCEmA+U/T2rnLPUbmFCkDGJmb5DnIGPWgDX8R6T/oENzcwYO/8A1inLbfTFVvDugSeI9Rt1XzJQsg+QttGBXq2gvpvifQXS/jd9Sj4nVBsU/QenSu/+E3haz0Gxne+00QXbsWhLnJK+2fagDx/X7a70fVTp1q0OAB5YR8+WMcg+5rf+Gl3HbTR20xMqzygGNeVDZ6muW8ZRXOqeMb+W0hlih80ocqV5zjNd/wDB7w4EvXMjM/lvuZh0IoA7L4peFTq2qaTdmEPaIPLkUIN3JG1gfSui0W3TS7EIUUSkBQMYwB0rd8T6nFY6aJcbwAAMDPOK5XSLg3kHntu3SclWPQ0Ab6TM/wAqjHHXpzU+4iNs8VmxSvkZPI/lUzTYRuQQaAJCx3DJ+XtVZmYMcFsdzSPJvAzwf5UyRiQAWyMc0AQyNuGMcdjSK+cBhg09ioxxxTVTHPHJzjtQBPGWVco3I54p4c7hjoPSmIdy5YinAICORz6UAT53YyOPfg0u8YOc8njNRFlz6E8Dmms2FwvGeKAJJHHHzHc3NRt/qyTknJ69cVCWBwQcbeSRTvNDKF2gsepxQBnpDM2obYzw/WtO202KJ+X+fGSetJYRyfOzHDA/lU6ZE29sEjjFAF6QKwAToprzb4tazc6ZpcgtkbsWZRnivRUkV1z3/Kua8T2iXFlfJNykkTK27pQB8R+K9Tm1XVJZSCqHnaDkVU0e2eeXdEWWVGBVh0FddrGgxRpct8kfzYVcjDDNc74fFxBOXhG4Bxnac4xQB23xHtJxYWEske3cAoKjg5HU+prO1/RF0DStOlu7sfaLxRKkSN9xexaut8RXMN9ZWsl6soA243DA6enf61yF5oN7r2qEiB5EwArb8BRQBr+FfFBmvobMlbiJBtUN3/GvZrq28P6NIHhtoIruaMOGlXchJ6jJ6V5NpltZeB7RLqW0WXURnZvGe3Fc3e+LLvWJZpLi5IZzuKgYAPtQB7HL4VsL9ZLmO+QyswbZCQVU+lQXUNnHfoiwzzxovlHzBwD9K8q0q+vbK7intbvyyGztzw2e5HevcPBsttrmniS5dYp4CCzbvllPagC80n2W1hh06OJIkGX+X5j6in2NwTKsyjhjyOmKnaPbM4kTDOxLE85FI9vuBMHVSCeMGgDSvsEIUPBGelZdzHlcsfqavqWki54CnFQ3MYeLnBx/KgDAu/lKnPA6EUUt9HGQcjJPUUUAcvogIlHGSOevGazL6QRSyk/eZick459K2dDj2I0jHopxzXL6hulvpVY7QuSTzQBTYwZeS4lKQpyTjgn0rndS1aJ1YyxReUvEY3EcemBTPEF8LhwkfFtF90d2PrXL3JJcqQWDcj69qANI6hJN81ssXHGFAz9altXuvmFxaRMDzvZcZ+lZNlbqs6tOChHTb0Fd5aanpx3TXkL3WYSinAHlv0B+lAGTYyW0BYtbESMfmwe1dJomp2kXmRhQYpeHEg+UA9cCuUuruCFXjnZY1Ayvq/0rnbu/mkjxEuyE8ZHWgD3nVL23uPCLWQljmtVX5XjOCuPavJk068vdVjs7ICTfyJCcAD1qPwn9tmsp1SQRwRAvvkbgV6x8FPDd74n1RRJZxyWMX+tlVuBnvkd6AOh+D3gjWIZLk6jeEPGwJDENn0GfpXc+KfElzpd1As0DEWx3kH+IdMV6RD4ettItlW3wIkUYA/nXhXxG+IttB4zl0r7El2f9UQ3RTjrQB5z8VviEdQ14PpSrArIAxx8270r0n4B38smmtd3peeec8EnqoFfPfibwxrFtfC7ltZYYbljJGzn5W5r1ex1C90LwSJrAukyr8wC4Ue+fWgD3LxDcSXXhxp05KnIyPQ1B4cI+wx/uyGxzj/Cue8G6g994DnjuiftSIWZS2TyM1Z8Dan9o0tPNB3qSMEUAdksQyuG5xUbKMnnJpyNuQO3J/lTHGWIOevAoAYM78fjT5DsHTII4xUkQwCQOgpJ1JXpg9TQBUfLtgKBSkqMAZPHNDxNkDtjninqiqw389sCgBUBKYzjPQ+1O+UEYz0yc09WZlORwOtEaEk8nAzgGgBgyXGM8k9f8aHchfVcVOIwFPXPoRUbKD0HTnGOlAEPzFsgEinKhDkk49BipgCF/TipYVV2XJYYOaAHQyFE+YDHr/So1bzHJIIHrUsyqwICnI6HH86ZEoDKMAZPY0AVbx5rbLQjcp6k9MVh+MNVjh0d5JOCUxt6lhXWzxZtpD904rz/xPoF1qqRAy7GJIO0/w+tAHyb4p1YXN5KqOzlZCF7ALmpPC+lXl5fQRxxyC3Z98hQ84HavUdf+FtrbTG7ld5dx646N1/KtDQbzRvDum3KM0c18q7o+PmP+yPpQB5/4jS8vb+3hLzpa2rfICOffNelapdaRZeFbVdLmgF06fOhOSjj+8a81v9UkvnkvJJGTdJu2Dv7e9UUvnkumaT5IzxjAGKANC3sLvXdVaI6qkt4o4DHIf2Bqqvg7Vy8jRafLJGpO50XgY65pYYp4IZJ7ZV3vyjqcEc+1X7Txjq2n2hgtrgxRzDad5LZHcj0oApWr2kaLB5QeRersTjP0rqoNWn02zSziUAufMYKfu1zkVmJntrqSNpWBPmJEMZx34rQt3iaWSaVJlfnAZSOPx60Aeo+EPEqXsJtLxzkHAlc889BXSPCbdg5diCOD2+leTaZbztD86nY3MZx9/POBXqeg3LT2MdvfKftewEZ7j396AL0QDIxAwCM9ajlXIxjAx2NXrNBkqQPmFLNEAcBQW6H6UAc1NGqcKvSitG5RUy20AD2zRQBwluii3cBeSNtcd4wl+zIURsO4G7FdXZZaCQktwOAe3NcNr7+fdSeb0J6k9KAOSnZpuCDk0W9lGgSaZ9zA8J6VoCzMcrAgbjyn0/xqu22ObnG3Hz56AUAMmitiwxEzbjxjtUEWs2enzkQxNNxtyxyBn+dQ3eqW6M0NtuReokHf2+lYMoAlygJB5Ge9AF67H2hd68x5JDkEnntVjTNGu3X7WcRwx/xE0/w9LI26GH/XYJVj90DuDV3Urll0opaSSwsG2zIRy34+lAHqHgCfw1q0EWnT/ZZJJE8pvN/iOeT9a+hdLbR/BHhtU0lI44UX7kIGT69Ov418S+B9PF3rMc/z+TAdz7RkivonVbmS18KokG/yVQcvjJGP50AW/HXxuOm2MioWN24xDHtz19a8Ku/E81zqjXWo3MQnmBffEg3ZrjNdvptQ1SaWaR3O4hdx6VHb2kt1gliduBj2oA9k0s23ifSLGK+1aSXJKxJIGJjx7+9eyXfhyxsPDvz5uLcwhArduO+K8C+HGi6ld63a28MUvkx/MQegA7n2r6h0y1kXT/smobJUZcb16A0Acv4A0y7jv53kCCxkhCqgA3Eg9T9RWvZaYlheTRc7S2dtXLW5i06dYTwM4B9O3FXLwiO8DABtw7HrQBbXaQAG6dPcUhbYTnkeoFKiAqCDwR2pHG0Edz7UALC4DgFQfb1pzybgOAM8ZxTAD94E89eKV1+cEenQ9qAGSFc5Y549OlNUqSQB7imuCWGATx0FJGBGeecnt/OgCdWYDqAM4Ipm/aDnPNTIuULbsZPHvTGXtnp0oAFc/wAXXOcdaXdt7jP50Rr8vXg9SKACWOBnnrQA4EkhasI21TkE/wC7UBD56d+uKXzGyeCc/rQBPHKvzZ5GM8Vi3OoNbX0Z2kxg4Y46VoxhmkOBgY596q3kMbsxKnDDBBFAGq97GYN6lWQ+9c9JcR3F1LjKIiEjPrWVa3N0mqzWr5SHZ8noa4bxLqes6XdXtwfLeCPO3fwMjtQBf8QtfzO8caiWOX/VgHp7VWX4VyapDJOJUtbt8H94OPdfxrhbTxrqZ1FZILdFiLCQZJJA710OofHYtMDf6WTBEwAaF8McdcigDy7xjoeqeFdTNvqtjKIkZjGYx8pXPXNcjeztczlgWEkx+UAEDmvpK11zw349uPtNxqM0dw6ErDIAGIH8OOleO6l4pn0u5eCw0q2kjyUDTRB24P6UAVtE8O6k+o232JXl24Yjd6cmvRPE2nw63Kb+ZNPgjjAVRGvlqSByo9TXnt18RtQbTBFBaR21yzETTRptJHYA9vpWbo+q3V3H5MfmyuGyqlifqaAOuutUlsPKsLeIxMh3I5AJz6fjV/TfEWoTXNrEtskpZsDdH0Oeq0vha0m1mExTJAUjJfz3xlcdq6m1utM026iaW4tkkiyYggyM+uR2zQBRvYb7TdWfVfOklkKj/RmG0qMenTFdJomrSSgzyqI5WIKgjJHtmsO5N1qcsfmt5wbpIW6eoHtWkbZ7UD7KJnXrMvZfpQB6XaMkm1wOGXd9KdduApBAz061Q8IyfadObd/C3GetaFwFUfIoPHJI79qAMG4kIDYVj25oqa6bdEysmT9OtFAHkq3u3R5GPDt8uQa5mdGMrSuMoDxnvWk0wGmrHH1Z+faopnVgIVOR/DgdaAM9IvOdfNDIp5DsMY965PxPK9xKYINhRWJLLwXre8R3IijNtAxMmMyEn/x2sG2j875p/wDj2BwzHgn2WgDCazwRvYRFgCofvWtbaPa20Yk1K8QgoT5UTZI+tW9djt9DuRFalrq5ZVIldOEzzhRWF9ikuJSRKrSM3zBjzn+tAFmXzmmQR7IIQMK2cZHrxXV+GtJsdV3Wl9c7rmZNsaxEcH1JPrXIXtpOtnboUdmXI6ds8V0/wmtnXxppKzIUSScbmbpx0/WgD1v4f+D4dAjezvrJ1u5Qccg7sdSTXP8AxP8AE8mm2U1ijx4fjYOST0/DFe9a3pN1Z6qdRuJw1r5eNijOPSvlD4wXVm3iSW1tFll2sWaSTg5J5AFAGD4a0F9Vu2llQx2sY3SO5xivUfBfh+wkuUt7W1lnRT80zD5F79a5f4caJf8AiiNdJ06aVFL75XIyqDuSa+hxocPg3wettb7ppIwShHWViOpoAhm1fSPDdqiRxIkrgYRR8ze5qHQviANUumtLZQlyo6Y5weM145qD6pPev9qjkkmnOAACxAPp7V3HgXw/LpV9FcJEks0i4mfdnAPWgD1Ge1NzCkgyZIsHcf5CtSds20TgAtwDkd6bbYjhUoRyMc+tTRIGicMOOvWgCOykJYjkdxViQZBBwM9KpLKYw2cZ7fSplmV4w3r+lAEmT0zTRuX+Ic8UxpBgEdSKWLJPp7dKAFkVuMdfpSlcMA2c+9TNxjGcjHejcrZIHzDvQAil8EjJ5prh92OM+oqzHtWMYOQeo701zknjp1oAgDMrjlec4qcKVBA6575pExnPY9KlyGz6CgBjB3IIPbHA4psh8v5iCBirSOO4P+NRXDCQEEduKAI7eXJLYwMc1SvmDzBHlWNG6c0ye+ihmETkgkheKlvrZb6zfadr/wALDtQBjanMttcwvGGYxkKS3Rs964P40RTQ6THMiLEjyKWG3OT/AEr0K9sppLJSmTMFxkLmo9a0xda8KXNpq4SMtFtEhHKjsaAPlexv8+I00uGYK90drS9g3bHtW/d+CLy0gnZWhuZ87Qq89R39DXJeILaTw/Lc2IgBkBwk5HJx3z2qz4V8UXawNBc3QWMkbmPBP1NAEekaBNpt7M0pcOnaM/NH+VReJ4msrs3Gls88KoDIZeSrdzXXeHWe4kvYDApXaZPlPLemfWudlnfRpJDNAtykqkSJMp+UZxkUAcbBqZBcXEayIwwQBiut0F9Elsbu/N3PZ3FlAZEgiba0zk4AH4GuU14p9rVY1RVC8bRjg81BaSpCmTzIW4x6e9AG7Y+JWt1dITNbwNwUD7wx9a6az12OEQmOxju4mIy0vBz7D0rjbnTzPEtzE6x8DKE4/KmW15J9llVThlPyhj3oA910K5W8RZtJuo0n2jzLctzBnj8R710sL38Q2tI0qnh84+n5V4N4QubxNVS9hjmWaLDfIDgkdvSvoHwvqyeJLcfaIkhvkXdLCP4/9of4UAdF4Tt2tptigeS65xnofStLUVI3DK46gUuhqiTELnAGADzS6puBYMBn2oA5ucNuPzHnnOTxRVi52q2R27GigDwxAEst/JYNgY9aq2xe2825l/gXK7u5roSFXSNuwHI3cCue1tsQRxYG4jLf4UAYEmZ52/5aOxyfc1QvYbhmCeYAq9RnAz61PcCR2byVO0DBZDUVwqeUscgJKY3HPNAEG2QwtIT5jrxknqKpNCgn83dmMjr/APXrV0yyee5H74pAT+8ZgQFX61Le29nbl10V0vYgxDM3ADUAZNvFJJOWCsICMBjnrW1pFmlnfW96b0fIw22275yf881Qv7PXILaGd7VoopQdrqc5A/lWZY4aeOUsPPRgcs3JOaAPqPRvEOs3Ok2cjSmaMjaysc49j+FYWreHfCfiLxLJb6466ffGJWWQHZub29feu28CaR/Znh2FpYN8zxCRZRyBkZrxL4y6BqEWqwajNKwEilQTn8DQB71pen6J8MfCaJaSJK8rgKyqMySNVC3fUNUt7mTVJWWeVvlX+GJe2D3r5p8N+Ir92bTb+7ku7RRvXc5fy8d1r2PQ/ETXzQWtvcCeJkG5nbBUDsPegDpdT0B4zbXCSkxrkllO07TU3h/BuzGhVRkrgjBIB9a6OKwee0jDNuQDgdsfWo7SztLO6EkxGRk56YoA0LBgGMaqWUHvnitlFO4kHkc1iHULd2DWvI9faqs19OJ9wYhQeQeBQBsTorFvXPOaq/Kj/dyPc9KhvLmWMB1UMrDjFZsl/KrARgBj94Y4oA3w67cAcjmpI2G05YZ+lZdnNK5G4At0xjFXM4JGD9aALIl5yRSq55yBUCbgAVxj69KVSd5zyOnFAFxXyOvTrT+N2RiqoJxjPapC5HTOfpxQBZVVAxjnNIGBY4BGB2pisxPo1KpAbJzg+nagBzuODnOMDio94weO3cVHK/70AL8vv0oRHabrhaAMq8tQ16kr4Cjvirun3wMbqobCk9aXUkOxjtyQOvpWbazywSokgGG6cUAa1vfEPlgNnPOfesPxks8sglhdwHjKuiHr6GtCI+YWBAz9MU8xlJB8yupHTvQB87+Kry2u7sWt2i+ZOSpDqAQRxgGuB8Q6K2nRJFbxtKjNkhh8270r6H+Mvg038dlf6bpqPsbNwUADAevvXEWMem2mqeVOBcRSEGSSVSTEcdvYdDQBx/witIrvVpJtXuHjit4y+wKeRnBBP9K1/E0Ft4gW4uNOeN4CCCp48vHYevSutjXRb3TtTj0qBUdYXR5IhtZPQ57+lc34A+G+vX9sk9kvm2fmlWSRsEccMPWgDyO3ja3v5bW4gWcqcAuM7R7Vs2vhyDU5z/ZKuGSMsySsAQVGWI9a9I+IXgl7TVItO0zTbs6lJjZckBUZvQnp17V55FoGtaVeNc3iTQSQk+ap9RwR9KAMW5mu/tBt4QwWP7pI5PrmtbSrRb5VmvrXyo92WlY43GpbfxM1nclvs0M0hzjK9CaZqlxf6jFGNwVWbcAgwMfSgDrote0W/sTZwLewSHiVYECo79Bz9K6nwpdDQpFlMjGQHDBuo9q8xXT7xGS6lB8ubABTgEgfzrsdHDLbKz5JYgYbqaAPf9LuVukjuoGBicYIHY1Z1EfuyxJOfauZ8AyP9i8kgKXO4EdM10VwGeOQMee3tQBh3Z3NgDIxg8UVNOCE5xnsc0UAeORPmIKcADgcVyWqJJc6i3mMQu7GB6Cujs5RskdRyqHr3rnL2JiWmIbL8cDNAGZqMkkZKWiiJcBSAcFveprCO1UTzamoZIwCWzg//XpsVoWmBuGMaL1ZuaZ4i1C0vbJLSCOMFuRJHySB60AUte8TxapcNBp9n9ksSmwRIeSQPvE1iC7ZbNIYkUMRwvX8ai/cWdxuR2lZTx2H41ZlFvc2jvahkcEYU9R7CgCWfX7uXShp8zABQArDgqM9PxrIt2kjnVowS+cgYzmpWs50KeerJuO0DHNdd4ZuhYTRxxWbTzdTuXIQDvmgD62+DeonVfBVkmrR7LtECsu3AIxwfyrD+NOmRSaFcrb7UYLn7menbPbivPfCXxLj0O5aPU3iEb4xGnVfrXe32tDxUUg0oPdWkqks0Y3GPjofSgD5GjE1nqEjSAwE59gR6V3Hwpk3eKoUt4ZBBLgNuOduOprofi74et20uD7HEIb20JEkZOWJPb2qb4B6c97eSCdXSK1TkEcsx9/pQB9Bfa1tofKBHAAC1nasqzQHfg5GGx/SpZLIwT+YSrZXCluq49KhQ7HEbrwV6k96AM60lEI8sqQM8e4rQYM7jHAbkfSnTW8ciAgdO1TJGoCnfuYcDFAEkqmWw+VhvTjrzVC2gw4eRgCOxrStUCs4ZTknqB6VWWEs75AI55zQA6CQJIXj4QHHPUitVWR1yO9ZDqAo9c1ctnPlnnBxigC78oGVOMVGG5OTwaacE9ucZqMAbzuzzQBcRlyB3HoM1IDnnkg9jVfrg8Y6U/OBjJz70AWOQx2nI9cdKez4HTjH4GoouRzg0sjZPagBQEKjIp8eMDgc+vOKgRjnnPTpU8bAYwcD0NAFe6I8wZ7jODTZYo3j4HI6EHmppjGzYwDjnmqxfaxUY57YoAhnjJZSijd3561SmeZtSjCJuTvz0rXwCq8kduRWZcmeF7iZArKi5Gc5NAG5byiYBMBgBjaT1ryTxt4Suxrwls4d+nXExkfA5jJ4Ofauv0jVLi5lM0cIUoOAW6mrWo+KLe3vY7C4aNZ5/wCDeMj3oA8/tJNL8FaZqMeorG+45ygG8L2G2s1vi7a6V9nj8N3ISzTc00UseN5/9lpvxC8P3cMur3IhaaK6+dXX/lnj2ryLWdGku7YmyikMm3cQqZ3ADqPagD1LxR8arTWYkeOyXeqfKshDDP8AeyOhrn9H1+88VxNZar5U0RX9ySAg3E4C5/xry/StLuXciaGSNYz97b09qs2s6afv8ycnDcQqSM+/1oA7bWvDEWhPPHql1BFdbwiwcMTxnPHasmG1uGjEcBaQA5JRckU+w8U6Jexxw6vZNMV+75pJKn1B61u6ZqNtpbQta2n7yRt8LMeg9/X6UAVNGuZp5re18ovCzbY0zyD6+xruh4eOiWRvhKkruQDAp3bKZpd4LFTdXWlRsDlUeJeRnqfrV3TGS5SVDOo3NuETHnHrntQB0vh7Uw7xMjMRxkV3EoVhvXlXG7IrgrCwjtUV7NhKCcuQcDPtXW6cxexBYnKHjnrQBW1HKqCPl/8Ar0UzUQcdSBnjiigDwm3H+hTbSQCKp+aUHAI3gBd3OKt2cmNMlJKnPFU7SVXaR3O4JHgZ9aAMLxH5sAMUUmBIPnUDt6VzmmFbObzFhMkrHaAOwPtXQzOLy9kZwVB4Kg4zXReGNMsZdO1C/a1bbb4GByxJoA89vdAvtwnMSoJjlF9a0F8P6xaaE109sxjlbyo2UDqev5VZ1Jp5LjzheuIVOVjA2kYpH8R6haQpD9rnNtgsN5B3DvQBiyo1vdQW8i4kT78m4scntXUwW11pdghjLm4lbnP93/Gr/hGDR9cuBNevJC8LZJwBnPcH6179Fp2j6NpEN5dpC6RRkMDjJHXOTQBxnhT4YaVDaWWr+IrR7mW4ZWjU554zjH+Nen+FvEmhaLcNp9lYQ2sBcjcmAAf8a878VfGbTR4Vmj8LoZrmI7cnGI19vXjNfO+o+KNWk1A3CXsqBm8xVVumT0NAH1x4s8L2XinVBLbzCKbzAW4zvFamgaJYaFNL9ktgr8AvjFeAfC34p3eka+thrjyS287KInJB2MfX2r6nVBcWgnwGLDII7igDjtXeVtRAJICkcCrEixyvGMDB7ipdTt2S6E5PG3GM96oxN+7yAQc7eDQBMsilvLX17j+tSPEwHynaD2qrZqwiZio68cVpBQVGeooAjIYL8p7jB9aWWLy2LEDnuTUyDPb5veklTem0r0HagCo0bnDdeeuKkXdkgdPp0qdfuhTnpn6UqocHf36YoARVJTGc9qFQ8DpT2yiYGcmnRg7tx60APGGUcHPoe1LsKgEZwBxmlONuB1NI+Qcg4Ht0oAdECwJJ6+lLIMHGT+NJCTgHquetK5LFc9BQA2LIOM/U4qZZOvPT9KjXIPT609GDFuvSgBkoBcY71C6MvOcn+lWONpIB/KjPynCgnvxQA2FGY7d2fXJp8sG4AA5JHOKCuNrZxz09RTnUuDjGOmAaAMOfSSkcv2WQITz16GuG17wj/adwl6JGF9EwzIynkfh15r0O9jeIEqTtI6LWLNfLZxA3Slo2G1tvGPqKANmxink0eOaZ0N0qBWyn3sDriuV1a0Oj2Et9p+ni5vZZdrmJT8qH0ArMm8QQ2WqsHvJF04qPNhc8Kc9Qew6VqrpF7aXC6p4d1MzQTkSPFO2+Mj65oA8a8R6tLc3EqwW0UMW7BRRgt2xXnl9axXE8yeRtfJO6vpS6stHOsO+pW9nAZELSFCCGJ/iI7VnaX4O8NSXStAsc0+flWSXIP4DtQB80w6ZKkZnljZ41zlU6n/61brrc2+kQSXU5jVDmIsfmA9MV3njbwf4itLi4uLSzhtrJn/eCH5vkPfvxXmt1aTQNE93BOFz0YHJXPGBQB2/gnxzc2Tvb6hKlzby4UK6jKH+9n+lelaNFZXkButJCyTNy8bDlfUivn0Wc0U+xFLCU5UY6CvSvAl1deZFHnYm77/TAH86APZtFt9oAI4I3GtuzjIWWIHqNynrxVbT0SezSa3cYYAH6+taMDMzElslRtoAzb3hCD1HaimajuEjKSceoooA8Bl2x6bGmcMecYqndSmCyVIEzNKc/hV2+RmjEYJznb9Kw9auDHIHj5dRsX2A70AULy5OnoTEsbOBySM4PvVXTNW1OBJQl3MvnDeUU4GPeo32TBpZF3sOvYE+9Vf3km5VDLz0BwMUAXZgsk0kc9ysZkHDsf0zTIrXT0jUzSMZcZVQNwb61kzNHbSN5m6UkDaD2PrT9LlL3gm8tXdeu/O0+2KAPRfBMVpeaxZwlo4o0O7EYzlV5wa2vjN4tivIV8O2U2Y8AyNnGTjjPtWd4OvNNj1JwYFglMO4hTkA/0rivGslndeIJFTfC3QEdD7mgDmQ89jO6qSj9D71JZW76hebcEluWIGK3o/CGuXiR/wCiSOGUusgGRtFX9B8LyQ3j29+3k+bGSsuD8px+VAHKgixukly/mxvlRnPSvuvwFrh1LwvpUrqB5sCE47EivjOHSbCK4a2EiTTZ5YnJznpX1F8HdRt7rQ4baJ0H2bEZAOMccUAdrrEatG2ACRk8isC4DoAqqSg6nsK6a9KsWCjcQMY61yN5M0d1JE2TCecetAGjaOpthjnP6VcjCeX1HHOap2rKsCYXHt6VaBBx/CB6jrQBMCME7QR19qhWTBKcZ5qTcAMAZPXFNUKx3HlqABgRjHX1xSxt1BIPaneYuAM89OKTcEySBx6UADZf04pU3LzjjtSLKM5zwPXpSvIOx9qACR8jcBj04pd4AB2im7l5JGRio2lAJJA2n3oAmWQ5PoD2qUsCAetV0lC4YZ/PtSvMecDIoAkDbs9vfFG4DJz1/Ckjk4Oeg9O1RGUFscfQUAWF4JJI7/SjJD9cjrTFbKjnP0qKRwDwD9cUAWNzLnBGPXvSDdE24Hg+9IvzLyQQefrSSAheR82OlAEjsJ4yR0461l6nppu4G2qGVuCTVm3cMkmD83PGcUy31eGJlSQ7ZDnhqAPM/HnhS4uNL8uwtH81VxwMhs+lbnwm0a+u/Dgsr2UQvECqITyw+ldxNcx3VuQeTkrkVyOs6FqNs6XWjXYgaJvM2sOpoA5D4g+FItCu43eX742BwDgetc/Y6VaQrKbS4JuAd5JkKlR6j1r2rU9Mj8Y6CkGoAx3Cgb27lvavPNS+Heoabpmpu+LyNFWS02MVkicHr7jHagDkZfFmqafbPY3ty76bKxKzFfnQ5/iHXFc5ql3/AGqz3CxiVwdg8vkdOvt61vaBILq7e1160eU4KiSRdrbu2aq+JPDMlrbyDSl2zH95L5ZwqDsCO596AMV0jW3FvNJiQEbCFyBnsx7VY0+wnW5VVkZIk5xG2R9c1zDwPbnddmRyOuxuGzXVeFr6SQt9jj2LsxMG6bfegD2vwZeww2kSTzArs2sO/Xg11yKFlP7zKkcHAwfevLrLy5I4BAhiJAzjgV6Fo9wJbEx7wXi4+oFADtSjTO7JyT070U2/GUBxntxRQB4Fj92ZTjCKcEjv2rzvVb2Sa4K46kgYrutQfydFkJ4Z2/MCuClQB3k654GeKAERHZQGHA44PX8Ky726l8wqGKrjhfSthWWBDJL/AKlRz61kXkDTSmSAFlIBC45ANAFMB5W4DM3510Hh7bCJsujEjaR3PuPpWRHbXEcbuEkBxt4HvXVeEfD8k8z3F0/2W0iGQ7j5m9cCgDf+G3hm51bxPIpUvFKGIY9OBSeN/BU9t40uf3JFnGiux28Lx3rpvD/jC28N6hHdaYGkSEEMHH+tHcD+7x3qp8Wtcn8Z6Kus6VFKkBIimiTj8T60AY1h41utGnW20y6EwyFKP8wQY6CuU1DxFqeqass90WlVWyUHChc9BjtVLTLWO2huL67+RY/kjBb7zkdh3xWZFdmEny0HI5J6k+tAHSXulTXMxuNJtppllOZFhXds7n6Aetei/BHxIuha1/ZV3E6G6YFd3UH1rz3wZr99o1hqQ02V4ZpwoWTdgkg5IPsa6jSNdklvBql7bouowyJIMJgtg84oA+rMYU787mGay7+3EcYmCg7Dnk0ug6/aazpUc4kUXLKCwxjBq9cHdbgPyCMfWgDPQ7iHPGanLkKMAevNQj5cRZK7enuKsqVAwTuHcmgCNnLMu1cjr74qdAACSBnuO9MPJIAxj3qSMBuTg0AMVCrcDvSklic7celTvgKMD2qEoN+AP0oAicHPC96jMb4wXBA6CrWw4z6elIcZ45oAgKyEMGxyOPY0jIe+B296tAnacAAnr3qNi3OOO9AESIwJPamy7gPlJJ6+tWFGVJY/Wo5DyckDb+tACBiI8g8kfSo4SzS4IJ6ck08rvYBWb8e9NgyZ8L936UATSbuACABTGk4AB96ddAiNiMt7VVX7itsOc8UAWoHbA4yM1PI2CRk8iktxuiDFsN6U9gDj0BoAjXZHGV2gE1lXlpE7mR1yW49xWpcRjZnaT3JzVZkJlUMc8fNjtQBj30FxZRr9ib5G/wBr7oxXMPrWpWWpob27D2p+Vg/YdjivRVsTJIJQCeoyPSsrV/DEeoSkzRqGyBk+lAFfTfGNrDdxW/lqqSciQn71dHNqTPbkIvnRsOSB+NcJqnhCX7REhw4h+WNgf4fQ4/nW+tpf2OmB490nlDPkg5ZvagDF1L95qSC20gyyPyZlPyke47VnyeDrjUr1pZDJb5XOUbg8dMVc1vWL6MwyWwMN0q5eFkxuB7U7S5b7VYVa8X7KMHZJHIQT7EetAHnXinwbqVnD5ssEV1C//LGM5ZPc+1Y2naS+mWqtDIqKzYcqdx+n0HrXr+i2jzLOt3dPNEH27mbOB79zSf8ACG6TbNK2nzqXcE7CwO72AoA5RdYtnsBa2Y/0mPDE+n0rpPC+oqZoi5wXXBrn7vS5dOkdILWNUJy3GSR7GnaVfRPdhA6oi8KhHP50AeiXxHlttGAvv1oqu90rWitkHI7e1FAHz9ra50uFAB0zyK5qa3iESu6fu0GP9411OoEPDACeFjycVy97ciOKWQEhz8qZ9aAOc1m+YkW8WFQcsuM81TgnCTxsA7OeGw3X6VBKpecqMs5OD7mrokjsWQJHvmI+bPb6UAdbpNzbWU9uDCZXk+ZVbkA+5qXW9em+0LHEFjy2GAXnPp7VT0aCUwC6kQjBwB1x/wDqp9hpQmuWnuXDLKScHqB60AZWrPdQzMoaZt67gAfl59a1vDseowgxXU+20ljz5W7GCemBW3fabALG3aFHBGQoYZyPU1L4e8N6lrN1GICx2HLHsB/hQBwniD7fbuls8cqxIp2nHByeSKxIUe4nWPkuxx05r2278H6nqcpMjKJUO0ktxj6VFL4IvLZZEFvCkxX5JHUfOfTPagDyq58xD9ntYcmMbmYc49a0brX59St7aDKRNarwydX9ST611yeC9WvrSeA2my6BwoGFJUdj65rmL3whqulzOJbG5UvlQmw8UAej/AzxTI91JZT7nV34L8nJr6HjVvJUkEjHFfJvwu0nUrDxJZSXNvNFAZRnflR1xX17CipbqGycD5TQBmzwscvweOmP1qFA3LE/KR0Hb6VoOSY8cZH61UEgjZ0PAPHB4oAWNGZiytu49atLH8oJwTVePb5gxuJ98CrG5tp5ABoAe4YY7+1MVCTx25pZNyjqM1HAzF9ucY9qAJvJdVycUyRWBxx6mrQEoYb8HuMGoCDu6Z70ARhSqZIAJOeKaQwfoMHtmpizBeFH1JqMFwV447cUACx/LyRjOMYqOWM5GMZFWVYkZ2cj86hlbLEsDnrjFAEG1woC4P4dqkhR1bcyAE8Uv8Hygj6daVGPfg980AG7J2HIbtUMkYGd3Xrz0FTRyYJydvYEUkihw2TkHkn1oAjt1O4qpyewq38+DkYx61HCNhU9ccVNI5HI5B7elAEflZGMsQOvNRsBHxwvPX1qUuVPQYpkoM2N/ODwPWgC1ZTA5UdOhx61JJIdxBx/9eqsAWMbR8uCTnpUhbq2cigCld/vHG47MHGR3p9qkkcLBpS3XGOaR05Z0JyeozUBMwYgghT1x0FAEMs0MsoS8ty5QcMwFYmq6PbX80EtjfyWskZJWLd8jfhWxdTbXKvgqRyGFY2p6TCcvbvuZTuxuoA43xdDrnhq9N7aFmtCi+Yo5Uk+nrXC6h4hluLgX1sjw3ERw4UEAA+9ep32qXNvDHFcBbiADY8DDg571z2p+FItTbz9KkEe4EyWjcEe49qAKnhrxZeaijWpMUpweTz0rj9RvJjfrcxOUiZiNqtwDmtrQ9Bk07WmESFFwQzL6HvU0Pha5t7y7s52i8qV9ySEjr1oA73wPcG+0JwwBeNs/WimfDuCS1ivYJQvQZ5ooA8fv5/LtQw++QFHtXD+IJH+0rGucquQB6mu1uri3e1ht3MaSlN+9vSvP7qUxNNJI4kd3O36UAJB5dnAH2K8uO/b6Vc06CG5kMs8Ze4I+QDgY96q6TCJmXzBvPUZrptGsne63v8AcXrigDobFF03w9BHOhdpSXx6c8Vc0yykaWPyI/lIOQq5yD1q5PYwT6ZDDG4kCHc2zkj2rovDmkSQW42grlgN3fFAFu102yiW1MySGYHcVzkAfSuq0mA2sLLZW6qjckkYYmrmh2FpByVLtnduauljMfkn5AxPbHIoA5ldMa4yWCrIQVJC81bs9BiKrvjZwWyVk5AIroo/LU4AwWGDjrVyAxRjjHPJHrQBjR6RBGMiHaOuB0pk+mxt80fA/wBpQc10YeJyMqCaDHERnHftQByq6Wnm75MO3YFRxXQxSA2q5A6YwabMkRbKjpnOKbBKASpXnGOaAIpYtxHyjP06VRurYb/MCjcRg1sOyg4xjjoeKhlCbcYOSM89qAMqNFAHJDAcgVMrgjBzzyOKQxYYdKXKgEnHAxQA53GBgg4FMiYDjsT+FQPj5SCCPSnJIDtA2+nFAGgSDycjHAxSZU43HA/lT4YwyZJ+UfqKlCqxYKB6UAVTJjgDr2oByOAc+1XVUFTu6d+OgqIqF3EHkd/SgCKMMTyQeOKWSE7QePx7UqrjvipJAAmBkg0AQoA7jB6cU10AkI4x+dTRoAuBxjnNQsoDeo+vWgCKTHy7V5z1NJHhQTgYHpUwhHcHmo2j2gqDwPagBQwBxkcijIweSQetIka4GcdeDRJwPloAiMZ5GSM9gacpAOCTke9P4OWPb2ppVTgg9OtADmbLBmOfUAU9mCxjZ175qMkEgEnFSko+ckc+1AFKUkzHoM9xQCwXAY560ky/Mcnjpx1pcqSQM8dM9KAGT4kBIC4xz/jVD7Ozh8fQdsVojAQK2CCKb5eMYGVPdqAOU1CECQRXEalXOBJjn6E1z9601ldlULR5Hyyj+H2rvL23JGB25xjqK5++iEnyuuR79vpQByQnmh1HzQhUtkSID8v+8v8AhVm7tJ1FrOJGngkBY8Z4HrjvRqELQXDRMN8Dep+7UukzNZs1s+4wt/q3/ut/gaAOl8JRoWL9GZNnXn8aKn8NsRJtkx85BDBaKAPlXxBcs0ZYcBVCA9/89a5oFimwZK5zj3rc1sr/AGfGT99n4H0FR+HrcSibzGREI4Zu1AGr4Qt13hph8oGQSOvtXVJEXcJHHgHoB/OqNiix29skBWQscEkdPpXaaFYK2CwO885z/KgDY8KWCWqM8o3My8jr+NdnaRKiKUXORwT2rGtoBCg2c7e4rfssMgBBDYH/AOqgC/ZFUIOcnuPWtiGXawAXIIwSD1rPjhCqqgZbjHrVuBNpJOenp0oA0I2VsHbyOvPAqwrYOeMY6+lVIl46jAFKW+UAtg/zoAmFxiTAznH1p6XDbTnGD75qhGBk9RjoQKkk2iNiO3HIoAttKJF3BsdSRULELjnNQIMYIbnoQKkQDo+aALHmrIu1mIIofauMk5/mKiMYDA/dz3NPZWKjkfWgCKTDqcMee2KqSFSm0v7E9DVsHHU5yePpTJLfcMnoO3rQBmXcmQWxuyOKltwFUsDzjP8AjVl7RWUHBOe1Si0CKBwFOBQA+CQup6Ae/etCMqqnkdaqmJlC4X3/APr1ZEe7BX8iKAFRhlhj8qjnKZx29aniiDcDgDgkUvkKx5+Zv0oAqRqCwHHHPWlnK7MYwc1aEQx90Y9qheAyEkY55GO1AFdW65OW9KHGCNwGad5QJ9Djr3qWNA2Aenr1oAYSoHTGRUcnl5zn8u9Tz24Ge5/lVfyj9APWgBiMgbhcqeaWRFJHI6Y9KlaAqhbg4GMjjiomi5OeR0oArSKFiYkn8Ki5G4E/mOtW5EBHHNQyJlcD73agCLcm9VBUAfpU2VUDjDHv6UhiAI57U0oG4bO4dMe9AEM0noAM96ajP14Izxg9qlMXyghsgcZqRIhnjqOfTFADQCWA3DipCcDHG0cY61GwOVAJz3p5ClSFHPXIoAguYw/Q4GM1zeoxFS2CD39K6h4t0bcnJ9TWTd23mZAJB75PSgDmrm2FzBlvmYc8euaprZLPbtA42svIbOOTW79nZZck45x61BeW/wA7MCfn9PWgCbQmxHA8mN6AocHriip9NtlClV4HUAnoaKAPkjXY8WtqMdWIpbC2aGMcHLdiK6K7so5LC3mZd/B2j3q5o2kPIyzSA4jG48dT2oA29B0hIYYSR1QMSfeu50m1WOMZz06Y6VQ0aAlUVgCVUdhiuo0+02vhjg54z0oAmt4QrZIIzxgitm1VkbAwSfQVX+zeY2Qpxke2av2tuI1Xk7vftQBdtxggLn8ulWSSqZJJyO9QWyMRn1qw2QuAMn3oAlt5Agwc4/OpCVx357iqsYbaAFHXqRmp1U5PBI7Z9KAFGQQBgLT22+UAf/1GkeM4IYHrTQkhAI49qAHxxEr0yd3ap0iK53EAk9BzT4lxHwDkdsdaUc5Ix9c9qAGff4GevOaWQg/dHAHf1pVVmJB9Tz2qZoCWXHI75oAqKMrxyfrQHO4MQcehq8LfCMCBzUS25Az07HP6UAMTH8Kknvj0qQAEtwSMcgilCugVY1x261NFuO3PQjvQBE5IbcOg9u1JExJGBye9WwHYcjHNKsWX6ZB9BxQBGGKKdo4zSNIq9M88cVYeLbu3AEH8qz9pD5UEDGAKAJ1fH3evc1GznJG31yKkQFg3QdjkUCMZyw29TjHpQBWOW5PCjpz2qSEkfMACM4/CrgTI9BQ0YD8Ec0AQyREpuyCG5NVpB14yD8vTmrsyhUzGevrVV8qpZxx2xQAiEbMEYIz9OtQuOuT19DTjI21g4x/hTZGG4Zz7mgCPBPA49RVeXJY4OOccVaUblyBwBx9ajIwSTgAe1ADFU4znk0KhP3u3filV0boeP51KQMYTGcZ6UAVnQLz27CmFz8qqrcjOasNGSBknI6VCqhWAXP0oAZ5fzNnJqNztYY59an554NRNyAOtACeackHgY784qqwzggA4pZDhivQVEr7uGyABxk0AMuUUDjk47VQnRSq5OSOcCtMKxZSRkk45qhdx+S54wME8UAGmtunGAOOuaKjsSylmyCCPXpRQB8+i3d9AsI0+/wAkn2JrutH00wW1tC65JUs317VkeHrRpU0+HG5VYAnHHSu+sbVjqGW+6SVU9Me2KAI9P0po+RkN6kda6C1syTljyPWr1pEmw5XJAq3ZQ55UdM5GKAIbeJlB+Xj1696tQxHkkZI4HXiplQngA9MAjvVhFbAwvI9KACCNsZI5pZFJJGOO1WIkdV7UqofNIP3ccCgCMRYQdM/pShTvXH8qt+WSuMYHrTkhbnAGaAIfLLHLDkcdKUI54AGT69qtwsejDrSxqS/IORx24oAhRCowVOPr0p0ELliWHTt71aEbq3zDK5qxjjIGMdqAKiwlDkA4PFPSEtnIIFWRknGM8/5NSOCOOKAKvlcAqSDjrSJDkMW6dqs4fABU4HfNPCEY3ADjigCsbbKg8gcdaQR7T8oPtxWhsYgkKck5FCxMM8Y7jjpQBUCex3GpUhbIwoOPepo4XE25uM5GanKFT25469KAKckJHB5x0qm1uQSWznPY9K22gLgMByD0qvJbsXYKOnf+VAFGC03fwnnn8fShrbDc9B+dakEJTaCenPI7014QZSRigDLkiIwc8HoKPKIUk446Z/lWkbfIB2n0A96ZJBgnGWBPI9KAMyRCxDAe+KhmtwVORV942JwAfUn0pHgbbgDLH8vpQBlNbsQQAMelNktzgDPBPStCKFhkk454FRvGxJ4JA7UAURCyjjt7g1DPGwOD+grXSE7cgDB4HFMktySdyk985x+FAGYkHIwBz05qcRbQScFuo9qsi0KgDGR9OaesJyQw46YoAzpo9wyp28VBHESc4bjitSSBicBOBznPSm+Syg8ZPrQBmMjEsNox/KmGPcnPBq/NFIrHK9eaiiiYhhjp9aAMua3LuWwOewqtLA6ODjHrz0reeM5bIHI4HpVR0bqRk9M0AUliUIqgE4qjf25fJVc7fwrbRMMQy8/SoLmH5SBjnuaAMW2g/dg4y3qPWitIRsmAB0HeigDx/wACgF1yBwwx+Vdpp4G+M4Gct/OiigDqLIZQZ54q/agGLJAzRRQBIeM49v5U9xjpxxRRQBdhA3nilA/eUUUAXCAEkAHA/wAKd2/CiigBo+8P89qltwB0FFFAEkZ/nT1/1cn40UUATWfMJPf/AOvUoAIGQD1oooAcwGV4/wA4p+B5acDluaKKAJAAHbAxwKkUAYwMc/0oooACADwAKfgZxgYoooAsIBgDHHPFV3AD8ADn+lFFAD1/1DnuM0T8RnHHyj+dFFACNwSBwKjcDPTvRRQBWf771Gw5oooAGAKjIH3jUAA3ngdTRRQARgE9B2p7Abz9aKKAGJ94VGP9YP8APeiigB8ygA4AHFVv+Wv4f0oooAbJ9wnvmooANv8AwI/zoooAjuOh+lU5gPLYY4oooArw8qpPXbS3H8FFFAFOf7q/SiiigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An angiogram (venous phase) demonstrates the aberrant right pulmonary vein draining part of the right lung to the inferior vena cava.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11777=[""].join("\n");
var outline_f11_32_11777=null;
var title_f11_32_11778="Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)";
var content_f11_32_11778=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?3/42/3746\">",
"         Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?33/8/33922\">",
"         Patient information: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/53/35668\">",
"         Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Attention deficit hyperactivity disorder (ADHD) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/attention-deficit-hyperactivity-disorder-adhd-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H383884812\">",
"      <span class=\"h1\">",
"       What is ADHD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;ADHD is a condition that can make it hard to sit still, pay attention, or make good decisions. ADHD often begins in childhood. ADHD can cause a child to have trouble in school, at home, or with friends. ADHD is more common in boys than girls. ADHD stands for &ldquo;attention deficit hyperactivity disorder.&rdquo; Some people call it just ADD (attention deficit disorder).",
"     </p>",
"     <p>",
"      There is no cure for ADHD, but different treatments can help improve a child&rsquo;s symptoms and behavior.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884819\">",
"      <span class=\"h1\">",
"       What are the symptoms of ADHD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children with ADHD have one or more of the following symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Increased activity, also called &ldquo;hyperactivity&rdquo; &ndash; A child might have trouble sitting still or playing quietly.",
"       </li>",
"       <li>",
"        Poor decision-making &ndash; A child might interrupt others or do things without thinking them through.",
"       </li>",
"       <li>",
"        Trouble paying attention &ndash; A child might be forgetful, lose things, or have trouble finishing a project.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms often begin by the time a child is 4 years old and can change over time. Children sometimes continue to have symptoms as teenagers or adults.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884826\">",
"      <span class=\"h1\">",
"       Is there a test for ADHD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. There is no test. If you suspect your child has ADHD, talk to your doctor or nurse. He or she will ask about your child&rsquo;s symptoms and behavior at home and at school. To find out about your child&rsquo;s behavior at school, you will need to ask his or her teacher.",
"     </p>",
"     <p>",
"      A doctor can make a diagnosis of ADHD only if a child&rsquo;s symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Are seen in more than one place, for example, at home and in school",
"       </li>",
"       <li>",
"        Last at least 6 months",
"       </li>",
"       <li>",
"        Start before age 7",
"       </li>",
"       <li>",
"        Affect his or her friendships or school work",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other conditions can cause symptoms similar to ADHD. For example, children who have trouble learning to read can also have a tough time in school. Your doctor or nurse will try to figure out what is causing your child&rsquo;s symptoms. But this might involve a few visits to the doctor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884833\">",
"      <span class=\"h1\">",
"       Is ADHD a condition that needs to be treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most doctors recommend that ADHD be treated. Children with untreated ADHD are more likely than children whose ADHD is treated to have a hard time in school, become depressed, or abuse alcohol or drugs when they get older.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884840\">",
"      <span class=\"h1\">",
"       How is ADHD treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;ADHD can be treated in different ways. Treatment can improve symptoms and help children do better at school, at home, and with friends. Children with ADHD might have one or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Medicines",
"        </strong>",
"        &ndash; Doctors can prescribe different medicines to help children pay attention and concentrate better. ADHD medicines are often very effective at improving the condition, but they can cause side effects. Tell your doctor if your child has any problems while taking ADHD medicine. Some children need to try more than one medicine to find the one that is right for them.",
"       </li>",
"       <li>",
"        <strong>",
"         Behavior treatment",
"        </strong>",
"        &ndash; You might find that you can improve your child&rsquo;s behavior by making changes at home. For instance, you can make a checklist for your child to use every morning so that he or she remembers what to do. Or you can have your child keep homework in the same place so he or she doesn&rsquo;t lose it.",
"       </li>",
"       <li>",
"        <strong>",
"         Changes at school",
"        </strong>",
"        &ndash; Teachers can make changes in the classroom to help children with ADHD do better in school. For example, a teacher might write down what the homework is every day so the child does not forget. Or a teacher might allow a child to have extra time to finish school work. Parents should work with the teacher and school to create a &ldquo;school plan&rdquo; that is right for their child. Keep in mind that a school plan might need to change over time as a child gets older or if symptoms change.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You may hear or read about treatments for ADHD that include things like special vitamins or diets. Experts do not know if these help improve symptoms. Check with your doctor before trying any of these treatments.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884847\">",
"      <span class=\"h1\">",
"       Can adults be diagnosed with ADHD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. ADHD can run in families. Some adults figure out that they have ADHD only after their child is diagnosed with it. For example, a man might see that he has the same symptoms as his son. ADHD can also cause adults to have trouble at work or with relationships.",
"     </p>",
"     <p>",
"      If you are an adult and suspect that you have ADHD, talk with your doctor or nurse about treatment. Some people also find it helpful to talk to a counselor or go to a self-help group to learn ways to manage symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H383884854\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/42/3746?source=see_link\">",
"       Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?33/8/33922?source=see_link\">",
"       Patient information: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/53/35668?source=see_link\">",
"       Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/32/11778?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15361 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-197.136.42.3-E93FDBD5C8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11778=[""].join("\n");
var outline_f11_32_11778=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884812\">",
"      What is ADHD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884819\">",
"      What are the symptoms of ADHD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884826\">",
"      Is there a test for ADHD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884833\">",
"      Is ADHD a condition that needs to be treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884840\">",
"      How is ADHD treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884847\">",
"      Can adults be diagnosed with ADHD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H383884854\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/42/3746?source=related_link\">",
"      Patient information: Medicines for attention deficit hyperactivity disorder (ADHD) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/8/33922?source=related_link\">",
"      Patient information: Symptoms and diagnosis of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/53/35668?source=related_link\">",
"      Patient information: Treatment of attention deficit hyperactivity disorder in children (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_32_11779="Log-roll technique";
var content_f11_32_11779=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F60409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F60409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Log-roll procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 415px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGfAhADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACikJA6mm+an98fnRcB9FNDqejD86cDnpQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5T4n+L8Gh/FzTfBzaf5tpM8EF1f+YR9nnmDGKPbjByAp5I4J9K9WrwfWPgNPrdp4ovdQ8QXK+ItV1D7dBLBK6W0QUjylaP+IoC4DdQG49/VtDs/EkOuXE+s6paXGmPawpFbQwbWjnCjzH3YyVJyQO2aAOiooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuX8f63c6RpsEWmtGt/dOVjZxkIqqSWI7jO1f8AgYrqK8q8aX39oeKZwpzDYoLZPTecNIQf++FPvGazqy5YtmtGHPNIs2Wv3OqWUVz5sib8hkz9xgcMp9wQR+FONxMeTK/51zWlyfY9WaIkCC9yQD2mUdB/vKCfbZ710NeTNu+56ail0Jlu50+7K4/GrVvrF5CwPmlh6Gs+ikpyWzBwi90dNaeKUE9tFeR7FmkWHzB0Vm4XP1OF+pFdRXld1AlzbSwS52SKVODg8+h7Gu88Kam2qaNE8zbruEmC44wTIvVsdgwwwHowr0MLWc04y3ODE0lB3jsbFFFFdZzBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc54k16Swv7eytVVpXjaaVj/AucKPqx3Y/3Gro68zvbw6jq+oXeQYzMYIuOQkfy9e4LB2Hs1YYipyQutzahDnnqaLa7ft/y2x9BTk16+U/6wH6isqivM9rPuej7KHY6G38TSqcTRKw9RW3Y6zaXeAJAj+jHFcHT9Nt3v8AXtPtEJVVf7VMw7JGQcfi5QY7gt6V0UcRUclHcwq0Kai5bHpdFFFekeeFFFFAFXVL2LTdNur24z5VvG0rAdSAM4HuegrxmIyOvmXG37RITJKV6GRjuYj6sSa7r4n322zsdMQ/NdS+dJ/1ziIb895j/DNcRXJiZXaid+Eho5EF7Abi3ZFfy5AQ0cgGSjg5VvwIHFbOkXw1CxSYrslBKSx5/wBW44Zfz6HuMHoazaitZzYaorMcWt2Vjf8A2ZeiN/wLhT7hPeuOaujrfc6SiiisACrXh29/szxDEWOLW/xBL6LL/wAs2/HlPUlk9Kq1DdRtLA6RuYpCMpIBkow5Vh7g4I+laUp8klIipDni4nqlFZ3h7Uhq+j215tCSMCsqA52SKSrr74YEZ71o17SdzyNgooooAKKKKACiiigAooooAKKKKACiijI9RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFLVrk2tm7g/MRgV57JplhJK0r2Nq0jHJcwrkn1ziuy8VNiCJR3auYrmqt81jroxXLcrpaCP/U3N/Ev92K9mRfyDAVOkuoxcW+s6hGv90lJf1kVj+tLRUKUl1NHCL6FuHV9WgjIW+Wd/71zCp/RNlOj8Q65H80g0y5/2FjeDP/Atz/yqlQSACSQAOpNP2ku5LpQfQda+J/EUl2YLtNLtpJC5t1SJ5VkxkhN5kU79oJ+5jg+lbdr4hvzEss+lLNGw4NpcBnz7rIEA9xuJFcjrrgaNc3MTAvbIbmNgejx/MPwyOfbNdRZDE14o4UTcDsMopP6kn8axqV6kHdMh0omkviawxiSLUI3H3kNjM2D6ZVSp/Amnr4l0YkCTUIbdjwFucwE/QPjNVaQgEYPIPahY2XVE+xXc6IEMAVIIPIIpa4OdbHTZ0jtrmXSHPzK8H7uFmY4wQR5TOcdCC3pWxb63e2jBNVtvPi6farNCcf70XLD/AICW9SFFdFPFQnvoZyptHSUVBZ3dvewCazniuISSN8ThlyOoyKnrpMwooqjqmqW2movnl3mcHy4Il3SSYx0X05GScAZ5IoAvVS1HVbDTtovruGF3HyRs3zyeyr1Y+wBrAnm1LU8m6mewtj0t7Z/3jD/blHIPsmMc/MwqF1tNKVpo7R8ysPNeCEyOxx959oLN9eTzWMqyWxvGg3q9B+v+L2ttKuZtM068lfbsilnjEMYkYhVBVyH+8R/Dj3rmrSBbW1ht4ySkSBFLHJwBjmp9cv4dSubG0hE4EbG6kEkLx8DKoGDAHljuB9YzSVw4mo5NJnZRpqF2gooorlNwq74I1KztUvb67W7E91JsTZZTOvkoSEwwQg7iWfI7MPSsXU3YwpbxSeVNdOIEfONmeWfP+yoZvwro4tX0Szijto9S06GOJQix/aEG0AYAxmurDe6+YwrLnXLc3/8AhJtKH3p5k/37aVf5rR/wlGi/xajCv+9lf5isNde0dmwuq6eSewuU/wAavwyxzJvhkSRD/ErZFdntn2Of6uu5d/4SjQ/+gpa/990f8JPo5+5erJ/1zRn/AJA1RuLiG2jMlzNHDGOrSMFH5msu/wDEmmWum3F7HcC7hhVmb7IpmxgZwSgOPxxR7Z9g+rruc54k1SHWfEV3dW3meRCq2iF1Zd23LMdrAEHc5U/7gqhUFnHJHbIJyGnbLysP4pGOWP4sSanrknLmk2dtOPJFRCormFLmCSGUZSRSpwcH8DUtRT+c/l29pg3Vw4ihyMgMf4iPRQCx9lNJFvbU0fD9+b6xPmMWngdoJSRjcynG76Hrx647Vp0/XdOGnWthd2pJhsoVtZ9xGWgHR2PcocsSezOeuKZWNWHK9CIO61CiiisyjV8FXLWut3Nmf9ReL56kn7sqgKw/4Eu0gf8ATNj3rua8pu3lgWO7tlLXNpItxGq9WK9VHpuXcv0Y16ja3EV3bQ3Fu4kgmQSRuvRlIyCPwr1MLPmhbsebiYcs79yWiiiuo5wooooAKKKKACiiigCOaaOFC0jBQPWuc1PxZb25ZYBvYU34iW00mgG8tWcPZN5zqv8AHF0cfgPm9SUA7153nPOc5rnrVJQdkdeHoxqK7OgvPFV/Ox2OEHtVH+29Qzn7Q/51m0Vyucn1O1U4rZHYeCtduZ9feyu5C6TW5ePP8LIwyB7kPn/gFd7Xi9hcGy1bTb0MFFvcozsxwqo3yOT7BGY/hXtFdlCXNHU8/Ew5Z6dQooorY5wooooAKKKKACiiigAooooAKKKKACiisXWtXe2R47Mx/aMcGQFlB9wCP50nJR1Y4xcnZEPisHZEe2a5utZNYi1uJbC726bqbf6vzR5kUh/2Gyu7v8p2twTjHNTnwn5gUy6rdo46i3SNVP4OrH9axlByd0dEKigrSMKqt9qVjYAm+vLe3ABb97IF4HU8muui8IaQvM8VxdE/eFxcyOrfVM7Pw24rxT43eJrSO5l8J+HILezsoiG1GS1RY/NftCMcYHVs98D+FhWdSKpx5pMuNRzfLFGd4s+Jcs7tbeGSI4QdrXrpksf+manjHueTzgd685vZZr+TzNQllupC3LTyZP8A302fy6ilj2BflxtA552j8z0H6k/SrNnbz3NysFlDJJcPwIok+Zh7KAW6fTFebKrKTO2MEjb+GPh2HV/FBtXuJLWNreU7rTaCcrtwcrgjDHtX0DFd6jDPPEyW+oCHHmG3BhkUkZC7WJVmxgn514I45GeF+EOiy2F7PPqGjXtnd+UVSeV3KMpIyNrchuBz9eldt4Jgnj8PQzXqgXt2z3U5xyWdiRn6LtXHYADtXRThzQ94ymk3oWR4g0oD99fQWz947lvJcfVWwad/wkGjf9BfT/8AwJT/ABp2m3Ml1d6hJuzaxyiCL0JUfOQf94lfqhqW01KwvZHitLy1uJEHzJFKrlR05ANHsEZ8nmWWEc8JVgkkUi4IOCrA/wAxWS1lcaWDJpRMtqvLWLnOB6RMfun0U/LwANnJqLUNA27p9BuG0u9GWAiA8mU+kkeCpz3YAN79qr6Jr14+l2E2s2ZM1w727PYxtKq3Ee4SRlBlxgo+CNwIXORnFQ6Ml8OpEvd3NGKOG8RdT0af7PdyDKzovDkcbZU43Acgg/MvOCp5rp9F1JdTtGcxmG4icxTwk58txg4z3BBBB4yCDgdK5Wwsb+61S6u9Ji+y2zoPNS9geLz5fVQcMpC8Fipz8oH3TVn7F4httTivbaysPMIWKZFvWKyx5zzmMYZckqeepHeuvDKpDRrR/gYVOV7bm5req/YfLtrZRLqE4JiQ/dUDq7+igke5JAHtj2VmIHknmka4vJsebcP95sdAP7qjJwo4GT3JJjs9G18zXeoXMumreXDgtAfMkG0fdQS8bQMnjYecnksakhupBc/Zb62ktLvBZVY7kkA6lHHDD2OGHcDIrWrzP0NKHIvUt0UVl+JLk2ui3BjkaOaUCCJ15Ku5CK34FgfwrA6Tnreb7bd3moZytxJtiP8A0yT5Vx7H5nH+/Vmo4IkghjihULHGoVVHQADAFSVxSd3c2SsrBRRVa9klVI4rUKbu4cQwhhkbj3I9FALH2U0kruyG3YtaHYQanqFxeXMUc0Ntm3hEiBhv4MjDPX+Fc9QVcV1KIsahUVVUdABgVX02yi0+xhtINxjiXGWOWY92J7knJJ7k1artSsrGPmNZQykMAQexFZ8+h6TcMWn0yxkY8FmgQn88VpUUxHN2/hKy06US6KI7SQchZIVmTPuT8/4BwKr+MJrptHtbS6EImnuV8zyWJGxPn3AEAjLKgI5xu6nrXWVwXii4+1eJXQHKWUIiHs74dx/3yIv1ob0HFalGiiisTcK2PBNmLm9uNUcEpFutYMjjOf3jD15AX2Kt61hyJNPJBa2nFzcyCKNsZCcElj/uqGbHfGO9ejadZw6fYW9nbKVhhQIoJycDuT3PqauC6mc30JpEWWNo5FV0YFWVhkEHqDXGpA+mXjabMzMqqZLaRjkvFnGCe7LkA+oKnqSB2tZfiDT5L+yBtmC3kDebAScKWwRtb/ZIJB9M56gU5x5lYhOzuY9FQWdwt1bpMgZd2QVYYZGBwVI7EEEEeoqeuM2Cn+FTeQveWNvq11B5DiWKIbJE8p8lRh1JADB12qQAAKZVaWf+z7611LokJMU//XFyNx/4CQrZ9FPrWtGbhLQipBSWp2UWpa1CwEsen3ik8spe3Kj6fvN35irH/CSRRuRd6fqMCA4EgiEwY+wjLMPqQKioruVWSOV0IvY09P1jTtQcx2V9bzSgZaJZBvX6r1H4ir9creWdreoEvLaG4QHIWWMOAfoapyWaWCb7G61C2cnakcE7Ov8AurG+UH5AD2q1WXVGTw76M7aiuTt7jXkjAN9Ztx/y3tjI2fdkaMH/AL5H41Mmq6zb8z29nfJ1PkFoHHsFYsGP1ZatVYsh0ZrodNRVHStUttTidrdmEkZ2ywyDbJE3ow7ex6Ecgkc1erQyAgEEEZBrxa+sTpOp3emFQi2zfuQOhhPMZGeTgfKT/eVq9prifiXpbPaQ6xbqDJZ/Lcc4zbnq3/ADhuei7+5rKtDmib4epyT12ZxFFFFeeeoRzxJPBJDKMxyKUYeoIwa9Z8Iag+qeGtPupm3TmPy5j6yoSj/huVq8qrsvhfd4/tXTmP8Aq5EuU9AsgIIH/Ao2J/366cNKzscmLjeKl2O7ooorsPPCiiigAooooAKKKKACiiigAoooPSgCjq12LW3Y5+Y9K4yVzJIzsckmtbxHcF7kRjotY1ctSV3Y7KUbK4yeGK4iaKeNJYm6o6hgfqDU9hqmpaQ37lm1Czzk288hMqf9c5D1/wB1uPRlAxUdFTGTjsXKKluaviPxrY2Xg7VtUtJlW8tbYuLeYYkSRjsTcnXBcgZHB7E18jzF2kllnd5Z5Gd5HY5LtyWJPUk9c98nOa+ldZ0iw1m0a21O1juIiOjDlfdSOQeOoryTxT8Krq1kkvNFkbUI8l/JmI81c9Qv8JH4A8D71ZYjmq28h0Yqnc4u382SNdkbBevTGffqP0PtVy2MlvIkkIuEkRgyMjhCpHcbSKpRRNC7R+W6SIcPE4ZHU9wR94Y9OSPTudHTbeW/uore2kYSyNtTeyBSf94/1INefK97HZHY+jPAmtPrHhOzvr393MAY5WcgZKnGfTng/jW7c28dzEY5TIB6xyMjD6FSCK5PRdGutNsfDWkO6YgMl1cshOGK9hz03SA/8BrpdWuntbeJotpke4hiAIzkNIob/wAdLH8K9GCdlfc521dlePQNPRSpS4libO6Ka6lljbPJyjMVPPPIoRN3iT5by38q3tAos1270Lv989wuEAHbhvw0bhZGgkEDrHMVOxmXcAexIyMj2yPqKo6dZut5cX13BBFezIkLNDIzhkQsV6gYOXb9OTim9RGddalLBrV1cTs4sbK0LmND98ksWJHcgRjH+8as6VETea/BGdvlalaXqt/cysQcD0yEbP8Avn1rMOnXF3N4gtCVEsw8qNnPSJogAeOcbjIR75rR0IyNHqV0mQ+pa2kMAI5McGxJAf8AvxOR7EVvT+LQwxHwna6jfW+nWrXF27LECF+VGckk4ACqCScnsKr6frVhfyiKCcrOQSIZo2hkIHUhHAJHPUDFU/GJDadbQj/WzXkAj/4DIJG/8cR6pXlpBewiO5jDqCGU5IZGHRlI5UjsRyKudTldjGnS543OqqjrGnRapYvbyko/3opV+9C+OHX3GfxGQcgkVU8L3U09tdW9zIZZLOcweaesi7FdSffDgE9yM8ZxWzWid0ZNOLsclpdw91YxvOoS4UtHMq9FkRirge24HHtWF4jm+061aWi/ctENzJ/vsCiD8vMJH+7W9CAusa2q8KLtSB6ZhiJ/Uk/jXKWrGea8vCQ32qdpFKnIKDCIR9UVT9Sa8+u+VNHpUnzJMs0UUVxG4VN4ZgN3eTak+fIQGC2HZufnk/EjaPZSRw1ULoPcSw2FuWE90Su5Tgxxj7757YBwP9oqO9djbQx21vFBAixwxKERF6KoGABXRRj9oib6ElFFFbmYUVlnWYF1UWLRzAmXyBNgeWZfL8zZ1znZznG3tnPFalACMwVSzEBQMkk4AFeXWkxukkvHzuu5GuOeoDHKg/Rdq/hXc+MJVi8M6grsV86P7MGHUNIRGD+BYGuMHA4qZ7GkFrcWiio2ie6nt7KEsst3J5QZTgoMEs2fUKGI9SAO9QtTRu2p0HgeyM00+rSA7GBt7YeqA/O//AmAA9kBH3q6+qpVdP05Us7ZnjgQLHBFgHaOAFyQOnvS2F7b38Hm2sokTO1hggq3dWB5Vh3B5Fa2MG7lmiiigRymuW/9naqtyqhbO9IWQgcJP0BPs4wO3zKOpakrpL+0hv7Oa1uV3QyqVYA4I9wexHUHsa5K1aRGltbo5urZvLkJGN/GQ4HowwfbkdQa560ftI0g+hZpkiLJGySKGRgQysMgg9jT6KwLNPwrdGfSxBIzGezY2zlm3MdoG1ie5ZCrH3JrZrjrWc6frUF0M+Rc7bWcD1Lfu2/BmK/R8n7tdjXbCXMrmLVnYKKKKoQUUUUAUr+x+0Mk1vNJaXsZGy4hwHAzkqc5BU+hBHQ4yBVqHWdTtcLfWSXqf89bNgj/AIxucAe4cn2p9FXGbjsROnGe5bi8R6U6KZrtbQs2xVvFNuWPoocDd+Ga1JESaJkkVXjcEMrDIYHsfUVz7AMpVgCpGCD3qhHpUNsc6bJPpzdhavsTPr5ZyhPuVNaqt3RhLD9mcXqenNo2r3WmtuMcZEluzc7oWzt59VwVPc7cnrUFb3jddTe0try6FncpZMTJcIGjkWFsBgV5U8hHLZXhDgVg1y1ElK62O2i242lugrX8GXKWni2yLk/6SklqOcAEgOCf+/WB/vVkVFcSyW6LcwqWltnS4RR/EyMHC/iVx+NKEuWSZVWPNBo9yoqO3mjuII54HDxSKHRh0ZSMg1JXpHjhRRRQAUVU1PULbTbbzruTapO1FAy0jHoqgckn0Fc8/iu6e/azttKzP5Yk2Sz7TGD0MhVWUAnIGGYkjpgMQnJLcqMXLZHWUVyGn+L5Wlniu9Omm8nBeW0AITuVZGIbcowcKGyGHqBXV280dzbxTwOskMqh0dTkMpGQR+FCknsJxcdySiiimIKD0oooA4DU7uNtYmt5CYrkZIikBVmUfxLn7y+4yKirvL6xtb+ERX1tDcxBgwSZA4BHQ4Pf3rnLzwkyFn0m/lh7+Rc5mj/Ak7xn/eIHpWEqT3R0wrLZmNRRc22p2JxfaZOVzgS2mbhCfTCjf+JQD3qKC5guDIIJo5DG21wjA7T6H0PtWLi1ubKSlsS0UUUijC8S+FNK8RKDfQslyowlzCdsij69xyeCD1rzPWfAGs2F8osxDqET7jGysY5X2qW2Y7ttBwM4ODyOAfaahsmWbXDKx/0fToWkkbGQJGHA+oTeSPR19ayqxi1dhzOOxc8O2KQaPopt5xOkMG3zN2Q6soOR+IGPbNX7u0e4v7GUsohtmeUj+JnKlV/DDP8Ajt96r2OkWqWwY2ywXM37yd4T5bM7ctllwTyT3p39i2uc+bqH/gfP/wDF1KrRWgue5p0VTGnWu3bIjTL0xNI0o/8AHiagOgaMSSdJ08n1Nsn+FL267BzkmpySRKqWKxnUboiCAsuRu5OW9VUbmPsDjk1HYalodjqtvp51W1EGi26wKJZ1LvMyjLMOu5U6nHPmt6Gk/wCEe0XOf7I07P8A17J/hV9FhtYMIscMMa9AAqqB+gFaRxaitEZVIubJtZkbUIdPvNMiXU7ZHZ1NtLGTu2lQwLMFIALg855HvVVItYu22Qaf9hHea8dGAHqqRsSx9iV+tWPCKmSXUryFStlcSIYjjAlIXDSr/sn5QD32ZGQQT0ddqippSaMVUlBcqKmlWEWm2S28JZ8Eu7vjdI7HLMccZJJ6YA6AAYFW6KxfEOpvAv2HT3U6lMODwfIQ5HmsPQYOB/EeOmSNG0kZpOTscxrF88Np4ivbZtrzXRht29JAsduCfYSKfwrNtoUtreKCEbY4lCKPQAYFTa4kcd1pel2+fJtlNzJzk8AogbPXJLtnrlM0leViJ80j1KUeWIU1mVEZnYKoGSScACnVALb+09Sh08jMAAnuvQxg/Kh/32HQ8FVcVjGPM7Gjdlc1fC1mfKfU5x+/u1HlgjHlw8lBg9Cc7j3ycfwit6iiu1K2iMgooooEUbPTo7W+u7lXdvtD+ZtYkhDtCnAzjB2g9M5zzzgXqKbI6xxs8jBUUFmZjgADuaAObu4F8RPNFe+b9ltpFdLW3fY8gywV3fI4O0sFUggYJPIAX/hHdJ2f8i9Fkf8ALT5PO+u/Of8Ax6r3hm1SDTTOokD3sr3jiTO4bzlVIPTau1cf7Na9cc5tvcy3OLuvD1tEGNtc3mnsRwt2PPhX3LZz+BcfSl8MafPY6+z6qsXmyQFbOSB98brkF+SAQx+TgjoDgn5sdnWJZWySeILyRyyralfJgHCAsuTLj+8csufY9yc6UpNuxSk9jUu7q3s4TLdzxQRA43yuFXP1NYd5c6Tdz/abWW7FzjaLvT4JJMgdAWVWRx14bIGeK3GtbdrpbloIjcouxZSgLhfQHrip66S2cu3iC6tGPmWV5fw54aCxnjlA7Aqy7T7ncPZa0o9etXjVjb6khIztbT58j2PyVrUUBqZf9vaYv+uu1tz6XKmE/k4FYPibUtI3JqdrqunmaBdkyC4T95DnJ6Hkryw6/wAQH3q7KmsqupV1DKeoIyDSaTVmGpyasGUMpDKRkEHIIqtPqFnBN5MtxEJ8Z8oNlz9FHJ/KnrpKRatdWiyyDSoCjRW8BKu0jZPkggjCKBuwMcMBkKpB6Ky09reHy4BDYRZyIbONQAT1ySOfwA/GuOUeV2Y3W7I5W5njubWWGS11Py5UKNtsZwcEY4+Suj8K6suraUjPIrXkJMVwuNrB1JGSp5XdjcAexq/9ijPLSXJb189x+gOP0rF8SwXlnZPqViGu7y0XfGAn71hn5o/lHzIR1XGc/MMlQKunNJ2M3Ub1Z0lFYX9p6q0UT21jp1yJQGjaK+cqyn+LPlYA/H6Zqz/xOm+b/iXRf7Hzyf8Aj3y/yrqsXc1KKyjd6pb83OnRzxj+K0ny/wBdjhRj6MT7GrdlfW96G+zyEumN8bqUdM9NyMAy59xQBaooopAFFFFADJoknhkimRXikUqysMhgeCDXmccElnLcWMxZpLSQw7m5LLgFGJ7koVJ9ya9PrifHEP2XVLO++byrlfsrAAn94MsmAO5G8e+FFKSuiouzMqipoNN1S5j85bSO0t+vm30vlZHqFAJ/Btpq5D4emeMu2s28qA4P2W0LEf8Aj7fyrFySKdWKOt+G+q29xoEGmm4hN7YbrdoN43rGp/dkjr/qynNddXllrpVvptxbxXLpqFnfT4aO8t1DpLsOHUYGRhQpGM9DnAIrpRaTQuWstRvrYnqol81PoFkDBR7Liu6nXTWpwSoXbcTrqz9Z1WHS4UMitLcSkrDbx/flb0HoPUngDrWMbjXGXYdRslTpvSzIkA9iZCuf+A49qZa2aQyNM8ktxdOMPcTNudh6eirnnaoCjJ45qpVl0FHDyb1Gw28st0b/AFFhLfMu0AHKQKeqR+3HLdWxzwABYWKNGkaNFR5DudlABY4AyfU4AH4CpKK5229WdaSSsjClsJ41g0/TF+zRwxlzeuN77mz931cnLMW45HDZ4XQNVg0K5a0T7W+lQwgTNlp0s5FwNoc5JGCcgZC7QcLk50NQtZrvy41upLeDnzREMO/oA/8ACOucc9MEY5rzm30O1lm3KltgBYB955ScAKSeWY4GO7H1JqoycXoTOCkrM7VWDKGUgqRkEcgilqhoFpJYaFptnMVMtvbRxOV6ZVQDj8qv12HnhRRRQAUUUUAFZ+qaLp2qFWvrSKWVRhJcbZEH+y4wy/gRWhRQB554x0m98OaFearpEr30NonnSWd0wz5Y+9slHIwuT8wYnHWuP0P4haHqkgillewmPQXWFVunR847jrgn0r3JlDKVYAqRggjIIr5e+MPw5l8Jzy6jpkTTeHZyQygEm23Z+Rsfwcna3vg84LcteLj70UdVCon7smeq3V0UeOC2Tz7yb/VQg4z6sx/hQd2/AZJAO1odrFZ2jW6uJZ1fdcSBSN8pwSec+2Bk4AA7V4R4I+I50S1t7CaxtVsFRY3nsYVjuCgHysedrYAOeBweOevu2gajp2p6bHcaPcRz2vTKkkhupDA8hueQecnmuCpPm22NZJrc0qKKKxEFRXPmi3l+zhTNsOwN03Y4z7ZqWigDM0I3niOyjuraY2Nkco0hjBndwcOFVshAGBHzBiSDwBgmLxDFp+kvDAsbapq0g8xVvZWeKNQf9a6DCDn7u1QSemAGItT211bST3Wizx215IvzJKheCVsYBdQQc9tykHgZyABXJ2sjC7njvhKmqOfMnExy0h6blPRk6AbeAMDA6D3MspUa8rbNfezzsZVnSjdHc6L4qt72eO0vojY3r8IrNujlPpG/GT7EKeDgEDNdDI6RRtJIyoigszMcAAdSTXmWl/Z5rkaheqzaZZSjywoybm6B+REH8W0jJ/2gvPytjflhuNVdJtZ2lFO5LJDmKPnILf32HqeBgYAIyd8X7OjNxgx4VVK0E5It3OuT36MmiLshJx9ulHykesS/x+xOF5BG8cVBaWkNlHIVLM7nzJZpGy8jY+8x+g+gAAGAAKtVkeJl8+yt7RVDvcXMSeWwyrqHDuG9titx36c5wfPnUctz0Y01TV0czJrmn3Oq6hcte2gTzBDE5kUbo1Ud88je0hHsasWt9aXZYWl1BOV6+XIGx+VdX5d7/wA/Ft/34b/4uqd9YC8AGoafYX6r0LqAw+gYHn/gQ/CuCUlJ3LVVroY0jrHGzyMFRQSzE4AHrWr4Ut5E05ru4VlmvG87YwwY0wAi+x2gEjszNWNrWiRQaVPdQPdxWsOJLqznfzBJEpDOqsSSCVGOGK4yMAnI7OtqKWrK5+YKKKK2EFFFFABWTrv+lmDSl5N3kze0Ckb8/wC9kJ6/PntWtWVoObqOTVJAN95gx8dIAT5Y/EEt9XI7CoqS5YkydkatFFFcRAVlSn7L4jjkb7l7AIAT2eMsyr+KvIf+AVq1V1G0W9tWhZijZDo4GSjqcqw+hAPoe/FXCXLK4Xsy1RWfpN691HJDdKsd9bkJPGvTPZl9VbqD9QeQQNCu01vcKKKKACiiigDC8QWn2dZdYt5JVntlEzxqfllVM5BH97YzqD7jOcDG4CCAQcg9DTZEWSNkcAowIIPcVQ8Nu0nh3Snc5ZrWIknudgrnrrZkSVmaVFFFc5Ji3AOiTS3ca/8AEskJkuI1/wCWLE8yqP7p6sP+BdS2dlSGUFSCCMgilrGtCdIu47GT/jwmJFo+MeU3J8k+gx932G3sM9NKpf3WVF20Nms3V9LS/EUiM0N3CwMU8bbXUZ5XPoR1BBHTIOK0qK3LMtF1a1cKXtr+H+82YZQPwBVz+CCk/ty2i41FJtOb1ulCp/38BKZ9t2fatWimAyGWOeJZYZEkjYZV0III9iKfWbNolhJK0qQfZ5mOWltnaF2P+0UI3fjmoZ7XWIIkGn6jDOQ2WW/h3Fh/dDRldv1KtQBsVheIVnhvNPvYgrIj/Zm5GYzLJGokXIIyBuH/AAL61ZivpI+NUS4tD08yO386In2KksB7sqiobqS31DUNPt7HUre/hjc3M5hwyqF+4pIJwS5DD/rm1E4Wi2zKVRfCaMVlbxuHEStKP+Wj/M//AH0eas0UV5wihrlvJc6ZItuu+eNkmiXONzowdRntkqB+NWbO4jvLOC5gJMUyLIhIxlSMjj8amrL0d2iuL6wkJJgl82PPeKQll/ANvUD0QV0UJbxLg9TUoooroLCmSyJFE8krqkaAszMcBQOpJ9Kgv72CwhElw2Nx2oijLSN2VR3PtVKKyn1F0n1dFWNW3xWQIZVPGDIf4mHXA+UE/wARAamAC7vNSUHTAtvbE/8AHzOhJcesacZHXDMR0yAwOabbaPB9puDfo987Das11h/kZcMoGNq55yAACCOvbTupWggeRIZJ2XpHHjc30yQPzIrGv4bm5tWn1maC1sEIeS28zCmP+LzZO/HO0YXqCWBzQI6nwjK8vh20eR2kX5likY5LxByI2J75QKc985rYrH8IK6+G7EOHCbSYVf7yw7j5YOechNoOefWtiu1bHnPcKKKKYgooooAKKKKACmyxpNE8UyLJG6lWRhkMD1BHcU6igDxjx38DbHUpnvvCNymkXh+b7M6k2zN7Acp7gZHHAHWvNR4T8feEb7z7XS9QinBB87TgbhJNvYqmSy+gZR0HHevrGisJ4eE9djaFaUVbdHlXg7xbe39oyeJ9F1DRrmJcvcXFpLDbPzjIdwApz/CT34J5x2QORx0royAQQRkHtWBN4bjhYto1wdP/AOmAQPAT/ucFf+AFRnk5rmqYLrBjVbuiNWVlDIQykZBB4Iqrb31vdSSQxSlZ0B3RspSRRkjdtYZxkHBxg9s1Fa+F9VsrmWa11SzVHyzWotGWJmzksP3hKE+3HJJBNPvPDupaoYhdy2tiYm3JNbM0sy+uxiFC59wwPQgisvqlS+xXtYlVbu805gmpKbi3Jwt3DHyv/XRB0/3l+XqSFFT39jY63YKJds0Lruimiblcj7yOOnB6jqD6GtEeHJX+W51i9eLoVjWOMsPdguQfdSvtTj4WsoT/AMSyW40wH7y2pXY59Srqyg+rAAnuTVrCVFqnZkurF6GBpCTDUpra/aNnsYo1tFhjEcSQsCAwQcByVcHHGAMAAkVuVm/2ZDpHiWTY00j3top82WQuzGJ23Z7AfvlwAAOuBWlWslJO0tzppWcVYKyrH/S9avLrrFbgWkXpnhpCPqdi+xjNXdQulsrC5unVmSCJpSq9SFBOB+VRaNaPZaZbwSsGnC7pnHRpGO52/FiT+NYVpWjbuOb6F2iiiuQgzNRiS61KxtriLzLYLJOQ33S6lQoI6H77MAe6g9q06xvFFgl7YxSvbJdtZyi5WB0DiTAKsoB6ttZtv+1ilt9Ls5reO40+6vIo5FDxPFdOU2kZBCMSuPwrrotcpUDYorL+xalF/wAe+reZnr9rtlf8vL2f1oEmtIdpttOmx/H9oeLP/AdjY/M1sXc1KKz5r27h2g6XcTN3NvJGVH4uyn9Kj/tqBOLi3v4WHUNaSMF+rKCv60WC5LrszW2h6jPGSHit5HUjsQpNOjeGwSwslU/MPKjCjgBUJyfbAx+IrP1TV9LvNJv7eDUbOSV7eRRGsylvuntnNPD+bq2juejWkr/j+6/xNYV1sZzZtUVl6YTJqusSMfmSWOBf90RK4/WRqdorvML64ZmKyXciopOdoTEWB9TGT+Nc1ibjNQnvJdRWy06WGF0i8+WSSMyBcnCLjI+8Q5zn+D3zUmjapFqULgFFuoSUniVs7GBKnB4yuVbBxzg9CCBmafZTat597dXkq2d2+6OCH5MxDhNzj5iCBvwCv3yDkVa1rTJPsUD6MkVvfWmxbcqoCrGGXdHtyAVKgjaSBkDkEAjp9inFLqVy6XJdbQ2wXVIFzLajMoAyZIf419yPvD3XHAJrUVgyhlIZSMgg8EVzA8S30aCO+8M6tDcEYygSaEnHXdGzNt+q59jVnSb8WulWdpBaahdSwQpEcWrw7iqgZzLtHb1qqUZJWY4M36K5/VLzU4bb7VK0NhahlGwL5053HA6fLuyQNqh8noa0dCu3v9HsrmYKJ5IlMqqCNsmMOuDyMNkYPIxitbF3L9FFFIDP8QTPb6DqU0Zw8dtK6n3CkirdtClvbxQxjCRoEUewGBVXXreS60PUbeAbpZraSNBnqxUgVYs7iO8s4LmA7oZkWRDjqCMisK/Qie5PRWZokhjjl0+UnzrNggySS0R/1bZPJ+Xgn+8rVpFgCASAT0B71zsgWq9/ax3tpLbzbgrj7ynDKeoZT2YHBB7EA1K8iI0au6q0jbUBP3jgnA9eAT+FQXt39lls1Kblnm8otnGz5WIPvkqB/wACoV+gEOjXUtxbPHdbReW7mGcKMAsACGA9GBDAdt2OoNaFZjRNF4iSVB8lxassp90ddmPwkk/T0rTrthLmVzWLugoooqhhRRRQA1mVEZnYKoGSScACszQVaaGXUZVxLet5igjBWIcRr6j5fmI7M7UeIx51jHY976VbYj1Q5aQe37tX/HFXr25isrOa5nJEUSF2wMnAHYdz7VhWltEib6E9FU9ImnuLCOa6AWZyWKD/AJZ8nCdTkgcE9yM8dKuVzvQkKwfEENtDqNhqE9lLdZ3WTmBhHKiyYKsr7lIO9VX7w++a3qzvER2aHezBA7wRm4RT/fj+df8Ax5RVU5cskxNXMx7zXbU4tNMnv4f4RdywwyL9WRmDfgq/U1at5deu4/3trY6afUzG5bH+6AgH13H6VsgggEHIPSlrubuapW6lGy02G2l85mkuLsgg3E53Pg4yB2UcD5VAHtV6iikMZKpeJ0V2jZlIDrjKn1GQRn6g1zGototom8xS6lfWbGTeiG4mRk+YguQQn+7kcHgV1Vc7rj3Nrps0en6fFbwwpIqzPIsaxDyyd6qoYYHPDbecfWmhM7Pw5aNY6FY2zvG7RxKMxHKD2X/ZHQewFaNQWCRx2NskEbRRLGoRGGCqgDAPuKnruPNCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwfFgNtFbakqArasVnbGSsDfeI+jBGP+yrVEDkZHIroyMjB6Vyl3p8+iOWsYJLjSjz5EQLSWvsijlo/9kcr0AIwFxqwvqjoo1FH3WVtddhbW8UZ+ea5hQD+8u8M4/74Vq0qx7+eK5u9Dkt5EkjN443KcjIgmBH4GtivNr7pG8twooorAQVlaUBZ313pyk+WuLmIEYCq7NlR64YMfYMo7U/SNWi1J7pFikikt5GTa+PnUMyiRcfwkq35Gmah+61zSp+vmeba4/3lEmf/ACDj8a2pXjKzCL1NWiiiuo1CiiigCG7tobu3eC5iSWJxgq6gg/nXP6dKTbeGJGP74FrSUf3XWJ94/BosV01YusaOkub2xRl1CJxPGFlZEkdeMMoO0llym4gkA+wqJw5kTKN9ibR+LzWV7i8GT9YYj/Wjw3/yChn74nnD/wC/5r7v/Hs1Vtr2JdSivImxZaiqxsTx5VwuQFcdmI+Q5xgxhepAqfS3W21XUNPZgpL/AGuFM9Y3xuI9f3m8n03L6iuRoyH+F/8AkWdI/wCvOH/0AVqVh+D720ufD+nRW11BNJDbRq6xyBiuFA5A6VuV3s3WxXvftXlAWQg8wtgtMThR64HU9OMj61UWPVUO64v7Hyx122jKfzMpH6U7WFBWE/Z764ZWJCWsxi/76O9QR9TWHdwW6zo0ui6LbTS8x/aWV7hyPRFQ7j7BiaEJsj1W7tYRLJZzSatqYzFFLI4MduzZAGVCqr84AHztkDODkdRp9oljaJBGzuFyzO5yzsSSzHHGSSTxgc1n6F4YudRAvdaubqEo3+iW8SrCkaYHzeWQdrE5xklgP7uSo3/+EZtG/wBdc6jL/wBvcif+gEVr7JtGHt4pkNISACScAc5NW4fDmnwuGT7aSOz307j8i5FSN4e0Z5PMfSdPaT++1shb8yM0/YvuH1ldjAOtabvMcd7BNKOPKhbzZM/7q5J/Ks+3uX027Z0s7yPRZmLPNPC0QtpWPo+G2MSTnGFbvhvl9BjRY0CRqqoBgKowBSuiyIyOoZGGGVhkEeholh4yVmZyrt9DhdUljtde0Zw4We7kktSv99PKeT8wYxg9tzetTaySlzpMgJwt3yPXdHIv82B/Ctu58MaTKsZgsoLOeIgxT2sSRyR4BAwcYxgkYIIwTxVOfwo0zwu+taizwP5kW5YMBsEZIEYzwxGPf1wRzPByWzBVUZ+tf8fGlEf6z7YNv/ft93/ju6jxF/x5QD+I3ltj/v8Apn9M1fm8M3d1LBJd6uyvbsZIfs1uqDdtK5beXzwxGBjr9MPbwv8Aa3ifVNRuJmibfGluPIRWwQG4yxOCeC2OelSsJU0H7WJRvGuG1O0hs4Vnm8uWYoZNhKKUU4OME5deCR9adJftb8X9hf2h65eAyKB6l49ygfUiug0zSLXTnkki82SeQAPNNIXYgdhnoPYYFaFdVPDqMbPcXt2nocrZ3treozWdzBcKpwTFIHA/KrFat7pWnX8ivfWFpcuv3WmhVyPoSKq3Hh3T5n3Yuoz2EN3LGo+iqwX9Kbo9mWsSuqKlFPbw5IP9VrOoqB0VhCw/HMeT+dRNo2rj7mp2LAdA9k2T9SJf6VLoyLVeDKt0iyX1kHA+RnkU+jbSv8maqmqkXeo2Wnr8wDrdTgfwohyn0JkC49Qr+lWb/RtXu4ljlttPk2NvSRL6WBlOCMjbGSOCR16EiqE5uvDdr5t1pEzwu/724huxPt4PzO8pUheMZPAyOgrGVCXNzMPaQb3NPTf+PXPYySEfQuxFWqo6IZP7FsDcRmKYwIZEbqrbRkH8c1H4elefSo7iR2cTvJNGWOT5buzJ/wCOleO1cUt2wuaVVtR2/wBn3Xmfc8pt30wareH5WnsJHd2c/arkBmOflE7gD6AAAe1UJpWuvA6YfNxeWSxR5YAvLIgVRkkclmHX1oUdbCuauj7v7JsvM+/5CbvrtFXKpSPeLGRPod+sGMMf3MgA/wB1XLH6AGmxPauA5jnDFtyxzxSBwR3VHGR+Ar0HFroaqcXsy/RVNJr27OzTtOuD2Mt2ht41PuGG8/gpHuK0LXw5E4LaxMdRdhgxOu23HsIuQf8AgZYjsRVRpSZE60Y+ZmLqSXEjR6ZDNqEina32cAopHUNISEBHcZ3e1XrfRLq72NrE0SxBw/2W2yVbH8LueXXODgKvocjIPQxokUaxxqqIowqqMAD0Ap1bxpRic060pBRRRWhkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcx4o0i3S4ttZt7X/AEi2m824MOQ0kZjZCSo4cqGzyCcAgdcHPsbsXOtXPkzrLataQSRFG3IcvLkjHHQL+ldvWTd+HdKupmmNmkNyxLG4t8wyknrl0wSPY5BwMiuavh/aO6eppCpy6GDpBcXGqRMWKx3XyE+jRo5x7ZY0mhOxguopGLSxXcytk5wGcuo/74da1D4XjWRpINT1KGVwA7h0fcB04dCBjJ5ABOec4GEj8KW0O+S3vdQiuZG3TTiUMZTgDJVlKA4AGQo4AHSub6nPujT2qOOt7ltKOmTXVldIV861lYBSNm7cZNoJYgFM5xgKzH67XiGQDSFv4P3v2R0u1KEHcinL7TnBJjLgc966bSdGtdNdpkMk9267XuZ23SMPTsFHfaoAzzioz4c0n7R5os1X5/MMaOyxFs53GMHYTnnJGc81r9Vbak3qL2xlGTUv+gFfn/trb/8Ax2k83Uu+g6gB6+Zbn/2rXW0V0exiH1iZyXm6l20HUMf9dLf/AOO1JF/aEjhW0e8iB/ieSDA/KQmupoo9jEPrEzmpLPWt+IrXT9nZnu3BH4CI/wA6cmi6rJxPqdvEh6i3tTvX6MzkfmtdHRTVOK6EutN9TlG8BaFcXf2rUoJNQutwcyTyYDEY2kom1CRgYJXIxWmvhnRvLZJdNt7jcQWa5XzmOM4yz5OBk4Ge59a2KKvlXYzbbKV5pWn3sccd7Y2twkYwiywqwT6ZHFUj4Y0w/dF4g7LHfToo+gDgCtqihpME2tjFXwxpWf3kM86d0uLqWZD9VdiD+VX7DTLDTt39n2Vra7/veREqZ+uBVuii1gbb3CiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACggEEEZB7UUUAYb+FdIcMggmSEjHkxXUscWPTy1YKB7YxTR4W05QEie9hgHAhju5VUD0XDZUegUgCt6ipcIvdDuzBi8JaRDGEgjvIox0SO+nRR9AHwPwq3YeH9H0+SOSx0qxt5YxtSSO3VWUYx1Az0rTopqKWyC7CiiimIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAozWF4m1htNktLeHb58+98MP4FABI98un61z7a1eMc+ZisKmIjTdmb06EqiujvaK4iDXrqMjcQwrb03Xorhgko2MaUMTCegTw846m5RSAggEcg0tdBgFFFFABRRRQAUUUUAFFFFABRTWkVBlmAFVpdSs4RmW5iQZxlmwB+NK6Q7Nluiis/XdVg0bTJr26JKpwiA/NI54VB7k8fqeKYjQorgU8b3BCmS2jDY5Ck4H0rQsvGdvIwFxG0ee/UVkq0H1Nnh6i6HXUVVs7+3vIw0EqsD6GrVaJ32MmmtwooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKgvrqKxsbi7uG2wwRtK59FUZP6CgDgNfuPtvii/kBzHbKloncZA3uR+LhT7x1XqtYLKLVXuRi4lLTTAHgSOxZ8e25jVmvFqy55uR69OPLBIKASDkcGiopLaXUJYNPgLK92/lF148tMEu2exCg4P97aO9TGLk0kVJqKuzufB9xPeaFDc3HSVmaL3jzhG99wAb6MK2qZFGkMSRRIqRooVVUYCgdABT69uKsrHjt3dwooopiCiiigAooooACcDJrD1bW0tspFhpPbtU/iK8+yWXBw7natcOzFmLMck1x4mu4e7E6sPRU/ekWbm/uLhiZJG57A1TkAkRlkAZWGCG5BFOorznJvVneklsX/AA7rw0RvsmpzEaWcmK4lfi2/2GJ6R+hP3enTGOf8Q6vJr+qm5YkWMJK2cR446GUj+83bPIXjgls33VXRldQysMEEZBFc1JC2k3CW8hzZSNtt5P7npG3/ALKe4GDzy3VGvKUeRmSoxjPnLFFFFSbk9pdz2kgeCRkIPY16H4X19NRj8qYhZ1HfvXmjEKpZiAoGST2rqvAWhT3VxDq92Gis1G62iOQ0p7SMP7uPug9c54wM70HLmstjmxKhy3e56JRRRXceaFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVznjy7MGhrbLjffTLbYIyCpy0gP1jVx+Iro64Hxfc/a/Eywqcx2EGDjp5shBIPuFVD9JDWVafJBs0ox5ppGfRRRXjHrBW34DsvPnudYkztO61tv9wMPMb8XUD6ICPvVz0scl3NBYWxcXF2/lKyfejX+OT/gK5PPU4HcV6faW8Vpaw21tGscEKCONF6KoGAPyruwdO752ceLqWXIiWiiivQOEKKKKACiiigAooooAz9c0mDWLH7PcF0KsJIpYzh4nHRl/MjnggkHIJrz547i0u5LHUFRbuIZyn3ZUPSRe4B9DyCCOeCfUay9f0W31m0EcpMVxHkwXCD54m9vUHAyOhrCvRVVeZtRrOm/I4WioyJ7a6eyv08q8jzkYwsij+NPVTkfTODzUleVKLi7M9NNSV0FQXltFd20kE65jcYODgj3B7EdQexqeikM5iPzbe5eyu23TKN0cmMecnTd9RkBgO+DwCKnZgqlmICjkk9q09Vsvt1ttR/LnQ74pMZ2t7juD0I9D261oeA/D0WrRnUNZWNzDI0QsA25UcfxScDccEFR0wQ3JI29NKPtXZGdSqqauxPCPhdtXMWoaopTTch4YD1ue4Z/+mfov8Xf5eG9Moor0oQUFZHmTm5u7CiiiqICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA+ZbX4+eImvQHk8Kyyf2ydOGlCOeK6eLft8wSGQov1Ixwa+mq8UPwNnl0W/0C58XXLeGr+/a/ubKOwiV2YuGwJSSV5VeQO3vXp2haLe6brWsXc+sXF5Y3fki1sZEASyCKQwVs5bdkE59KAN2iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAbI6xozyMFRRlmJwAPWvLLaX7V518d268la5+cYYKx+RT7qm1f+A11/i6SXUPM0K3kMKTwFruYAFkiYlQqg8bmw/JzgKeORXPN4bG47pLmcjpI988RP/AUUL+lcGMqJ2gdWGajeTIKKedDuoSWW4u2AHyoJI5VB/wBrciMR/wACzVJLTULm9ttMk5F45jF5EjRbFA3PlWyUfaDt5YE4PtXHGDk7I6/bRtdnUeA9OLtPrM68zDybUHtCDy3/AANhnjqqofWuwqO2gitreKC3jWOGJAiIowFUDAA/CpK9mEFCKijzJyc25MKKKKokKKKKACiiigAooooAKr6heW+nWU13eyrDbwrud27D+p9hyay/EGpyxv8A2dprL/aEsZYueRboePMIwcnOdqnG4g9ga5m58J6ZPbtGYIy5IIkZcOCO+9drk+5bPrXPVxEabsaQpuWpy+v3lx4g1M6jMz27x8WSd7dPfsWbjcOh4XkAE2dK1P7VIba5QQ3qLuKD7rr/AHkPcZPI6jv1BMWp6RfaUwK77uADoRmQ9yVIHzYH8GA2AcFzWfIkV7BFJFKRgiSGaJhlT2ZT07+4IJByCRXFN+01Z6VPltaJ1FFY+l6qZLgWN+Y0viC0e3hZlHUqD3HdecfStiudprc0Clsr+bR9RF/ArywldlzAvJkQZIKj++pJI9QSO4ISiqhNwfMiZxU1ZnpVtPFdW0VxbyLLBKgkjdTkMpGQR7EVJXBeFdWOlXyafctnT7qT9w7H/UysfuE/3WJ49GOP4lA72vYp1FUjzI8qpBwlZhRRRVkBRRRQAUUUUAU9T1G202FZLuQIGO1R3JxnA/KuWu/GyZItrdiPVjTPiouLPRnH/P8AFD9DDKf/AGUVxVctarKLsjtw9GM480jrB40ugeYUIq/Y+NYmYLdwsoP8S81wlFYqtNdToeHpvoeyWF7BfwedayCSPOCR2PpVmub+Hdsbbwna7uWlkmmz6q8rMp/75K10ld8XdXPLkrNpBRRRTEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRWX4jv5LHTj9mx9tuG8i2BGR5hBOT7KAWPsp70m0ldhuZEU/wBs1PUroKpQTfZonA5KR8EH6SGWrNQWVtHZ2cNtDny4kCLuOSQBjJPc1PXiVJ88nI7IqysFN8PQfbb+bU5M+VCz21sp6ZBxJJ9SwKj0CkjhzTqb4cu4rG5udMuZVQtI9zbFjjejtucZPUq5bIHQMnrW+Dt7TUirflOkooor1TmCiiigAooooAKKKQkKCSQAOSTQAtc9qmtPNI9loxDSglJrvGY4MHBA7PICCNvQEfN2Vqt5qM2uDZYyvb6UeDOhKyXI/wBg9Vj/ANoct2wMM0sEUdvCkMEaxxRqFREGAoHQAVxV8Vy+7Dc1hTvqyOztIrRGEe4u53SSO255GxjczHknAA+gA6CrFFFec3fVnQMljSWMpIMqf8/nXHah4auW1q2i06aBHvXcS7wSBgbvO2jHPUNyAzFDlSTXVahO8MKrAA1zM6wwqwyC7HAJHXA5Y47Ka2tG0e30xGZf315IP31y4/eSn3PYeijgdq6sLRc3zPYidTk23KGn+ENJtdMks5IDcmbBlnmP712HQhhjbgkkbcbScjB5rlNTsbrRLkQXpMtq7BYLzHDZOAkmOFfkD0btg/KPTKiureG7tpbe5jSWCVSjo4yGB6g13VaMaisZU60oO55tRU+taTN4eJd5Gn0osAkzkl4M/wAMh7r2Dn2Dc/M1B7gm4+z28TTTBd74IVIl5+Z2PCjg+pODgHBry505QdmelGpGUeZEssayxtG4yrDBwcfrXVeDdakulbTdQcvfW67klb/l4i6b/wDeGQG9yDxuAHKW+m3l1hpruUKedthEoUf9tJeHHuqir0Hhq3W6il/0qOWFi8U6ajMWVsEZ2n5ehIx05xitKNX2T12Oes41FZbnolFZHh2/luYZbW+YNfWuBI3A81DnZJgdNwByMDDKwHABOvXqxkpK6OBq2gUUUUwCiiigDkPifHnQLafHFveRsf8AgWYh+sgrga9M+IEXm+DtUbr5EYucevlMJMf+OV5nXHiV7yZ6GDfutBUN1MttazTv9yJC5+gGamqveQ/aoktMcXcsdqfYSOqE/wDj1c6V3Y6pOyuexeF7R7Dw1pNnL/rLe0hib6qgB/lWnRRXqHihRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAIzBVLMQFAySegFcjBcPq16dTYkW20x2adP3ZIJkI9XIBHooXoS1XvFUxuJbXSV/wBXchpbnvmFSAU/4EWA56qHqpp139st2lCbAJZYsZznZIyZ/Hbn8a4MZV+wjalHqy1TJZEiieSVlSNAWZmOAAOpNVp9Qgj0iTUkJktlgNwCo5ZAu7jPqKr+Kf8AkWdX/wCvOb/0A1wJXZuLDrljLJGheaEyEKhuLeSFXJ6KC6gEn0HNGv6Ymp2YAjia5gbzbcyruUOARhh/dIJU+x4wcES6o0nlGL+zvt1vIpWSMMmSPTa5AI/GszRdSFoktlqwksmiZjbm8lTdJD1HzBiCV5U8k4UE/eFbzp8nvRHJWLGn6XpNzY291BplvbedGsg2RCORMjOMrgg/jVtbAxc29/qcT9mN5JLj/gMhZf0rO8PalCbORWF1zcTurtbybCjSuykNtwQVIIIPStGXV9NhGZr+0j/35lX+ZrqUpF8sWtUWrd9RgBP9qTXDdhcRRlR+CKp/WkF7rqnJudMkH937JImfx80/yqh/wkGjf9BfTv8AwJT/ABqxDqmnz48m+tZM/wByZT/I1XtJIn2UH0LQ1jWRwdN09v8Aa+2uufw8o/zpf7Z1j/oF6f8A+B7/APxmkR1cfIyt9DmmyzRxDMsiIP8AaYCn7WQvYQFOra03Sz06L/t4eT/2Ray7y71DVb5tMv5LU2KRCa5WGNl3AkhY2JY5U7WLDA4UA5DEVK+vaQjFX1WwVh1BuEB/nWPI63Wg6pOjArqN6bYspzhTIttkH/dXP41nVqzUd9yXTgtjRj1WX/hH5tUaJCrK0ttEMgup/wBWCf7zcduN2O2TpT3McE1tFIT5lw5RABnkKWP0GFPP09ayvElyiT6Np+MteXqABf4ViBmLfTMar/wIVYm58TWef4bOfHvl4s/yH51wWAfrd5NZ2X+hokt9Mwit43OFZyCcn2ABY+ymqnhlATeyiKWMiXyWZ5fMMzJ96QkADduZl4AACKAAABTb68lHiVIktLm5W2tRIFiCYLSMVByzAAgRsPo5qLSNTjsvD6edHJ9vSR43tAV817gksVAzjLZLZzjad2cc1rytU9Oo7dS3Nc3R8TQ/Y7aC4SxhMjCacxgSSZVSCEbkKJMjjiQVrrrmpxndc6RE8fpa3fmP+Tog/wDHq5/Sbi8tLZmudGvzczuZrhleBhvOOB+8yQoAUcZwo71Jd3lpeNGssesW8y9DFBcLg+5QbW/HIrrpN04qKB0oy1e51+maxZakWS2lInQZeCVTHKnuVbBx79D2JrQryvVrbT71o4LrWrC7nQ7o49QWPzI2x1jaPY8bf7QyRS6Nd+I9Oa4WxupdQjtZAklndzrMwJUN8sxwzAhhgsVK9Srd+iNVdTGVBrY9RkRZI2SRVZGBVlYZBB7GuD07RrTSdUvbAKoVZTdW0bc5RsfNz1Kn92P7qog4zz0fhvxFba5ACsNxa3I3B4ZoyMMp2sA2MNgjtz6gHim+MIlGlC9AxLZSLOJB1WMMPMH0KbuPoeoFTXh7SGhnBuL1IqKKK8c6ypdLcW91HqFgA9zCpRoScCaMkErnseMqex9ia6TT7yHULOK5tmLRSDIyMFSOCpHYgggjqCCKxqpCSTSL031sCbWQj7ZCvcf89VH95R1xyyjuQorswtfl9yWxjUhfVHX0U2KRJoklidXjdQyspyGB6EHuKdXpnOFFFFAFfUrRL/TrqzlOI7iJ4mx6MCD/ADrw22vUXTba4vJY4TJGrMXYKASAT1r2bxTNLbeGdWnt5DFNFaSujjqrBCQRXLWPhyxtHDxwQxNgD9xGEJx0y/3yffdzXHi5KNrnThpuFzgRq2nEgDULQk9P3y/41r6DGt14l0SLIaN7reSOfuI8g/VBXbtp8LKVZrgg9QbiQ/1rMGj2WmX+nXlpDHFdC8jHnLGqcOdjBtoAbKswGcnLCualUTmjoqVW4tWPQKKKK9U84KKKKACiiigAooooAKKKKACiiigAooooAKKparfCytiwx5h+6CM81zkXiu+jP+laSkiDjNrchnPvtdVA/wC+qlzSdmUoSaukdhRXOReMNOPF1FfWr/3ZLZnH4tHuUfnV638R6JcMFg1fT3c/wC4Td+Wc0009hNNbmrRSKwdQykFTyCO9UtX1OLTIEkkimmkkbZHFCoLOcE9yAOATkkD8SKG0tWIvVha/4u0DQCy6vq1pbyqMmHfulx67Fy2Pwrx74q+LPHLzPb2+n3ukaS7bUktf3kkgPA3SRklSTjCjHJx83WvNbDwlrt7JmDQ9TaRzuDzwvFknqcsFHPu1clTFqOkVc6aeH5tZOx9S+FfGvh/xVJPHoeoLcSQ43I0bxtg9wHAJHHaujrxPwL4W1aw0iWz1HTNIiSRw5a5LXL7hnlkyV+mGGOetdtZaffW8Hktrd95J/wCWMe0IB6KzBpAP+B8dsDiiOMjb3tyZ0bP3WdtRXDXujtJGBbXU4fPJup55xj0A80Yqj/wjsp5I0Qt/fOmsW/7683NH12PYn2LPR6K4C1sfEFlIGs9eiSMcmGW1eZG/77lLAeysBW5HrepQf8femJOg43Wc4LH32OFAH/AjWkcVTl1sS6ckdHRXP2fi7SruaaGEagbiAgSxf2dcbkz0yNnQ84I4ODgmo9X8Q3EUUUdnpt2st1J5EE86qsasQWLMpYOQFVjjbzjGRnI3urXJSbdije38U/jWWCIMwS0KNJ/DvRgWUfQSrnt26g4j8Of8g11/uXNwn5TOKgvrZdMisLqIkraSETyMRueOT/WOx4H3isjH/ZJqWzP2XXb22P3LpRdxfUAJIB7DEZ+rmvKxGsm+51qPJoVtOtTe+DP7ODBZBavYsx6B0BiJ+mVNW5g2teGZFQeS97aEBX/gLp0P0zRpu221O/s9xw7C7jXGAFfhgPU71Zj/AL4punsbLVLjT5D+7mLXVux7gtmRfwZs/RwOxrAC7pt2t9p1rdopVZ4lkCnqMjODU0sUcqhZUV1BzhhkZrN0P9zLqNn/AAwXLMmepWQCT8tzso9lrVruTurm6d0FFFFABVeaztZ8+dbQyZ/vxg1YooAzW0LSHPz6XYN9bdD/AEp0Wi6VEcxabYofVYEH9K0KKdwsNRFRQqKFUdABgVxuqXTW3hRHjG6X+0zMy/7Md0ZpvySOTHvgd67Ss6bRdPlF4fs0aSXcbxSyIuGIYYbn34z64GegqJR5rEyjcyPFP7vXdFuP+eO7nt800CH/AMdZj+FaeoEQ65pMxIxL51oB7sokz/5BI/Gs2az1DWIVgv7c2zx2ksMkxKlXmcBQyAEnbwzc4PK984brssmqaXoclspS+kuIrmOItghkUu6MewwChPbdWDg7RRm0zVP7rxOmP+Xmzbd7eU4x/wCjjV828BuRceTH9oC7PN2jdtznGeuPas+yW5u9UN7dWslqkUJhhjkZS5LEF2O0kY+VAOc8N7Vq1vTTUUmax2Ciiq0ryLf2434hZHUrgct8pBz7AN+dUMmkRJEKSKroeCrDINZh8O6UA3kWaWjNnc9mTbsfq0ZU/rWtRQBi2GiPpUsMmkahcRLCjJHBcYniG4gknOHJ46l88n1NWtYutautF1Cye3sLk3FvJEJUkeEgspH3CHz1/vCtCirVSSIlSjLcqxTfb9MSa0lMYuIQ8UmASu5cg4PBxnNM0m8a9sleVQlwjGKZB0WRThgPbIyD3BB71V02RrC4TS7hFSMA/Y5F+68Y6J7MowMdwMj+IK6yAj8RanGnCPDBcMPVz5iE/wDfMaD8K8+UeVtMh6GjDNHOm+F1dQzLkHPIJBH4EEfhUlZukxNDcamnSL7UXjX0DRozfm5c/jUVkJL7Sr2zllkjmR5rYyKTvRcnY2T/ABbChz61NgNXw5I1hfSaWQTaurT2p7RjI3x/TLBl9iwGAorpK4CW/dvD1prTrtuLILeSInYqCJUHvtMi89zXXadrWn6hL5Vtcj7RjcYJVMcoHrsYBse+MV6uGqc8LPdHNUjZ3Ro0UUV0mZieMWxobxd7iaGDHchpFDY+i7j+FQVWvLgatq4eNs2Vg7LGR/y0nwVds9woJX6l89Aas15eLmpTsuh00lZBVLUxvawjPCvewEt6bZAw/MqB+NXao60kh06R4EMk0DJcxxj+No2DhfxKgfjXPTaU02XLY7Cio7aeK5top7dxJDKgdHXoykZBH4VJXuHGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcn4mlL3wTPCrWPWjrxJ1F8+lZ1cc/iZ3U1aKCkkRZFKyKrKeoYZFLRUllH+xtL3Fv7Nstx6nyF/wqK68PaLdoqXWkadOqnKiW2RgD6jIrTop3YrIj0COC2uLjRxGFs3iE0EQ4VQPldFA+6o+Q49XOK37Nma2QSFi65QswwWKkjd+OM/jXN3J8m/0y6H/ACzuVRsdSsgMePpuZT/wGupDqZGjB+dQGI9Ac4/ka46ytIlqzHUUUViAVn3yWfm5up5IWIzkXDxA/kQKvOwRGYgkKMnAJP5DrWb/AGvu/wBVp+oyf9sNn/oRFNCK8l14dH+vu9McjvNMjn82JNTR2WnahEs1lcyGLorWl46oPoEbb+lOOt20f/H1DeW2Opltn2KPUuAVA+pqExeH9UdrgLpl1J0My7GYf8CHI/OmIfb2eo2GqR39veC+aOF4RDdhUyGZScSIvH3B1Vu9Sx6kNd1lpRG8S6chgeFyCUuHwWBwSMhPLII7Sn3FZC6ML/W4LfQ/EWp2xVWa5jhuFuEVcfKW81X2ktgAArkbiOhq14KtGtdDBlCm4nnlmlcMzb2LnDZYk9Aveu2k5qnrsKCTmbrqrqyuoZWGCCMgisq60SDylewAt7yHm3lyWEfT5AM8RnABUYGOmCARr0UzoauctqmrwLFb3UhW11e0JJsnceZKp4eNB1cNjK44LKvoRWhqskF9pC3dpOiyxyK9vKR92bdtCEcHJJKFeD8xHBrZqm2l2DXovGsrY3QO7zjGN2cYBz644zWXsV0I5CPTbO4hubm5vZopJ5gifuoyihVzjgk85Zjn3A7ZOhRRWqVtEWlYKKKKACiiigAooooAKKKKACqsFhZ29zJcQWlvFcS58yVI1VnycnJAyeatUUAFFFFABVS4YNf2kefmG+XHsBt/9nFW6yz++8Trjj7LZnd7+a4x+Xkn8xTA1KKKKQBRRRQBXvbSG9hEc4PyncjKxVkb1UjkHkj8SOhrK8KW+23u70yzTfbZzIjzPuJjACIR2CkLvAAA+etDWlnfR79LPd9qaCQRbTg79p24P1xWRJd2+pLDounJcQRtEDN5lvJDsgGAVUso+ZuF9QNx6gZyrbETNHQpGuY7q8zmG5nLwf8AXMKqAg9w20uPZhUWmTJDaanqc52QSzPPkDP7tFCBhjqGWMMMdmFO1aRpDHpVixjlmTLunHkQ5wWHox+6vvk87TVDUrqMXltYW9tOdNsnQ3DW0RcIygNHEFX5sDCscDj5ARhiRzpN7GYXMMsfhQ2cy7LzUS8Zj6lHnZmcD1CBmP0Q1vXdpbXkYju7eGeMHcFlQMM+uDVGzE1/frfTRvDbRKVt4pFw5J6yMD9044UcEAtnrgW9Nu/ttsZgmwebJGOc5COyg/jtz+NdVOLirs1itBq211buXsNSu4MnPlyN58ZP0fJA9lK1XuNV1e8uW0gvbAFN1xeWpeNol4+QKd2GYZwQ2QMng7c6lZXhz95Yy3XU3VxLNv8A76biIz/37CflVVK0oR0ZE6cexowRRwQxwwIscUahURRgKB0AFSVjSxJrOoyxTESadanY8X8M0uASG7FVBHHILE5GVFSaEPIe/shxFaz7YQe0bIrgD2BZlA7BQO1cjptR5mFtLmrRVWzuxcy3cewq9tN5Tc5B+VWBH4MPxzWfqGoyyeFr2/tlaO4gilfYDkiSInK57jcpH0qLCubfhe4MEtxpMx/1P722PTdCx+6P9xvlwOimP1roa4lrtGi0vWbclY42SRi/yfuJAA+7PQAEOfdB6V2qsGUMpBUjII6GvWw1TnhrujlqRsxaKKK6CAooqtqF/a6db+dezpDHnaCx5Y9lA6knsByaALNFcdqXi26aaO20fTy1zJyPtJwyp2kMY6L14dkbggAkYrLfRdU1Y+Z4j1u7kU/8udk/kQAd1JUBnHucVm6kUaxoykdxcarp1tcm3uL+1iuAu4xPMocD1xnOPerNvPDcwJNbSxzQuNySRsGVh6gjrXAjwva2lqI9GmubBlkWUATySRkhg2GQtgg4wcYOO9Y+g61fadeak6KUltI5rjUYLiTbAzFsjygGbYMKx3YGQ4ZgSwwo1U2VKg0tD1qiq+n3kOoWUN1bMWilXcuRgj1BHYg8EHoRirFamAUUUUAcl4qVLa4WaV0SN+NzEAZrHR1cZRgw9Qc11Ov6xDZOsEunTX6MMssXlnb9Q7KKx473wldSBbnR445j1E2lkgfVwhX9awlTi3udEakktjPorVZfAW8o6+GA/dWEAI/Cr1poXhS8XdaaVoc6+sVvE38hR7HzH7fyOcoPAya4/wDaI0XTrDSNCaw06ytEe9YSNDAsZbEbEAkDkYDH8K8OFrD5qmSCNlKK/KA8jIb8RkH8K5a1RUpcrOilepHmPpaVlu9S0+yidWZphPIFOSqRndn/AL7CL/wKte31OwfV7qIXtqJxtg8rzV3ErknjOerY+oNfM9ne3WnQ3EWnXU1skpWR/s7eW0q553MuGfq3Un73vVaRIgky+WjRlfMC44Yj/wDUPzrkqVVJ6F+wb3Z9b0V8mWEj27RLbu0WxWU+WdvQjB49ufxq1JruqR20rx6lfZdisSfaXwT0Axnpxn6VnzIPYPufUV5d21lbtPe3ENvAv3pJXCKPqTxXIXfxM8ORXcFraTz39xPIsca2sRIYsQBh22qeSOhNeAMxZnmnZriZMIskh3MxwO57k1No88Vr4j0SWVv3dreWxLds+agOf0/Wqg1KSQnR5Yttn1IZdRUZbQ9QC9yHgOPwEmfyrK1aw03WBi88Oz3t0PuCWwZWDdsSsAFP+1uGPWvQqK9T6nBO6bOD2rKOkW7WGj2sNwY/OihUTNGoCs4UbmAwOpzXM+GwR4d0sN977LFn67BmuzZQylWGQRg1xnhok+HdLLfe+yxZ+uwZq62yNcNuzSooornOoKKKT6daAForL+z6weG1CxA9UsmB/WU/yo/s+9bl9Zu1PpFFCB+qH+dMDUorL/s26/6Deo/98W//AMao/suY/f1bUW/GMfyQUAalFZf9kv8A9BPUf+/i/wDxNH9mTj7msaiv/fo/zjNAGpRWX/Zt3/0G9Q/74t//AI1R9l1VOItTgcetxabj/wCOuo/SgDUoqnZC/V2W9e1kXHyvCjIc+6kn+dXKQBRTXJVGYKWIGQoxk+3NZv8Aak68y6RqMa/3v3T/AKI5P6UAalFZf9t2veHUQf8AsHz/APxFH9sK/FrY6jcN6fZzF+su0frTsFzTrL8Pfv4J9QP/AC/SGZP+uQAWPH1VQ2PVjVbUrTVtZsLm1aSLS4J4mjyoE02CMc5+RfcDdnsR1pmj/wBqz2S+XfwLJGTHLHc2odo3XgrlGQY7g7RkEHvRYV9ToaKy92tR8eXp1x773h/TD0vnaz/z4af/AOBz/wDxmiw7mnRWZ52s/wDPhp//AIHP/wDGaTztZ/58NO/8Dn/+M0WC5qVlXdvfRak95p6W0xlhWF0nlaPbsZipBCtn77ZHHQc07ztZ/wCfDT//AAOf/wCM0nnaz/z4af8A+Bz/APxmk43VmJ6kVtpE8L3E39ozfarpQJ5FReCM48sEHaBnAB3DAzyxLHRsrWKytkgt1KouTycliTksSeSSSSSeSTmqfnaz/wA+Gn/+Bz//ABqj7Rqy8vp1ow9Irwk/rGP50KKWwJJGhPIIYZJG+6ilj9AKpeHYzDoGmxv99baMN7naMn86il1NvLZb7StQiiYFWYIswOe2I2ZvxxUnh+ZG0u2txcwz3FtEkU/ltna4UZBHUH2IBpj6mlWHZ2eq21nDp0MtrHbQqIkugS0pQDA+QjaGxj5skZGdvOBuUVLinuJpMgsbWKytY7e3UiNB3OSSTkknuSSSSepOapWv/Iyajjp9mtyf97dL/TFalZGlSop1a/mdUha4f53ONqRKIzk9huRz+NRW+EU9h+n863qpX7g8oH/f2nP/AI6UqrY7P+Ec1HzMbPOvd2fTzpc07w1cpPpM2qy5iS8ke5JkBTbGPlQkHp+7RM++aqMjnwfBbSKVudTAR0I+ZWnbdLgf7IZ2/wCA1zWu7GQzR4op7O/8PXcmfOtBcbc/MI5wwcfg4k/BlFcrpFy9hpcF9aTzafI0SyP9kOFLED/lnyrnJwMqetW7rzLnWb++jmmtrn7RJCkkRwyon7sryCCp2bsEdTkcgGrOhWUMus6baAYitlNwsZ5DCMBVH4M6MPda9SnB07y7mMrTlyo63RNV8Upbk6na6ZcFgDGDO0MqDHIk2oys3uuAOnOMnTTX76Pi60aRyehs7hJAPr5nl4/AGmSSJEheRlRB1ZjgCqz3TSkLZKJCf+WpH7tR65/i+g/Eip9rI3dCBZfVtVuWAt7W3sYs5LTt5shHpsXCg++5voawcPPqTixkN3eoSlxqVzh/JHeNAMDd/sqAo6tk8NMTNqczWkU8ws4G23FyjbGlcHmNCMYA6MwwQflBzuxrW8EVtAkNvGkUKDCoihVUewFTKbe5UacY7EOn2MNjCyQ7md23yyvy8rd2Y9z+gGAMAAVbooqDQK4vxLpE954ttbjS4NPe8S2Mjvex70QhsJ8o5y2W+bIx5Y64wevubiG1gaa5ljhhX7zyMFA/E1x2n3E+qy6/e3V+mmWSyCJ8xmO4jt0jDKS7EeXks7crkBuoI4pCl2PQ/Cgi/wCEc06SDzNk8K3GZCCxaT52JxxklieOPStWsbwdcrd+FdKmRomBtowfKACghQCMDhenTt07Vs12o81hSMcAmlpk3+rbHpQBxGpSGW9lYnPNVakuP9fJn+8ajrie56C0QVVuNNsblt1xZW0p9ZIlb+Yq1RSGeffFjQbc+EWubCzgjks5lnbyowrFMFGGQOmHyfpXky/v4MAnzAfMjZeobvj8+h6hq+lbu3ivLSa2uUDwTI0ciHoykYI/I189+IdAuPDOsvY3DN9mJMltcEcSR+p/2hnB+voRjmxEW1zGlJpOxmQykuiYVJOqDPB9ceo9R1Hp0qXfsIwMbDwO6g9VPt6Hp0pZUjdSs+xd3XcMo/ofr+v1qJ4GiwzynYOFzID+pGfw3VyaM31KlxIZJDBbu8QjIV5AMEccDHqAeT6Edzwrk2DefkuiLtKyNkxD+8Ce3v3HHBHJpgC2SFhlmBdu3JOT06Y+X6VbKjyyrKrx55V14H1Hb69Ktu2hKV9RQWAXJO7nbgdz1IB6n3OAM1UuVM+IYWwVO8uOQD0QA/7xznvzTzZYQrZuUB5MLNwR6A88fgfwojmHltFHH5UqHJRjypP8THOT9en1NJaaoHroz7S8MarHrvh3TNVhxsvLeOfA7FlBI/A5H4Vp15H8CdX/ALM8CQWutyJZ2YlkbT57hgiPFuO5dx/iD7+PQjGcHHoo1eW5/wCQbpt1cRnpPJiGM/8AfR3Ee4Ug9jXvQlzRTPGkuVtGvXIadGbaXULRgR5F3JtPYq581cewEgX/AICa2jeavF802lQyJ/dtbsO/5OqD9a5/UdRA8S2rNbX0BuoTbyrPAwSN0JZPnGUOQ0g4Y5IUVNVXia0JWkadFFFch2hRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZUQ+zeI5ox9y9gE4A7PGQjE/VXiH/AK1ap3QC31lIBl2Z4c+ilSx/VFpgXKKKKQBRRRQAUUUUAFFFFABVO+0yzvnWS5gVpkGEmXKyIP9lxhl/A1YuJPKgkkxnYpbH0FV9IeSTSbJ538yVoEZ3xjcSoyaYFb+z72D/jy1STaOBHdxiZVHsRtc/UsaVZNZRgrW2nzDvILh48/wDAdjY/76NalFFwsUZbu5iXnTp5W/6YyRkfmzL/ACrBEOoFngew1A6a0zTmALbh3LMXKM/ncoWJ4CjI4JIznrKKTs9xNXOEury+t/DVlpF5oOoCNlS0lYPA/nIBhlRBIWZnUEYA4BJzxz0dhod/CILp7e8mit1PkWtxcRmWI428ADBO3jLSE4J7k1fs3jt/FEMl2QEmg8i2cnASTdll+rjbj/rmR356utqVGFrnLUm4Ssjw/SpWn0y0mk+/JCjtn1IBP61qeHJhH4jlYw3MpjtMDyYHlxvfnO0HH3B1rL0uJodMtInBDRwopB7EKBXVfDttniW8U/8ALW0Uj/gDnP8A6MFdDjdWMYycXc1bH7Bcs81tDGJUcq+6Hy5EbrhgQGBwQeexB70/Wbl7LSL66iAaSCCSVQ3QlVJGfypPFMAuPENkllczWt2sDNcywBCTFnCKwZWHLbipxn5Xx1OcfVJrue0urWN4dTtp42hZLdSkqgjB+flCxz0Owe4Fcko8rsdsJ80bm5p1olhYwWsZLLEgXc3Vj3Y+5OST6mrNcppvibUJLv8As678Paj/AGhGgaR4mgMOOzFvM+XPXacnrjcBmtYW+pXisLy4SzjP/LO0O5/fMjDofZQR2apsWn2J77U7azkWF2aS5cZS3iG+Rh67R0GeNxwB3IqFv7UvCAvladAQOTiWf6Y+4pHr84q1Y2NtYRslpCsYY7nbqzt/eZjyx9ySatUDM630i2jnS4nMl3dKcrNctvKn1UfdT/gIFc58RrdEXTr+FIjfJN5cW8ZDsFaWNdv8RLxqAOD8xAIJzXaVxvjW4in17QtOZ5iqSm7lS1QyTrgFY2CKCxG4kkgHG3J4Bpx3JlZI3/AVwx1TVoFlluFYpPK0tuYXikKhNpGADlUBBAzgckgiu1rnvCFhcw2r3uoSSNd3KhMPGEYRIzmPco6OQ+W6DJxgYroa64Ky1OCbTk2gpHG5SKWiqJPPNcvLLT9Rkhury2hcnIWSVVOPoTVAaxph6ajZn/tuv+NepUVi6K7m6rtdDzSG8tp/9RcQy/7jhv5VJJI8YBNnqDA947KZx+imvR6KPYruHt32PNlmkbpY6p+Onzj+aVT1vQZfEFg1pdaBfzxE7lb93E0bdmUu6kHn+nSvVaKfsYi9vI+VdY+FvizTvNks9Lu7myQZUrLF5uOesaMdx6cjOfQVycvhzVIWxPpuqwuw/wBXJayxk/UFQSPbFfa1FYSwcG7p2NI4qS31PiV9J1HRkRdQsbyzVyXhNzC0YdepPzDnBbBxwAw9KXy9w3wZRl4KdCPYf4dP519Y/EXwpH4u8OyWYZYryJvOtZW6LIARhv8AZIJB+ueoFfKc9tPY3k1tNE0VzbsY3ibqNpIK/UEH26eua4sTQdJ3Wx14esqit1IVVZV4AWQZOOgb1Psf1B/WbT5o7bUrO8uLSG8+zSBvKnHyyesb+xHfp0ODgZYQGfMf8Q8xD7jr+eR+tB2yFW5CyjaR3BHI+hHNcyk4u6N2rqzPsbw7fWOpaFY3mkhBYSxKYURQoRcY24HQjGCOxGK0a8a/Zz1oy6fqWizE74XF1Fk8Yb5XCjsAyg/WSvZa96lP2kFI8apDkk4hVTVbGPUtPmtJmZVkAw6feRgcqw9wQCPcVborQg5GwuHk8y3uwEv7f5Z0AwM84dR/cbBIP4HkEC5V7WtITUPLmhf7Pfwg+TOBnGeqsP4kOBkfiCCARizXF3ZYXUtPuE45ltlNxET7bRvA92VRXLOm09Dtp1lJWe5cqvHe2st1JbRXMD3Mf34lkBdfqOoqtHrelSPsTUrMyf3PPXd+Wc06+TTL2EC/WzniU5AmCsAfXms7G1+xformnfRLdsW2v/Y37bdQDgD0CSFlH4CkGpLHxbeJ9OmH/TwiSN+Hlsn8qLCudNRXODVNTX/Vxi8X+9Hp90in8QrinjVNbc4h0Eyn03Tx/wDocAH60+SXYXtIrqdBRWXFda3x53hi+57xXNuwH/fUin9KsGXUwVH9gaic9SJbbj/yLT9nLsL2sO5coqsX1H/oB3//AH8t/wD47SGTUv8AoBagf+2tv/8AHaOSXYPaw7lqiqTXzx8XOn6lE3oLV5f1jDD9aibW9Oj/AOPm6S1b+7dAwN+TgGk4tdClOL2ZpUVDbXMF1H5lrNFNH/ejcMPzFTVIwooooAKzpZS+vW9uoDJHbySyf7DFlVPzHmfkadqurWWlQl724SM4JWPOXfH91eprM0nVNOQ3F3eanp63dy25k+0ofLQcImc9hkntuZscU0mJtbHRUVm/29pH/QVsP/AhP8aP7d0j/oKWH/gQn+NFmF0aVFZ39t6Wfu6hav8A7kob+VKNXtG/1f2mX/rlbSyf+gqaOVhzLuaFFURqcZ/5ddT/APBdcf8AxFOF3PJ/x76ZqU3/AGw8r/0YVp8kuwuePcuUVXjbUXYBtEvkB7tJBgflIalltNZ3fubSwKH/AJ6Xbq34gRkfrT9nLsL2sF1HMAwIIyDwRWZ4Zc/2LbQOf31qv2WUHrvT5SfocZHqCD3rRGl61JybjTrf28t5v1ylMXR9Xt2keObTJ2c7nAheDecAZJ3PzgAdOwp+yl2J9tDuTUVGYNVihLT6fHK+eEtLgOfxMgQVAZ71OZtF1GNfX90/6I5NLkl2KVWD6luiqX28D71nqQPp9hmP8lxSi6uJP+PfStRlP/XIR/8AowrS5Jdh+0j3LFxBFcwtFcRpLE3VHUMD9QarCxdQVj1DUljPVPtTtn/gTEsPwIqxFHqc6Ns0x4JB0F1MiqfxjLn9KVdN1ub70mm2ePQPc5/9F4/WrUJ9CJVKb3PPDC1pf39m7OzQ3DkM7FiVc715PJwGxk91NTaaYo9es3nluIkmV7UNDM0WGcqwJZSDyYwo9SwrrdQ8DzXd4L0aw4u2jEUnmW6tGVBJG1QVYYLN1Y9aYfh1bXELR6jql7KjjDJCEiU/T5SwPuGyO1dFm42ZyXSldbFtdOtAuGgSUk7i837x2OAMlmyScADJPQD0q2BgYFTx+FtLjjSONLxFUADbfTjOPUh+T7mkfwzAv/HpfalbHuRcGbP/AH9D/pWDovudCxEexi+GQDpEc5/19wzTT+okJO5T/u/c9goHatWqNt4Y1azu7h7XWbQ20xLmGWxY4c9WBEowT1IAwTyACTm4uiaq52zarbIh6m3syrj6FnYfmppeykUq8LA7KiM7sFVRksTgAetU11OGdEawSa/35Cm0QyIT6F/uKf8AeYVrW/hrTkdZLpHv5lO4PeN5gDf3lT7in3VRW1Vqj3ZnLEfyo5eLT9Xvf9YYtMgP0mnx9PuIffLj2rb0vTLXTY2FshMkmDLM53SSkd2bqfbsBwABxV2itYwUdjGU5S3CiiiqICiiigAooooAKKKKACiiigAooooAK+V/i/Nb/wDCzdXeHhfNSN3x8hcQxbhnpuzt4619UUx4Y3kjkeNGkjzsYqCVz1we1ZVqSqx5WzSlU9nLmPj+z8Pa7ci0lttE1OWO4lMUbi2ZQxbLLgkDjCn5ug7kV3fwv+Hw1DxNrFp4jto7iz01WhkaKRgn2h8NtVxjJRWYNjocV9EUAY6CsYYOnB33NZ4qclY8W+G3hO78KfF7UrLdJLYpp8kkU7D70ckkezdjjdlHHbO0nABr2miiuiEFBWRhObm7sKKKKskKKKKAGSxRzIUlRXU9mGRVQaRpobcNOsw3qIFz/Kr1FADY40jXbGioPRRinUUUAFFFFABRRRQAUUUUAFFFFAGfd6JpV5IZLzTLGeQ/xS26OfzIqs3hjSP+WNobceltK8A/JCK2aKLDTtsYZ8MWI/1c2op/2/TN/wChMaB4Y0/rJJqDn1N/MP0DAVuUUuVdh88u5T0/TLHTg4sLOC33/fMaBS59WPUn3NXKKKZIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11779=[""].join("\n");
var outline_f11_32_11779=null;
var title_f11_32_11780="Esophageal varices Endosc";
var content_f11_32_11780=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63682%7EGAST%2F64026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63682%7EGAST%2F64026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophageal varices",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 212px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic images from a patient with esophageal varices who presented with hematemesis. The varices appear as markedly dilated and tortuous columns of veins in the mid and distal esophagus. The varices were treated with injection sclerotherapy emergently and later with variceal banding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of JB McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bleeding esophageal varix",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A jet of active bleeding is visible from an esophageal varix in a patient with cirrhosis. Bleeding from esophageal varices can be massive.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rome Jutabha, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11780=[""].join("\n");
var outline_f11_32_11780=null;
var title_f11_32_11781="LLL atelectasis I";
var content_f11_32_11781=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57305&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left lower lobe atelectasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left lower lobe atelectasis due to an aspirated foreign body in a small child. A wedge- shaped opacity is seen in retrocardiac location (arrow). Its oblique lateral border is formed by the major fissure. The left hilum is obscured partially and displaced caudad. The residual left upper lobe is hyperexpanded, accounting for the increased lucency in the left hemithorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11781=[""].join("\n");
var outline_f11_32_11781=null;
var title_f11_32_11782="Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis";
var content_f11_32_11782=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Yujuan Choy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11782/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/32/11782/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H5618873\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute procedure anxiety is an excessive fear of medical, dental, or surgical procedures that results in acute distress or interference with completing necessary procedures. Patients may experience anxiety in anticipation of",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    during many types of procedures, including for screening (eg, mammography), diagnosis (eg, amniocentesis or endoscopy), and treatment (eg, angioplasty or open heart surgery).",
"   </p>",
"   <p>",
"    Specific phobias are a subset of the varied manifestations of acute procedure anxiety, diagnosed under DSM-IV-TR criteria only when the patient&rsquo;s fears are specific to the procedure and its immediate effects (eg, fear of suffocation during an MRI) rather than fears not specific to the procedure itself (eg, a fear of the underlying illness that might be diagnosed). Specific phobias related to clinical procedures include blood-injection-injury phobia, dental phobia, and MRI claustrophobia.",
"   </p>",
"   <p>",
"    This topic addresses the course, screening, assessment, and differential diagnosis of acute procedure anxiety in adults, related to common medical and surgical procedures. The topic includes specific phobias with anxiety related to clinical care. Specific phobias unrelated to clinical care are discussed separately. The epidemiology, clinical manifestations, and treatment of acute procedure anxiety are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=see_link\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=see_link\">",
"     \"Psychotherapy for specific phobia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=see_link\">",
"     \"Pharmacotherapy for specific phobia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=see_link\">",
"     \"Acute procedure anxiety in adults: Epidemiology and clinical presentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=see_link\">",
"     \"Treatment of acute procedure anxiety in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619323\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases of acute procedure anxiety, the anxiety tends to peak prior to the procedure and decrease immediately after the procedure. This pattern has been observed in short, prospective studies of sigmoidoscopy screening for colorectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/1\">",
"     1",
"    </a>",
"    ], colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/2\">",
"     2",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     neurosurgery/brain",
"    </span>",
"    biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/3\">",
"     3",
"    </a>",
"    ],",
"    <strong>",
"    </strong>",
"    percutaneous coronary intervention (PTCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/4\">",
"     4",
"    </a>",
"    ], and cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, a study of PTCA that followed patients for a longer period of time after PCTA found anxiety level to be equally high six to eight months post-procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The course of specific phobia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=see_link&amp;anchor=H19509089#H19509089\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\", section on 'Course'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619330\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the prevalence of acute procedure anxiety in response to certain procedures (eg, dentistry, prenatal testing, MRI examinations, colposcopy, breast and prostate biopsy, cardiac surgery, and neurosurgery), it can be useful to routinely screen these patients during the pre-procedural workup. The role of screening for other procedures is less clearly established.",
"   </p>",
"   <p>",
"    Among the instruments available for screening patients for acute procedure anxiety, we find the following to provide the best balance of psychometric properties and burden.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619337\">",
"    <span class=\"h2\">",
"     Dental anxiety",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Dental Anxiety Scale&ndash;Revised (DAS-R), a brief, four-item patient self-administered questionnaire, is suggested for screening and measuring the severity of dental anxiety. The Dental Anxiety Scale has been shown to be a valid and highly reliability measure for dental anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/8\">",
"     8",
"    </a>",
"    ]. A score of 13 or above constitutes a positive screen. A score of 15 or higher indicates a highly anxious patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619344\">",
"    <span class=\"h2\">",
"     MRI claustrophobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Claustrophobia Questionnaire, a 26-item patient self-administered questionnaire, measures fear of restriction and fear of suffocation in certain situations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/9\">",
"     9",
"    </a>",
"    ]. It is used in research, but is long for use in clinical practice. A six-question version, known as the Claustrophobia Miniscreen, is suggested for screening patients for MRI claustrophobia. A study of 80 adult MRI patients suggested that the six items can discriminate between patients who will and will not panic during an MRI scan [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/10\">",
"     10",
"    </a>",
"    ]. A score of nine or above on the Miniscreen was highly predictive of panic during the scan. Further psychometric evaluation of the Miniscreen has not been conducted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875733\">",
"    <span class=\"h1\">",
"     IDENTIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of acute procedure anxiety can be identified by the following features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excessive fear or anxiety about a procedure triggered by the thought of needing to undergo the procedure, by the need to attend an upcoming, scheduled procedure, or during the procedure. &nbsp;",
"     </li>",
"     <li>",
"      The elevated anxiety stems from concerns related to a clinical procedure. (See",
"      <a class=\"local\" href=\"#H875645\">",
"       'Focus of fear and anxiety'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The anxiety causes significant distress or avoidance of the procedure; avoidance includes delay in scheduling the procedure, early termination of the procedure, or the patient&rsquo;s need for pre-medication in order to complete a procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute procedure anxiety is diagnosed as a specific phobia using DSM-IV-TR criteria when the focus of the patient&rsquo;s fear is specific to the procedure or its effects. The diagnosis of a specific phobia is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=see_link&amp;anchor=H19509096#H19509096\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=see_link&amp;anchor=H2928505#H2928505\">",
"     \"Acute procedure anxiety in adults: Epidemiology and clinical presentation\", section on 'Specific phobias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875771\">",
"    <span class=\"h1\">",
"     ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An assessment of a patient presenting with possible acute procedure anxiety should include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875645\">",
"    <span class=\"h2\">",
"     Focus of fear and anxiety",
"    </span>",
"    &nbsp;&mdash;&nbsp;The focus may be related to concerns about the potential risks and complications of the procedure; perceptions of pain and discomfort during the procedure; fears about implications and outcomes of the procedure;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    uncertainty about illness and disability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=see_link&amp;anchor=H12823250#H12823250\">",
"     \"Acute procedure anxiety in adults: Epidemiology and clinical presentation\", section on 'Clinical Manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875638\">",
"    <span class=\"h2\">",
"     Understanding of procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may have an inaccurate perception of the risks, complications, pain, and discomfort associated with a procedure or preconceived negative notions of the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875631\">",
"    <span class=\"h2\">",
"     Severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determine the severity of anxiety (mild, moderate, severe) and the extent of avoidance behavior. Avoidance behavior can be manifested by avoidance of doctor&rsquo;s appointments, delay in scheduling the procedure, missed appointment during the procedure day, or avoidance of follow-up of test results. (See",
"    <a class=\"local\" href=\"#H5619330\">",
"     'Screening'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875616\">",
"    <span class=\"h2\">",
"     Past experience with procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Past experience with a procedure may lead to lower [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/11-14\">",
"     11-14",
"    </a>",
"    ] or higher [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/11,15\">",
"     11,15",
"    </a>",
"    ] levels of anxiety when the patient undergoes the procedure again. Familiarity with a procedure may alleviate unwarranted fears about the pain or discomfort caused by the procedure. Increased fear upon repeating the procedure may be due to concerns about progression of the underlying illness, such as in a study of patients undergoing coronary angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/15\">",
"     15",
"    </a>",
"    ]. A past negative experience with a procedure can increase anxiety in patients who are repeating the procedure, as seen in patients undergoing gynecological exams [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11782/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875609\">",
"    <span class=\"h2\">",
"     History of acute procedure anxiety",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient has previously experienced acute procedure anxiety, the clinician should inquire about previous coping strategies or past treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875602\">",
"    <span class=\"h2\">",
"     History of specific fears",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should ask whether the patient has previously experienced specific fears, in particular, fear of seeing blood, fear of injections, fear of dental treatments, and fear of being in small spaces. The patient should be asked about associated fainting if he or she has a history of blood-injection-injury phobia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H875595\">",
"    <span class=\"h2\">",
"     Comorbid anxiety disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of other anxiety disorders, such as generalized anxiety disorder, may be particularly vulnerable to the development of acute procedure anxiety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=see_link\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/15/10488?source=see_link\">",
"     \"Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619373\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute procedure anxiety should be differentiated from other mental disorders characterized by anxiety and avoidance of particular situations, or from a general medical condition in cases of fainting or panic attacks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619380\">",
"    <span class=\"h3\">",
"     Generalized anxiety disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized anxiety disorder (GAD) is characterized by excessive worries about a number of different areas that may include health or treatment-related concerns, but anxiety is not limited to worries about a specific procedure. GAD is also a chronic condition, whereas acute procedure anxiety is more acute and circumscribed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619387\">",
"    <span class=\"h3\">",
"     Agoraphobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agoraphobia is characterized by anxiety and avoidance of places and situations from which escape is difficult or embarrassing in the event of a panic attack. The focus of fear in agoraphobia is fear of losing control and consequences of having a panic attack. It is not about harm caused by the phobic situation or fear of suffocation or confinement as in MRI claustrophobia. An agoraphobia diagnosis requires anxiety and avoidance of multiple situations, rather than one type of situation, such as an enclosed space. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/15/10488?source=see_link\">",
"     \"Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619394\">",
"    <span class=\"h3\">",
"     Panic disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with panic disorder may have a panic attack while undergoing a clinical procedure. However, in panic disorder, the focus of fear is the fear of the panic attack itself and concerns about the consequence or implication of a panic attack. Fear is not focused on aspects of the procedure, as in acute procedure anxiety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=see_link\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619401\">",
"    <span class=\"h3\">",
"     Adjustment disorder with anxious mood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing an extensive clinical evaluation for a severe medical illness may be anxious during a medical procedure. However, the anxiety experienced during the procedure is in response to the stressor illness and not limited to aspects of the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619408\">",
"    <span class=\"h3\">",
"     General medical conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who faint during a medical procedure that involves exposure to injections or blood, it would be important to rule out underlying medical conditions before diagnosing a blood-injection-injury phobia. Some causes of fainting can be readily identified with a brief history, such as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A vasovagal response",
"     </li>",
"     <li>",
"      Dehydration",
"     </li>",
"     <li>",
"      Hypoglycemia",
"     </li>",
"     <li>",
"      Orthostatic hypotension secondary to medication side effects",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A cardiac and neurological workup for syncope is recommended to rule out more severe medical conditions, such as a prolonged QT syndrome (eg, in a young patient with EKG abnormality), pre-existing cardiac diseases, CNS tumors, primary brain cancer, metastatic disease to the brain or a subdural hematoma (particularly in the elderly patient). The medical evaluation of syncope is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H14005354#H14005354\">",
"     \"Evaluation of syncope in adults\", section on 'Initial evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who experience an unexpected panic attack (especially associated with shortness of breath, palpitations, and chest discomfort) during an invasive procedure that may potentially compromise the cardiac or respiratory system, a medical work-up for an acute cardiac or respiratory condition should be completed before attributing the panic attack to acute procedure anxiety. Cardiac conditions that may present with panic-like symptoms include acute coronary syndrome or arrhythmia; respiratory conditions include pulmonary embolism (including air embolism), pneumothorax, or hemothorax. Air embolism to the lungs should be considered in any procedure that involves injections or central venous catheter placement. The evaluation for general medical conditions that may mimic a panic attack is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=see_link&amp;anchor=H9381822#H9381822\">",
"     \"Panic disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'General medical conditions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5619962\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute procedure anxiety is an excessive fear of medical, dental or surgical procedures, in anticipation of or during the procedure that results in acute stress or avoidance. (See",
"      <a class=\"local\" href=\"#H875733\">",
"       'Identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute procedure anxiety is diagnosed as a specific phobia using DSM-IV-TR criteria when the focus of the patient&rsquo;s fear is specific to the procedure or its effects.",
"     </li>",
"     <li>",
"      In most cases of acute procedure anxiety, the anxiety tends to peak prior to the procedure and decrease immediately after the procedure. (See",
"      <a class=\"local\" href=\"#H5619323\">",
"       'Course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given the prevalence of acute procedure anxiety in response to certain procedures (eg, dentistry, prenatal testing, MRI examinations, colposcopy, breast and prostate biopsy, cardiac surgery, and neurosurgery), it can be useful to routinely screen these patients during the pre-procedural workup. (See",
"      <a class=\"local\" href=\"#H5619330\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Screening instruments useful for specific phobias pertaining to procedures include the Dental Anxiety Scale&ndash;Revised and the Claustrophobia Miniscreen. (See",
"      <a class=\"local\" href=\"#H5619330\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute procedure anxiety is an excessive fear of medical, dental, or surgical procedures, in anticipation of or during the procedure that results in acute stress or avoidance. (See",
"      <a class=\"local\" href=\"#H875733\">",
"       'Identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute procedure anxiety is diagnosed as a specific phobia using DSM-IV-TR criteria when the focus of the patient&rsquo;s fear is specific to the procedure or its effects.",
"     </li>",
"     <li>",
"      Assessment of the patient with acute procedure anxiety includes: (See",
"      <a class=\"local\" href=\"#H875771\">",
"       'Assessment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Identifying the focus of fear and anxiety",
"     </li>",
"     <li>",
"      Determining the severity of anxiety and the extent of avoidant behavior",
"     </li>",
"     <li>",
"      Assessing the patient&rsquo;s understanding of the procedure",
"     </li>",
"     <li>",
"      Obtaining a history of prior procedure anxiety, specific phobias, or other anxiety disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of acute procedure anxiety includes general anxiety disorder, agoraphobia, panic disorder, adjustment disorder with anxious features, and general medical conditions (eg, fainting secondary to dehydration). (See",
"      <a class=\"local\" href=\"#H5619373\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/1\">",
"      Simon AE, Steptoe A, Wardle J. Socioeconomic status differences in coping with a stressful medical procedure. Psychosom Med 2005; 67:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/2\">",
"      Byrom J, Clarke T, Neale J, et al. Can pre-colposcopy sessions reduce anxiety at the time of colposcopy? A prospective randomised study. J Obstet Gynaecol 2002; 22:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/3\">",
"      Pringle AM, Taylor R, Whittle IR. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 1999; 13:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/4\">",
"      Trotter R, Gallagher R, Donoghue J. Anxiety in patients undergoing percutaneous coronary interventions. Heart Lung 2011; 40:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/5\">",
"      Vingerhoets G. Perioperative anxiety and depression in open-heart surgery. Psychosomatics 1998; 39:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/6\">",
"      Guo P, East L, Arthur A. A preoperative education intervention to reduce anxiety and improve recovery among Chinese cardiac patients: a randomized controlled trial. Int J Nurs Stud 2012; 49:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/7\">",
"      Astin F, Jones K, Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty. Heart Lung 2005; 34:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/8\">",
"      Ronis DL, Hansen CH, Antonakos CL. Equivalence of the original and revised dental anxiety scales. J Dent Hyg 1995; 69:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/9\">",
"      Radomsky AS, Rachman S, Thordarson DS, et al. The Claustrophobia Questionnaire. J Anxiety Disord 2001; 15:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/10\">",
"      McIsaac HK, Thordarson DS, Shafran R, et al. Claustrophobia and the magnetic resonance imaging procedure. J Behav Med 1998; 21:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/11\">",
"      Reddy DM, Wasserman SA. Patient anxiety during gynecologic examinations. Behavioral indicators. J Reprod Med 1997; 42:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/12\">",
"      B&ouml;l&uuml;kba�� N, Erbil N, Kahraman AN. Determination of the anxiety level of women who present for mammography. Asian Pac J Cancer Prev 2010; 11:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/13\">",
"      Carlsson S, Aus G, Wessman C, Hugosson J. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study. Eur J Cancer 2007; 43:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/14\">",
"      Mitsonis CI, Mitropoulos PA, Dimopoulos NP, et al. Anxiety and depression in cataract surgery: a pilot study in the elderly. Psychol Rep 2006; 99:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11782/abstract/15\">",
"      Lenzen MJ, Gamel CJ, Immink AW. Anxiety and well-being in first-time coronary angioplasty patients and repeaters. Eur J Cardiovasc Nurs 2002; 1:195.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17123 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-F42F8ABDFE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11782=[""].join("\n");
var outline_f11_32_11782=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5619962\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5618873\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5619323\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5619330\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5619337\">",
"      Dental anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5619344\">",
"      MRI claustrophobia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H875733\">",
"      IDENTIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H875771\">",
"      ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875645\">",
"      Focus of fear and anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875638\">",
"      Understanding of procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875631\">",
"      Severity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875616\">",
"      Past experience with procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875609\">",
"      History of acute procedure anxiety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875602\">",
"      History of specific fears",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H875595\">",
"      Comorbid anxiety disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5619373\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5619380\">",
"      - Generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5619387\">",
"      - Agoraphobia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5619394\">",
"      - Panic disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5619401\">",
"      - Adjustment disorder with anxious mood",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5619408\">",
"      - General medical conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5619962\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/39/9849?source=related_link\">",
"      Acute procedure anxiety in adults: Epidemiology and clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/15/10488?source=related_link\">",
"      Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=related_link\">",
"      Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44713?source=related_link\">",
"      Panic disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6806?source=related_link\">",
"      Pharmacotherapy for specific phobia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25527?source=related_link\">",
"      Psychotherapy for specific phobia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/24/22921?source=related_link\">",
"      Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/18/9512?source=related_link\">",
"      Treatment of acute procedure anxiety in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_32_11783="Keratoderma in Sézary syndrome";
var content_f11_32_11783=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratoderma in S&eacute;zary syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 727px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A thickened retention of keratin on the palms and soles, so called keratoderma is a common finding and one that can also help to differentiate&nbsp;S&eacute;zary syndrome from other causes of erythroderma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11783=[""].join("\n");
var outline_f11_32_11783=null;
var title_f11_32_11784="Emergency airway management in the patient with elevated ICP";
var content_f11_32_11784=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergency airway management in the patient with elevated ICP",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Andy Jagoda, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11784/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/32/11784/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute elevations in intracranial pressure (ICP) from trauma, stroke, infection of the central nervous system, or other processes often require emergent airway management. In managing these patients, certain medications and techniques reduce the likelihood of major fluctuations in cerebral perfusion pressure, which can exacerbate brain injury.",
"   </p>",
"   <p>",
"    This topic will discuss emergent airway management in patients with elevated ICP. Other aspects of emergent airway management and diseases that cause elevations in ICP are reviewed separately.",
"   </p>",
"   <p>",
"    For further discussion of emergent airway management: (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For discussions of injuries and diseases that elevate ICP: (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=see_link\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3481?source=see_link\">",
"     \"Skull fractures in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=see_link\">",
"     \"Overview of the evaluation of stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39335?source=see_link\">",
"     \"Management of vasogenic edema in patients with primary and metastatic brain tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link\">",
"     \"Initial approach to severe traumatic brain injury in children\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral perfusion pressure (CPP) is the driving force for blood flow to the brain. It is calculated by taking the difference between the mean arterial blood pressure (MAP) and the intracranial pressure (ICP), as expressed in the formula CPP = MAP &ndash; ICP. The pathophysiology of elevated ICP is discussed in detail separately; issues of particular relevance to airway management are highlighted below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=see_link\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autoregulation is the ability to regulate cerebral blood flow (CBF) over a wide range of MAPs. ICP is typically preserved through a MAP range of approximately 60 to 160 mmHg. When severe intracranial hypertension develops, autoregulation often is lost. In this setting, excessive systemic hyper- or hypotension can aggravate brain injury by causing cerebral hypoperfusion and hypoxemia, with resultant cerebral edema and increasing ICP. Hypotension is especially harmful and must be avoided whenever possible.",
"   </p>",
"   <p>",
"    Patients with intracranial hypertension present a particular clinical challenge, since many airway management techniques potentially increase ICP. Often, these patients are the victims of multiple trauma and present with hypovolemia with or without hypotension, thus limiting the choice of agents and techniques available.",
"   </p>",
"   <p>",
"    In such cases, it might appear that increases in MAP would be beneficial by allowing CPP and oxygenation of brain tissue to be maintained. However, because of the loss of autoregulation in patients with intracranial injury, increases in MAP can translate directly into increases in ICP. Thus, not only is the driving gradient for CPP increased, but the absolute ICP is increased as well. Accordingly, it is important to try to maintain the MAP in a reasonable range (approximately 100 to 110 mmHg) to optimize cerebral perfusion and to minimize absolute ICP.",
"   </p>",
"   <p>",
"    The techniques and medications used in airway management may increase ICP through several mechanisms. These include the reflex sympathetic response to laryngoscopy (RSRL), other reflexive responses to stimulation and manipulation of the upper airway (eg, laryngoscopy and placement of the endotracheal tube), and the direct increase in ICP stimulated by certain medications used during intubation.",
"   </p>",
"   <p>",
"    The RSRL is stimulated by the sensory innervation of the supraglottic larynx, which results in increased serum levels of epinephrine, norepinephrine, and vasopressin&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The innervation of the upper and lower airways is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/60/10186?source=see_link\">",
"     \"Neuronal control of the airways\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of the laryngoscope or attempted placement of an endotracheal tube results in a significant afferent discharge that increases cardiovascular sympathetic activity. For direct laryngoscopy attempts up to 45 seconds in duration, the longer the attempt the greater the sympathetic nervous system stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/4\">",
"     4",
"    </a>",
"    ]. Both the lighted stylet and fiberoptic techniques result in reflex sympathetic responses that are comparable to direct laryngoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/2,5-7\">",
"     2,5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The catecholamine surge caused by RSRL leads to an increased heart rate and blood pressure, which significantly enhances cerebral blood flow (CBF) through redistribution and increased cerebral blood volume [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Ultimately, these hemodynamic changes can exacerbate intracranial hypertension if autoregulation is impaired, and therefore, it is desirable to mitigate such responses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RSI FOR ELEVATED ICP",
"    </span>",
"    &nbsp;&mdash;&nbsp;We believe rapid sequence intubation (RSI) is the preferred method for securing the airway in patients with suspected elevated intracranial pressure (ICP). This recommendation is based upon its high success rate and low incidence of complications. However, no outcome studies have been performed to determine the best approach to airway management in these patients.",
"   </p>",
"   <p>",
"    RSI protocols are designed to minimize potentially adverse reactions, such as the reflex sympathetic response that occurs during airway manipulation. Assessment of the airway and the performance of RSI are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When performing RSI in the patient with elevated ICP, gentle, controlled technique is desired and prolonged or multiple attempts at intubation should be avoided whenever possible. Minimizing stimulation of the supraglottic larynx reduces the reflexive responses that can exacerbate elevations in ICP. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The use of RSI in patients with the potential for neurologic deficits carries the responsibility of performing and documenting an appropriate neurologic evaluation, when possible, prior to the initiation of neuromuscular blockade. The assessment should include the patient's ability to interact with surroundings, pupillary reflexes, and motor response to voice and pain. The careful recording of these findings establishes a baseline for comparison during subsequent monitoring, as well as providing important prognostic information.",
"   </p>",
"   <p>",
"    Maintaining oxygenation is vital in patients with elevated ICP. Preoxygenation plays an important role in RSI by allowing the clinician to maintain high oxyhemoglobin saturation without requiring bag-mask ventilation while neuromuscular blockade takes effect, thereby minimizing the risk of aspiration. However, if the patient's oxygenation is compromised, positive pressure ventilation with a bag and mask may be required throughout the preintubation sequence. In such circumstances, the increased risk of aspiration is offset by the hazard of inadequate oxygenation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link&amp;anchor=H7#H7\">",
"     \"Rapid sequence intubation in adults\", section on 'Preoxygenation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Do not forego appropriate induction and neuromuscular blocking agents in the comatose patient who is to undergo RSI. The pathologic reflexes described above do occur in comatose patients, though they may appear unresponsive [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PRETREATMENT AGENTS FOR RSI",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Overview and approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial pressure (ICP) can increase as a result of the reflex sympathetic response to laryngoscopy (RSRL) and direct reflexive responses to airway manipulation. The mechanisms by which these responses occur are outlined above. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    To blunt the rise in ICP caused by these adverse responses during RSI, we suggest pretreatment with a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    and a short-acting opioid (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    ) in patients whose conditions would be exacerbated by a rise in ICP. Such conditions may include acute brain injury, ischemic stroke, intracranial hemorrhage, meningitis or encephalitis, cerebral edema, and hypertensive encephalopathy (",
"    <a class=\"graphic graphic_table graphicRef69683 \" href=\"UTD.htm?8/25/8603\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=see_link\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We give",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV two to three minutes before intubation, followed by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    IV over 30 to 60 seconds. Fentanyl should",
"    <strong>",
"     NOT",
"    </strong>",
"    be given to hypotensive patients or patients with hypovolemia who are dependent upon sympathetic drive to maintain a minimally compensated blood pressure.",
"   </p>",
"   <p>",
"    No outcome studies have demonstrated that transient increases in ICP result in worse patient outcomes, and the use of pretreatment medications should be viewed as supplementary (ie, nonessential) in RSI. Nevertheless, both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    and short-acting opioids are relatively safe and may be beneficial when given in the proper setting. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Lidocaine'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H7\">",
"     'Ultrashort-acting opioid'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    While short-acting beta blockers (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40536?source=see_link\">",
"     esmolol",
"    </a>",
"    ) minimize reflex hypertension and tachycardia due to laryngoscopy, they are not used in the acute trauma setting because of the risk of hypotension. The use of a defasciculating dose of a nondepolarizing neuromuscular blocking agent to reduce the ICP response that occurs during the fasciculations caused by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    is of unproven benefit and is not recommended. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Beta blocker'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H9\">",
"     'Defasciculating dose of NMBA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lidocaine",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no high quality evidence that directly addresses whether pretreatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    effectively reduces the rise in ICP caused by laryngoscopy and endotracheal intubation (ETI) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In small randomized and nonrandomized clinical trials, intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    has shown mixed and inconsistent attenuation of the blood pressure and pulse response to ETI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/9,13-16\">",
"     9,13-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies of the drug's effect upon ICP have also found inconsistent results. Several small randomized trials have found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    minimizes the rise in ICP in patients undergoing neurosurgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/17\">",
"     17",
"    </a>",
"    ] or endotracheal suctioning [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. In contrast, other randomized trials have found no benefit from pretreatment with lidocaine in blunting ICP rise during ETI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/21\">",
"     21",
"    </a>",
"    ] or endotracheal suctioning [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the conflicting evidence, we believe",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    is a reasonable pretreatment agent for patients with elevated ICP, given its relative safety and the potential benefit of blunting further ICP elevations in patients at risk for secondary brain injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ultrashort-acting opioid",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single pretreatment dose of an ultrashort-acting opioid (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/9/3223?source=see_link\">",
"     alfentanil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/47/15094?source=see_link\">",
"     sufentanil",
"    </a>",
"    ) given over 30 to 60 seconds mitigates the reflex sympathetic response to laryngoscopy (RSRL) without causing hypoventilation or respiratory depression.",
"   </p>",
"   <p>",
"    Multiple small randomized trials have demonstrated the effectiveness of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    in this regard when given at a dose of 5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    IV [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, this dose may cause premature respiratory depression during RSI. Some observational trials found that fentanyl, at a dose of 2 to 3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    IV, mitigates the RSRL [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/14\">",
"     14",
"    </a>",
"    ], but other studies found no benefit unless",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40536?source=see_link\">",
"     esmolol",
"    </a>",
"    was given concurrently [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. Administering a reduced dose of fentanyl (3",
"    <span class=\"nowrap\">",
"     mcg/kg)",
"    </span>",
"    seems to provide the best balance between the desired (sympathetic blockade) and undesired (respiratory depression) effects.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/9/3223?source=see_link\">",
"     Alfentanil",
"    </a>",
"    showed superior hemodynamic attenuation of RSRL in one study, but is relatively unknown to emergency physicians and not used for other purposes in emergency practice [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Beta blocker",
"    </span>",
"    &nbsp;&mdash;&nbsp;In multiple small randomized trials, the short-acting beta blocker",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/37/40536?source=see_link\">",
"     esmolol",
"    </a>",
"    , given at a dose of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV, has demonstrated the ability to control both heart rate and blood pressure responses to intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/26,30-32\">",
"     26,30-32",
"    </a>",
"    ]. Unfortunately, esmolol may cause hypotension, which must be avoided at all costs in the head-injured patient. For this reason, although esmolol is consistent and reliable for mitigation of RSRL in elective anesthesia, it is generally",
"    <strong>",
"     NOT",
"    </strong>",
"    used for this purpose in the emergency department.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Defasciculating dose of NMBA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no high quality evidence to support the use of a small (ie, defasciculating) dose of a nondepolarizing neuromuscular blocking agent (NMBA) to blunt the potential rise in ICP caused by the fasciculations that accompany",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    (SCh) administration [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/33\">",
"     33",
"    </a>",
"    ]. This practice adds complexity to airway management without clear benefit and we do not suggest such treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CHOICE OF INDUCTION AGENT FOR RSI",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"     etomidate",
"    </a>",
"    (0.3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV push) be used as the induction agent for rapid sequence intubation (RSI) in patients with elevated ICP, particularly those who are hypotensive or at risk for hypotension.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     Ketamine",
"    </a>",
"    (1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV) can also be used as the induction agent in normotensive or hypotensive patients. For patients with elevated ICP who are at no risk of hypotension, sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"     thiopental",
"    </a>",
"    may be used. Induction agents for RSI are discussed in detail separately; some aspects relevant to their use in patients with elevated ICP are described here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"     Etomidate",
"    </a>",
"    is a short-acting imidazole derivative with rapid onset, stable hemodynamics, and minimal impact on respiratory drive. Etomidate has a safe hemodynamic profile, even when used in patients who are hypovolemic or cardiovascularly impaired. It has been shown to decrease the basal metabolic rate of oxygen utilization of the brain (CMRO2) and ICP in a fashion similar to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"     thiopental",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     Ketamine",
"    </a>",
"    is a dissociative anesthetic with analgesic and amnestic properties. Among its many effects, ketamine stimulates catecholamine receptors leading to increases in mean arterial blood pressure and cerebral blood flow. Thus, we believe ketamine is an appropriate induction agent for normotensive or hypotensive patients with elevated ICP. However, the use of ketamine in head-injured patients remains controversial among some clinicians; this issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link&amp;anchor=H10#H10\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\", section on 'Ketamine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"     thiopental",
"    </a>",
"    is an ultrashort-acting barbiturate that provides a cerebroprotective effect by decreasing CMRO2. In addition, sodium thiopental decreases cerebral blood flow, thus decreasing ICP. This ability to decrease both ICP and CMRO2 makes thiopental attractive. However, thiopental is a potent vasodilator and negative inotrope that can ultimately reduce mean arterial blood pressure and CPP [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/36\">",
"     36",
"    </a>",
"    ]. Consequently, thiopental should only be used in patients with stable hemodynamics, and even then should be used with caution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CHOICE OF NEUROMUSCULAR BLOCKING AGENT FOR RSI",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    (SCh) (1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV) be used as the neuromuscular blocking agent (NMBA) for rapid sequence intubation (RSI) in patients with elevated ICP because of its rapid onset, consistent and reliable effects, and short duration of action [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/37\">",
"     37",
"    </a>",
"    ]. NMBAs for RSI are discussed in detail separately; their use in patients with elevated ICP is described here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=see_link\">",
"     \"Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In animal studies, SCh causes a temporary increase in intracranial pressure (ICP) during the fasciculation phase [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. However, one small observational study in humans showed no such effect [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/40\">",
"     40",
"    </a>",
"    ], and the clinical significance of this phenomenon remains unknown.",
"   </p>",
"   <p>",
"    The administration of a small \"defasciculating\" dose of a nondepolarizing NMBA or a mini-dose (20 mg) of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    has been used to reduce fasciculations, but the effect of these practices upon ICP remains unclear and this approach is no longer recommended. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Defasciculating dose of NMBA'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Nondepolarizing (ie, competitive) NMBAs do not cause an elevation of ICP.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"     Rocuronium",
"    </a>",
"    is the most commonly available short-acting competitive agent. However, although rocuronium is relatively short-acting, spontaneous respiration does not return for up to 45 minutes after its use. Studies have not demonstrated an outcome benefit to the use of a nondepolarizing versus a depolarizing NMBA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     AWAKE INTUBATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, an \"awake\" approach to intubation may be preferable when a difficult airway is predicted in patients with elevated ICP. Awake intubation is discussed further separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link&amp;anchor=H20#H20\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\", section on 'Conditions precluding use of a paralytic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks and benefits of awake intubation must be weighed carefully in this setting due to the risk of further elevations in ICP from the stimulatory effects of intubation. The most gentle intubation technique possible, usually flexible fiberoptic intubation, should be used.",
"   </p>",
"   <p>",
"    Although patients with elevated ICP have a decreased level of consciousness, the use of topical anaesthesia, intravenous sedation, and intravenous opioid analgesia is advisable. When time permits, a drying agent (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/20/11591?source=see_link\">",
"     glycopyrrolate",
"    </a>",
"    0.2 to 0.4 mg IV) improves the efficacy of topical anesthetics and should be used. Topical anaesthesia, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    4%, can be combined with a vasoconstrictor, such as topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    0.5%, and administered via nebulizer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11784/abstract/41\">",
"     41",
"    </a>",
"    ]. The choices of sedative agent and opioid analgesic are the same as for the patient with normal intracranial pressure and are guided by assessment of the patient's hemodynamic and respiratory status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     INITIATING MECHANICAL VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical ventilation in the patient with elevated intracranial pressure (ICP) should be predicated upon two principles:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Optimize oxygenation",
"     </li>",
"     <li>",
"      Avoid ventilation mechanics (eg, positive end-expiratory pressure, high peak inspiratory pressure) that increase cerebral venous congestion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reduction in PaCO2 tensions in the brain leads to vasoconstriction, decreased cerebral blood flow, and decreased ICP. Therefore, patients should be ventilated in such a way as to target the lower limits of normocapnia (PaCO2 of 35 mmHg). Hyperventilation to a PaCO2 of 30 mmHg should only be used when osmotic agents and CSF drainage are not effective in managing an acute rise in ICP that is accompanied by neurologic deterioration. Carbon dioxide tension can be followed with arterial blood gases or capnography.",
"   </p>",
"   <p>",
"    Long-term analgesia and sedation should be used as needed to permit effective mechanical ventilation, minimize sympathetic response, and reduce elevated ICP. If these measures are ineffective, pharmacological paralysis may be needed. Further discussion of mechanical ventilation and monitoring in the setting of elevated ICP is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=see_link&amp;anchor=H16#H16\">",
"     \"Mechanical ventilation of adults in the emergency department\", section on 'Elevated intracranial pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=see_link&amp;anchor=H10#H10\">",
"     \"Mechanical ventilation of adults in the emergency department\", section on 'General invasive positive pressure ventilation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=see_link\">",
"     \"Evaluation and management of elevated intracranial pressure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The techniques and medications used in airway management may increase intracranial pressure (ICP) through several mechanisms. Such elevations can cause harm in patients whose ICP is already high due to acute brain injury, ischemic stroke, intracranial hemorrhage, meningitis or encephalitis, cerebral edema, and hypertensive encephalopathy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapid sequence intubation (RSI) is the primary method for securing the airway in patients with suspected elevated ICP whose airways are not anticipated to be difficult. Assessment of the airway and the performance of RSI are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"       \"The difficult airway in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"       \"Rapid sequence intubation in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"       \"Rapid sequence intubation (RSI) in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of pretreatment medications is supplementary (ie, nonessential) in RSI. When time allows, we suggest pretreatment with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      and a short-acting opioid (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      ) to blunt the rise in ICP during RSI in patients whose condition would be exacerbated by any further increase (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We give lidocaine 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV two to three minutes before intubation, followed by fentanyl 3",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      IV over 30 to 60 seconds. Fentanyl should",
"      <strong>",
"       NOT",
"      </strong>",
"      be given to hypotensive patients or patients with hypovolemia who are dependent upon sympathetic drive to maintain blood pressure. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Overview and approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Lidocaine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Ultrashort-acting opioid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"       etomidate",
"      </a>",
"      (0.3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV push) be used as the induction agent for RSI in patients with elevated ICP (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"       Ketamine",
"      </a>",
"      (1 to 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV) may be used in hypotensive or normotensive patients. For patients with elevated ICP who are at no risk of hypotension, sodium",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"       thiopental",
"      </a>",
"      may be used. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"       \"Sedation or induction agents for rapid sequence intubation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"       succinylcholine",
"      </a>",
"      (1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV) be used as the neuromuscular blocking agent (NMBA) for RSI in patients with elevated ICP (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We prefer succinylcholine because of its rapid onset, consistent and reliable effects, and short duration of action. Nondepolarizing (ie, competitive) NMBAs such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"       rocuronium",
"      </a>",
"      do not cause an elevation of ICP and can also be used for RSI in this setting. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Choice of neuromuscular blocking agent for RSI'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=see_link\">",
"       \"Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/1\">",
"      Kayhan Z, Aldemir D, Mutlu H, O��&uuml;�� E. Which is responsible for the haemodynamic response due to laryngoscopy and endotracheal intubation? Catecholamines, vasopressin or angiotensin? Eur J Anaesthesiol 2005; 22:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/2\">",
"      Takahashi S, Mizutani T, Miyabe M, Toyooka H. Hemodynamic responses to tracheal intubation with laryngoscope versus lightwand intubating device (Trachlight) in adults with normal airway. Anesth Analg 2002; 95:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/3\">",
"      Shribman AJ, Smith G, Achola KJ. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth 1987; 59:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/4\">",
"      Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine. Anesthesiology 1977; 47:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/5\">",
"      Tewari P, Gupta D, Kumar A, Singh U. Opioid sparing during endotracheal intubation using McCoy laryngoscope in neurosurgical patients: the comparison of haemodynamic changes with Macintosh blade in a randomized trial. J Postgrad Med 2005; 51:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/6\">",
"      Barak M, Ziser A, Greenberg A, et al. Hemodynamic and catecholamine response to tracheal intubation: direct laryngoscopy compared with fiberoptic intubation. J Clin Anesth 2003; 15:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/7\">",
"      Tong JL, Ashworth DR, Smith JE. Cardiovascular responses following laryngoscope assisted, fibreoptic orotracheal intubation. Anaesthesia 2005; 60:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/8\">",
"      Moorthy SS, Greenspan CD, Dierdorf SF, Hillier SC. Increased cerebral and decreased femoral artery blood flow velocities during direct laryngoscopy and tracheal intubation. Anesth Analg 1994; 78:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/9\">",
"      Chraemmer-J&oslash;rgensen B, H&oslash;ilund-Carlsen PF, Marving J, Christensen V. Lack of effect of intravenous lidocaine on hemodynamic responses to rapid sequence induction of general anesthesia: a double-blind controlled clinical trial. Anesth Analg 1986; 65:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/10\">",
"      Moulton C, Pennycook AG. Relation between Glasgow coma score and cough reflex. Lancet 1994; 343:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/11\">",
"      Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature. Emerg Med J 2001; 18:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/12\">",
"      Butler J, Jackson R. Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Lignocaine premedication before rapid sequence induction in head injuries. Emerg Med J 2002; 19:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/13\">",
"      Helfman SM, Gold MI, DeLisser EA, Herrington CA. Which drug prevents tachycardia and hypertension associated with tracheal intubation: lidocaine, fentanyl, or esmolol? Anesth Analg 1991; 72:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/14\">",
"      Splinter WM, Cervenko F. Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Can J Anaesth 1989; 36:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/15\">",
"      Abou-Madi MN, Keszler H, Yacoub JM. Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine. Can Anaesth Soc J 1977; 24:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/16\">",
"      Bachofen M. [Suppression of blood pressure increases during intubation: lidocaine or fentanyl?]. Anaesthesist 1988; 37:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/17\">",
"      Grover VK, Reddy GM, Kak VK, Singh S. Intracranial pressure changes with different doses of lignocaine under general anaesthesia. Neurol India 1999; 47:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/18\">",
"      White PF, Schlobohm RM, Pitts LH, Lindauer JM. A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning. Anesthesiology 1982; 57:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/19\">",
"      Donegan MF, Bedford RF. Intravenously administered lidocaine prevents intracranial hypertension during endotracheal suctioning. Anesthesiology 1980; 52:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/20\">",
"      Bilotta F, Branca G, Lam A, et al. Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma. Neurocrit Care 2008; 8:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/21\">",
"      Samaha T, Ravussin P, Claquin C, Ecoffey C. [Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine]. Ann Fr Anesth Reanim 1996; 15:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/22\">",
"      Yano M, Nishiyama H, Yokota H, et al. Effect of lidocaine on ICP response to endotracheal suctioning. Anesthesiology 1986; 64:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/23\">",
"      Chung KS, Sinatra RS, Halevy JD, et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth 1992; 39:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/24\">",
"      Cork RC, Weiss JL, Hameroff SR, Bentley J. Fentanyl preloading for rapid-sequence induction of anesthesia. Anesth Analg 1984; 63:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/25\">",
"      Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981; 36:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/26\">",
"      Hussain AM, Sultan ST. Efficacy of fentanyl and esmolol in the prevention of haemodynamic response to laryngoscopy and endotracheal intubation. J Coll Physicians Surg Pak 2005; 15:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/27\">",
"      Adachi YU, Satomoto M, Higuchi H, Watanabe K. Fentanyl attenuates the hemodynamic response to endotracheal intubation more than the response to laryngoscopy. Anesth Analg 2002; 95:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/28\">",
"      del R&iacute;o Vellosillo M, Gallego Garc&iacute;a J, Soliveres Ripoll J, et al. [Bolus administration of fentanyl vs continuous perfusion of remifentanil for control of hemodynamic response to laryngoscopy and orotracheal intubation: a randomized double-blind trial]. Rev Esp Anestesiol Reanim 2009; 56:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/29\">",
"      Payne KA, Murray WB, Oosthuizen JH. Obtunding the sympathetic response to intubation. Experience at 2 minutes after administration of the test agent in patients with cerebral aneurysms. S Afr Med J 1988; 73:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/30\">",
"      Raymondos K, M&uuml;nte S, Krauss T, et al. Cortical activity assessed by Narcotrend in relation to haemodynamic responses to tracheal intubation at different stages of cortical suppression and reflex control. Eur J Anaesthesiol 2003; 20:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/31\">",
"      Oda Y, Nishikawa K, Hase I, Asada A. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg 2005; 100:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/32\">",
"      Feng CK, Chan KH, Liu KN, et al. A comparison of lidocaine, fentanyl, and esmolol for attenuation of cardiovascular response to laryngoscopy and tracheal intubation. Acta Anaesthesiol Sin 1996; 34:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/33\">",
"      Clancy M, Halford S, Walls R, Murphy M. In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review. Emerg Med J 2001; 18:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/34\">",
"      Moss E, Powell D, Gibson RM, McDowall DG. Effect of etomidate on intracranial pressure and cerebral perfusion pressure. Br J Anaesth 1979; 51:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/35\">",
"      Modica PA, Tempelhoff R. Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression. Can J Anaesth 1992; 39:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/36\">",
"      Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/37\">",
"      May N, Anderson K. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Suxamethonium (succinylcholine) for RSI and intubation in head injury. Emerg Med J 2012; 29:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/38\">",
"      Lanier WL, Iaizzo PA, Milde JH. Cerebral function and muscle afferent activity following intravenous succinylcholine in dogs anesthetized with halothane: the effects of pretreatment with a defasciculating dose of pancuronium. Anesthesiology 1989; 71:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/39\">",
"      Cottrell JE, Hartung J, Giffin JP, Shwiry B. Intracranial and hemodynamic changes after succinylcholine administration in cats. Anesth Analg 1983; 62:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/40\">",
"      Kovarik WD, Mayberg TS, Lam AM, et al. Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury. Anesth Analg 1994; 78:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11784/abstract/41\">",
"      Sun HL, Wu TJ, Ng CC, et al. Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. J Clin Anesth 2009; 21:103.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 266 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-CEC8CE9A1B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11784=[""].join("\n");
var outline_f11_32_11784=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RSI FOR ELEVATED ICP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PRETREATMENT AGENTS FOR RSI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Overview and approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lidocaine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ultrashort-acting opioid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Beta blocker",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Defasciculating dose of NMBA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CHOICE OF INDUCTION AGENT FOR RSI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CHOICE OF NEUROMUSCULAR BLOCKING AGENT FOR RSI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      AWAKE INTUBATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      INITIATING MECHANICAL VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/266\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/266|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/25/8603\" title=\"table 1\">",
"      Causes of elevated ICP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=related_link\">",
"      Advanced emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=related_link\">",
"      Evaluation and management of elevated intracranial pressure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=related_link\">",
"      Initial approach to severe traumatic brain injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39335?source=related_link\">",
"      Management of vasogenic edema in patients with primary and metastatic brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=related_link\">",
"      Mechanical ventilation of adults in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=related_link\">",
"      Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/60/10186?source=related_link\">",
"      Neuronal control of the airways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=related_link\">",
"      Rapid sequence intubation (RSI) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=related_link\">",
"      Sedation or induction agents for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3481?source=related_link\">",
"      Skull fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_32_11785="The coronary microcirculation in disease states";
var content_f11_32_11785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The coronary microcirculation in disease states",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Frank W Sellke, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11785/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/32/11785/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The coronary microcirculation, which consists of resistance arterioles, capillaries, and small veins or venules, plays a major role in the delivery of blood and nutrients to the myocardium. In addition to its physiologic role, the coronary microcirculation is affected in a variety of systemic and cardiac disorders. These may be considered functional alterations, involving changes in the responsiveness of the coronary microvasculature, and structural effects, as with alterations in the number and diameter of the coronary microvessels. While much of the microvascular vasoregulation occurs due to metabolic and autoregulatory factors, microvascular tone and, hence, myocardial perfusion, is also influenced by the vascular endothelium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ENDOTHELIAL DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial-mediated vasodilation is abnormal in a variety of pathologic conditions, including atherosclerosis, hypercholesterolemia, diabetes, hypertension, cigarette smoking, ischemia reperfusion, and aging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"     \"Endothelial dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanisms underlying these abnormal endothelium-dependent responses include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A reduction in the synthesis and release of nitric oxide (NO), resulting in part from deficiencies in L-arginine, the substrate for endothelial nitric oxide synthase (eNOS), and the co-factor tetrahydrobiopterin.",
"     </li>",
"     <li>",
"      Abnormalities of G-protein signaling, resulting in reduced activation of eNOS in response to endothelial cell receptor activation. In addition, the enzyme arginase may be increased in activity after ischemia-reperfusion, decreasing the available L-arginine [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In some of disease states (eg, hypercholesterolemia, hypertension, and diabetes), there is increased vascular production of superoxide, which reacts rapidly with NO, leading to the formation of the toxic peroxynitrite anion. While peroxynitrite can produce vasodilation, it is a weak vasodilator; as a result, much of the vasodilator capacity of NO is lost.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the initial studies demonstrating abnormal endothelium-dependent vascular relaxation in various disease models were performed in larger vessels, subsequent experiments showed that most, if not all, of these disease processes affect the coronary microcirculation in a similar fashion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairment of endothelium-dependent relaxation in the coronary microvasculature is of particular interest in the setting of hypercholesterolemia and atherosclerosis. One of the first examples of an alteration in the coronary microcirculation in atherosclerosis was made in monkeys fed a high cholesterol diet for 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/2\">",
"     2",
"    </a>",
"    ]. These animals developed impaired vasodilation, and in some cases paradoxical constrictions, in larger vessels in response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"     acetylcholine",
"    </a>",
"    , bradykinin, and thrombin. Impaired vasodilation was also seen in the coronary microvasculature, where overt atherosclerosis does not develop. Similar findings have been made in other animal models of diet-induced atherosclerosis.",
"   </p>",
"   <p>",
"    In atherosclerosis, the serotonin 1B receptor is upregulated and serotonin produces augmented vasoconstriction, a result of calcium mobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/3\">",
"     3",
"    </a>",
"    ]. Other studies using in vivo techniques showed that vasoconstriction caused by serotonin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/213?source=see_link\">",
"     ergonovine",
"    </a>",
"    , which is normally modulated by the endothelium, was markedly enhanced in the coronary microcirculation of hypercholesterolemic monkeys [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/4\">",
"     4",
"    </a>",
"    ]. These findings are striking because the coronary microcirculation is spared from overt atherosclerosis. Thus, vessels that have been exposed to a high cholesterol milieu, even in the absence of atherosclerosis, develop abnormal vasomotion.",
"   </p>",
"   <p>",
"    While it is difficult to perform such studies in human vessels, investigators have used Doppler techniques to measure coronary flow in humans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=see_link\">",
"     \"Clinical use of coronary artery pressure and Doppler flow measurements\"",
"    </a>",
"    .) Diminished flow responses to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"     acetylcholine",
"    </a>",
"    have been demonstrated in humans with hypercholesterolemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/5,6\">",
"     5,6",
"    </a>",
"    ], an abnormality that can be corrected by reducing the serum cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=see_link&amp;anchor=H9#H9\">",
"     \"Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease\", section on 'Reversal of endothelial dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Impaired endothelium-mediated relaxation has also been demonstrated in humans with or experimental models of hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/7\">",
"     7",
"    </a>",
"    ], ischemia followed by reperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both type 1 and type 2 diabetes are risk factors for the development of CHD, and type 2 diabetes is considered a coronary equivalent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27226?source=see_link\">",
"     \"Prevalence of and risk factors for coronary heart disease in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diabetes is associated with vascular dysfunction. Increased oxidative stress, which is associated with diabetes, may inhibit nitric oxide, which contributes to endothelial dysfunction. Oxidative stress may also directly affect an active component of metabolic vasodilation.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     Hydrogen peroxide",
"    </a>",
"    produces vasodilation by oxidation of thiols and activation of p38 MAP kinase. Thus, coronary metabolic dilation appears to be mediated by redox-dependent signals [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/11\">",
"     11",
"    </a>",
"    ]. Other factors also play a role, including abnormal autonomic regulation of vascular tone, changes in vascular smooth muscle reactivity, altered voltage-gated K+ channel function, and impaired vasodilatory response to hypoxia, which may have significant implications for the metabolic regulation of blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Role of endothelin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased vasomotor tone in atherosclerotic coronary arteries is partly due to endothelial dysfunction; however, endothelin-1 also contributes to the exaggerated vasoconstrictor response. Administration of an endothelin receptor antagonist produces significant dilation in atherosclerotic arteries, especially at stenoses (16.3 and 21.6 versus 7.3 percent in normal arteries), suggesting that endothelin significantly contributes to the resting tone in atherosclerotic arteries (74 versus 39 percent in normal arteries) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cardiac syndrome X",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac syndrome X is a term used to describe the phenomenon of angina pectoris with normal coronary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/16\">",
"     16",
"    </a>",
"    ]. This condition has three characteristic features:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Angina or angina-like chest pain with exertion",
"     </li>",
"     <li>",
"      ST segment depression on treadmill exercise testing",
"     </li>",
"     <li>",
"      Normal coronary arteriography, with no spontaneous or inducible epicardial coronary artery spasm on",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/213?source=see_link\">",
"       ergonovine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"       acetylcholine",
"      </a>",
"      provocation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been suggested that chest pain in patients with cardiac syndrome X is due to impaired endothelium-mediated vasomotion in the cardiac microvasculature. For this reason, cardiac syndrome X has also been called",
"    <strong>",
"     microvascular angina",
"    </strong>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis and clinical features of cardiac syndrome X are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19864?source=see_link\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries: Pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5802?source=see_link\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     After coronary artery bypass graft surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial function of the coronary microcirculation is altered following cardioplegic arrest and extracorporeal circulation during coronary artery bypass graft surgery (CABG) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. This abnormality persists for some time after cardiopulmonary bypass, and normalizes thereafter. A number of factors may be involved, including increased release of products of COX-2 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Such a deficit in endothelial function may have important clinical implications because of the frequency with which cardioplegia is used in cardiovascular surgery. It is not uncommon for patients undergoing CABG with complete coronary revascularization to exhibit signs of myocardial ischemia during the hours following surgery; it is possible that the mechanism, in part, is alteration of endothelial function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=see_link\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\"",
"    </a>",
"    .) In addition, it is likely that the arteriopathy often observed after cardiac transplantation is in part related to endothelial injury resulting from inadequate vascular preservation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=see_link\">",
"     \"Pathogenesis of and risk factors for cardiac allograft vasculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic heart failure, due to either an ischemic or nonischemic cardiomyopathy, is associated with endothelial dysfunction and impaired endothelium-mediated, flow-dependent dilation of coronary and peripheral arteries due to a reduction in the synthesis, release, and response to NO [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"     \"Endothelial dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12872?source=see_link\">",
"     \"Nitric oxide, other hormones, cytokines, and chemokines in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is evidence for increased free radical formation in heart failure, and it is possible that these species inactivate nitric oxide. Support for this hypothesis comes from one study in which vitamin C improved endothelial function in patients with heart failure in association with an increased availability of nitric oxide [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=see_link\">",
"     \"Nutritional antioxidants in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Heart transplantation can normalize peripheral endothelial function in patients with nonischemic cardiomyopathy, but has no effect in those with prior ischemic cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/25\">",
"     25",
"    </a>",
"    ]. Endothelial dysfunction in patients with a nonischemic cardiomyopathy is probably a consequence of hemodynamic alterations that are reversible after transplantation, while endothelial dysfunction is also due to the presence of systemic atherosclerosis in patients with ischemic cardiomyopathy. Persistent endothelial dysfunction also may result from vascular inflammation associated with viral myocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of endothelial dysfunction after heart transplantation is associated with the development of transplant vasculopathy. In one study, for example, 58 percent of transplant patients with such endothelial dysfunction developed angiographic evidence of arteriosclerosis at one year compared with only 13 percent of those with normal function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/27\">",
"     27",
"    </a>",
"    ]. The development of microvasculopathy in heart transplant patients is associated with reduced long-term survival [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=see_link\">",
"     \"Pathogenesis of and risk factors for cardiac allograft vasculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cyanotic congenital heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with cyanotic congenital heart disease manifest a significant increase in basal coronary blood flow. However, coronary artery flow reserve remains normal. In necropsy specimens studied from hearts of patients with various congenital anomalies (including Eisenmenger's syndrome, structurally abnormal hearts with ventricular hypertrophy, structurally normal hearts with ventricular hypertrophy, and normal hearts) remodeling of the coronary microcirculation was noted to be the key mechanism for preservation of flow reserve in cyanotic congenital heart disease. The increase in vascular diameter compensated for lower arteriolar length density and was the principal anatomic basis for maintenance of normal flow reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiation induced vasculopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endothelial dysfunction and vascular dysregulation contribute to the pathological effects of radiation on tissues. In murine intestinal arterioles subjected to radiation, significant increases in superoxide and peroxides were observed. Irradiated microvessels pretreated with a superoxide dismutase-mimetic demonstrated significant improvement in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/35/6707?source=see_link\">",
"     acetylcholine",
"    </a>",
"    -induced vasodilation compared with irradiation alone, suggesting that superoxide contributes to impaired endothelial function after irradiation. Thus, radiation seems to induce acute microvascular dysfunction in the resistance arterioles of the intestine and presumably other organs. This effect is likely mediated primarily through a damaging action of radiation of the endothelium [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6097547\">",
"    <span class=\"h2\">",
"     Microvascular changes due to smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential impact of smoking on the coronary microcirculation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=see_link&amp;anchor=H7#H7\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Vascular reactivity of coronary collaterals",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of collateral vessels significantly alters coronary vascular reactivity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8216?source=see_link\">",
"     \"Coronary collateral circulation\"",
"    </a>",
"    .) When a coronary artery is gradually occluded, flow to the subtended myocardium persists via perfusion through collateral vessels. When these vessels fully develop, they are capable of providing normal resting perfusion to the region previously served by the occluded vessel, although at a lower perfusion pressure.",
"   </p>",
"   <p>",
"    Since collateral vessels represent \"new\" vessels, there has been interest in factors that might modulate their reactivity. For the most part, these vessels have normal endothelium-dependent vascular relaxation and normal responses to most agents studied in vivo. Endothelial release of nitric oxide may be responsible for the vasodilation of coronary collaterals [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/31\">",
"     31",
"    </a>",
"    ]. In contrast, alpha-adrenergic receptors have not been identified in isolated rings of collateral tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Coronary collaterals contain beta-adrenergic but not alpha-adrenergic receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Studies in animal models have shown that beta blockers induce vasoconstriction of coronary collaterals during exercise, thereby reducing collateral blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/34\">",
"     34",
"    </a>",
"    ]. A similar effect can be induced by inhibitors of nitric oxide synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/35\">",
"     35",
"    </a>",
"    ] and by platelet activating factor, which causes platelet aggregation and the release of the potent vasoconstrictors thromboxane A2 and serotonin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mature canine collateral vessels, vasopressin-induced constriction is markedly enhanced when compared to its effect on similar sized native coronary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. In vivo, vasopressin markedly reduces perfusion to collateral-dependent myocardium in doses that have no effect on normally perfused myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/39\">",
"     39",
"    </a>",
"    ]. This effect may be limited to pharmacologic properties of vasopressin as illustrated in a study in which the administration of vasopressin antagonist had no effect on collateral perfusion during exercise in pigs with developed collaterals [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The coronary arterioles nourished by collateral vessels develop markedly abnormal vascular reactivity, characterized by impaired endothelium-dependent vascular relaxation and enhanced constriction to vasopressin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/37\">",
"     37",
"    </a>",
"    ]. These findings, which were originally made in vitro in microvessels from a canine model of collateral development, have also been observed in a porcine model of chronic ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The factors responsible for the impaired microvascular endothelium-dependent relaxation in the collateral-dependent region have not been determined. This abnormality may be related to increased local levels of NO resulting from enhanced expression of inducible NOS (iNOS), as occurs during ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/43\">",
"     43",
"    </a>",
"    ]; such a change could lead to reduced activity of eNOS [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/44\">",
"     44",
"    </a>",
"    ]. Other possible contributing factors to impaired collateral flow include changes in shear stress or pulsatile flow in the collateral-dependent microvasculature [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/45\">",
"     45",
"    </a>",
"    ] and increased expression of heparan sulfate matrix proteins, such as syndecan-4, that can affect vascular reactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Effect of angiogenic growth factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collateral growth and coronary microvessel function can be altered by the direct perivascular application or infusion of angiogenic growth factors such as fibroblast growth factors (FGF-1 or FGF-2) or vascular endothelial growth factor (VEGF). These therapeutic interventions improve myocardial function and perfusion in chronic ischemic models and can normalize endothelium-dependent relaxation in the collateral-dependent vasculature [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/41,42,48\">",
"     41,42,48",
"    </a>",
"    ]. However, there is little evidence that growth factor therapy or gene therapy improves myocardial perfusion in any clinical significant manner in clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/4/6216?source=see_link\">",
"     \"Therapeutic angiogenesis for management of refractory angina\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ROLE OF ENDOTHELIAL FACTORS IN THE RESPONSE TO INJURY AND VASCULAR GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;NO and NO-related factors may play a role in the growth of vascular cells and blood vessels. NO is a physiologic inhibitor of smooth muscle growth as illustrated by the following experimental observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The response to vascular injury is markedly increased by pretreatment with L-NAME, an inhibitor of NO formation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/51\">",
"       51",
"      </a>",
"      ], and in mice deficient in eNOS [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The response to vascular injury is reduced by local transfection of the rat carotid artery with the gene coding for eNOS [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The effect of NO on vascular smooth muscle growth is mediated by cyclic GMP and can be mimicked by cyclic GMP analogs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. In addition to inhibiting smooth muscle growth, NO may also promote apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effects of NO on smooth muscle cell growth have obvious implications for neointimal formation in atherosclerosis and following vessel injury. Thus, there has been substantial interest in using nitric oxide donors, or organic nitrates, as an approach to modify the atherosclerotic process or to prevent restenosis following angioplasty. However, studies to date with these drugs have not shown any obvious benefit.",
"   </p>",
"   <p>",
"    While NO and other cyclic GMP-activating agents inhibit the growth of vascular smooth muscle, they do not alter the rate of growth of endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/59\">",
"     59",
"    </a>",
"    ]. On the other hand, proliferating cells (eg, following endothelial denudation) express about sixfold as much eNOS mRNA as confluent cells [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/59\">",
"     59",
"    </a>",
"    ]. The net effect is that proliferating endothelial cells that grow back to recover exposed intima produce large amounts of NO; the NO will tend to minimize platelet adhesion and vascular smooth muscle proliferation in the area but will not interfere with the endothelial cell proliferation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Angiogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;New vessel growth involves several distinct steps [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased vascular permeability and dissolution of the bond between the endothelium and basement membrane",
"     </li>",
"     <li>",
"      Migration and reattachment of endothelial cells",
"     </li>",
"     <li>",
"      Proliferation and migration of endothelial cells and the formation of a tubule, which is the rudimentary vascular structure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Almost universally, pathologic conditions that can lead to angiogenesis, such as tissue hypoxia and inflammation, are associated with the production and release of growth factors, suggesting that these substances are critical to the formation of new blood vessels. In addition, the respective growth factor receptors must be upregulated and inhibitory factors must be inhibited if the growth factors are to play a role in the initiation and later steps of vessel development [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8216?source=see_link\">",
"     \"Coronary collateral circulation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also a strong relation between the release of NO and the regulation of blood vessel growth and development. Substance P and growth factors such as VEGF and FGF, all of which stimulate the release of NO [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/61,63,64\">",
"     61,63,64",
"    </a>",
"    ], induce new vessel formation in vivo and increase the permeability, migration, and proliferation of postcapillary endothelial cells in tissue culture [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. On the other hand, inhibitors of NO synthase suppress angiogenesis, and the proliferative effect of VEGF.",
"   </p>",
"   <p>",
"    There are, however, contradictory observations concerning the role of NO in angiogenesis. In different models, NO synthase was involved in angiogenesis induced by VEGF but not that induced by FGF-2 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/66\">",
"     66",
"    </a>",
"    ] and, paradoxically, angiogenesis was inhibited by the NO donor sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    and the NO synthase substrate L-arginine and increased by inhibitors of NO synthase [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. It is possible that the effects of NO differs between species and between vascular beds within species.",
"   </p>",
"   <p>",
"    In contrast to the robust angiogenic response is seen in many animal models of chronic myocardial ischemia, the angiogenic effects of exogenously delivered growth factors such as FGF-2 and VEGF have been relatively modest or negative in human trials, especially when given intravascularly [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/69\">",
"     69",
"    </a>",
"    ]. This difference could be related to a diminished response to angiogenic growth factors in the setting of atherosclerosis, hypercholesterolemia, diabetes, and other causes of endothelial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. In addition, the expression of pro-angiogenic factors, such as VEGF, may be diminished and the expression of anti-angiogenic factors, such as endostatin and angiostatin, may be increased in conditions such as hypercholesterolemia and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. This may negatively affect both microvascular and macrovascular collateral growth in response to chronic coronary artery occlusion, and thus may affect overall myocardial perfusion.",
"   </p>",
"   <p>",
"    The diminished potential of angiogenic growth factors to induce collateral development may have adverse implications for the use of gene-, protein- and, cell-based therapies to increase perfusion to ischemic myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/49,50,74-76\">",
"     49,50,74-76",
"    </a>",
"    ]. It is possible that adjunctive therapies such as statins and NOS substrate (L-arginine) may improve the angiogenic potential of these growth factors as a therapeutic modality [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/70\">",
"     70",
"    </a>",
"    ]. However, the role of statins in collateral growth is biphasic, and some studies have suggested that statins may not necessarily improve collateral development and may actually diminish perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/77\">",
"     77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/4/6216?source=see_link\">",
"     \"Therapeutic angiogenesis for management of refractory angina\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18617?source=see_link\">",
"     \"Genetic and cellular therapy in heart failure and myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     STRUCTURAL CHANGES IN THE CORONARY MICROCIRCULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with cardiac hypertrophy due to a variety of causes have chest pain suggestive of myocardial ischemia. Ischemia due to microvascular disease is an important risk factor for cardiac events in patients with hypertrophic cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32841?source=see_link&amp;anchor=H9#H9\">",
"     \"Natural history of hypertrophic cardiomyopathy\", section on 'Mortality'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac hypertrophy is associated with a reduction in the maximal capacity of the coronary circulation to dilate in response to either reactive hyperemia or pharmacologic stimuli [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/78-80\">",
"     78-80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two hypotheses have been proposed to explain this defect in vasodilator function:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As the myocardium hypertrophies, the coronary resistance circulation does not increase to keep pace with the larger myocardial mass. Thus, peak flow normalized to myocardial mass is reduced because of the relative paucity of coronary arterioles.",
"     </li>",
"     <li>",
"      There is a structural alteration of the microcirculation, due to actual loss of coronary resistance vessels (seen in hypertension or diabetes) or due to medial hypertrophy of these vessels (seen in hypertrophic cardiomyopathy) (",
"      <a class=\"graphic graphic_picture graphicRef73467 \" href=\"UTD.htm?40/33/41494\">",
"       picture 1",
"      </a>",
"      ). These structural changes can alter autoregulation and the perfusion pressure in the subendocardium. However, while there is a significant association between diastolic dysfunction and measures of microvascular function in clinical diseases such as diabetes, the actual relationship between endothelial dysfunction, connective tissue content, and cardiac diastolic failure is not strong. Other factors probably have a more important role in the early pathogenesis of subclinical diastolic dysfunction in diabetes and other illnesses [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has been assumed that the loss of maximal vasodilator reserve reflects a structural alteration of the coronary microcirculation. Consistent with this hypothesis is that the defect is observed during maximal vasodilator stimulation; in this setting, the resultant flow must reflect the driving pressure for perfusion and the cross-sectional area of the coronary resistance circulation. It is unlikely that the loss of maximal vasodilator reserve is due primarily to endothelial factors since some of the vasodilators administered in pharmacologic studies (adenosine and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/2/37923?source=see_link\">",
"     papaverine",
"    </a>",
"    ) largely act independent of the endothelium.",
"   </p>",
"   <p>",
"    The defects in microvascular function tend to normalize when the underlying abnormality responsible for hypertrophy is corrected, as with aortic valve replacement for severe aortic stenosis. However, the normalization of microvascular function is not closely correlated with regression of hypertrophy in this setting. Possible mechanisms of improved myocardial blood flow after aortic valve replacement include reduced extravascular compression and increased diastolic perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11785/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The coronary microcirculation, which consists of resistance arterioles, capillaries, and small veins or venules, plays a major role in the delivery of blood and nutrients to the myocardium. It is adversely affected in a variety of systemic and cardiac disorders. The following are summary points of this topic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endothelial-mediated vasodilation is abnormal in a variety of pathologic conditions, including atherosclerosis, hypercholesterolemia, diabetes, hypertension, cigarette smoking, ischemia reperfusion, and aging. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Endothelial dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with cardiac hypertrophy due to a variety of causes have chest pain suggestive of myocardial ischemia. Ischemia due to microvascular disease is an important risk factor for cardiac events in patients with hypertrophic cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Structural changes in the coronary microcirculation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nitric oxide (NO) and NO-related factors may play a role in the growth of vascular cells and blood vessels. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Role of endothelial factors in the response to injury and vascular growth'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/1\">",
"      Hein TW, Zhang C, Wang W, et al. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 2003; 17:2328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/2\">",
"      Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990; 81:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/3\">",
"      Ishida T, Kawashima S, Sakoda T, et al. Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries. Circulation 2001; 103:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/4\">",
"      Chilian WM, Dellsperger KC, Layne SM, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990; 258:H529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/5\">",
"      Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/6\">",
"      Yokoyama I, Momomura S, Ohtake T, et al. Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy. Circulation 1999; 100:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/7\">",
"      Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/8\">",
"      Piana RN, Wang SY, Friedman M, Sellke FW. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation 1996; 93:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/9\">",
"      Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990; 82:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/10\">",
"      Matsunaga T, Okumura K, Ishizaka H, et al. Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes. J Cardiovasc Pharmacol 1996; 28:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/11\">",
"      Saitoh S, Kiyooka T, Rocic P, et al. Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol 2007; 293:H3720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/12\">",
"      Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003; 41:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/13\">",
"      Miura H, Wachtel RE, Loberiza FR Jr, et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 2003; 92:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/14\">",
"      Li H, Gutterman DD, Rusch NJ, et al. Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes 2004; 53:2436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/15\">",
"      Kinlay S, Behrendt D, Wainstein M, et al. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 2001; 104:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/16\">",
"      Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004; 109:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/17\">",
"      Cannon RO 3rd, Epstein SE. \"Microvascular angina\" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/18\">",
"      Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 1993; 105:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/19\">",
"      Ruel M, Khan TA, Voisine P, et al. Vasomotor dysfunction after cardiac surgery. Eur J Cardiothorac Surg 2004; 26:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/20\">",
"      M&eacute;tais C, Li J, Simons M, Sellke FW. Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion: role of COX-2 expression. Circulation 1999; 100:II328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/21\">",
"      Katz SD, Khan T, Zeballos GA, et al. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 1999; 99:2113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/22\">",
"      Kubo SH, Rector TS, Bank AJ, et al. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/23\">",
"      Katz SD, Krum H, Khan T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol 1996; 28:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/24\">",
"      Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 97:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/25\">",
"      Patel AR, Kuvin JT, Pandian NG, et al. Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation. J Am Coll Cardiol 2001; 37:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/26\">",
"      Vallbracht KB, Schwimmbeck PL, K&uuml;hl U, et al. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 2005; 111:1784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/27\">",
"      Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation 1996; 93:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/28\">",
"      Hiemann NE, Wellnhofer E, Knosalla C, et al. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation 2007; 116:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/29\">",
"      Dedkov EI, Perloff JK, Tomanek RJ, et al. The coronary microcirculation in cyanotic congenital heart disease. Circulation 2006; 114:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/30\">",
"      Hatoum OA, Otterson MF, Kopelman D, et al. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol 2006; 26:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/31\">",
"      Frank MW, Harris KR, Ahlin KA, Klocke FJ. Endothelium-derived relaxing factor (nitric oxide) has a tonic vasodilating action on coronary collateral vessels. J Am Coll Cardiol 1996; 27:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/32\">",
"      Harrison DG, Chilian WM, Marcus ML. Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res 1986; 59:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/33\">",
"      Feldman RD, Christy JP, Paul ST, Harrison DG. Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function. Am J Physiol 1989; 257:H1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/34\">",
"      Traverse JH, Altman JD, Kinn J, et al. Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise. Circulation 1995; 91:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/35\">",
"      Traverse JH, Kinn JW, Klassen C, et al. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region. J Am Coll Cardiol 1998; 31:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/36\">",
"      Kinn JW, Bache RJ. Effect of platelet activation on coronary collateral blood flow. Circulation 1998; 98:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/37\">",
"      Sellke FW, Quillen JE, Brooks LA, Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 1990; 81:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/38\">",
"      Rapps JA, Jones AW, Sturek M, et al. Mechanisms of altered contractile responses to vasopressin and endothelin in canine coronary collateral arteries. Circulation 1997; 95:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/39\">",
"      Peters KG, Marcus ML, Harrison DG. Vasopressin and the mature coronary collateral circulation. Circulation 1989; 79:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/40\">",
"      Symons JD, Longhurst JC, Stebbins CL. Response of collateral-dependent myocardium to vasopressin release during prolonged intense exercise. Am J Physiol 1993; 264:H1644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/41\">",
"      Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996; 270:H1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/42\">",
"      Sellke FW, Wang SY, Friedman M, et al. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 1994; 267:H1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/43\">",
"      Laham RJ, Rezaee M, Li J, et al. Adaptive responses of ischemic microvessels: Increased expression of inducible nitric oxide synthase but not endothelial nitric oxide synthase (abstract). Circulation 1997; 96:I355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/44\">",
"      Ravichandran LV, Johns RA, Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 1995; 268:H2216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/45\">",
"      Uematsu M, Ohara Y, Navas JP, et al. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol 1995; 269:C1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/46\">",
"      Li J, Partovian C, Li J, et al. Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice. Microvasc Res 2002; 64:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/47\">",
"      Zhang Y, Li J, Partovian C, et al. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol 2003; 284:H2078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/48\">",
"      Bauters C, Asahara T, Zheng LP, et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 1995; 91:2802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/49\">",
"      Robich MP, Chu LM, Oyamada S, et al. Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles. Expert Rev Cardiovasc Ther 2011; 9:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/50\">",
"      Lassaletta AD, Chu LM, Sellke FW. Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol 2011; 106:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/51\">",
"      Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 1994; 14:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/52\">",
"      Moroi M, Zhang L, Yasuda T, et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 1998; 101:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/53\">",
"      von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995; 92:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/54\">",
"      Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/55\">",
"      Yu SM, Hung LM, Lin CC. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 1997; 95:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/56\">",
"      Itoh H, Pratt RE, Ohno M, Dzau VJ. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 1992; 19:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/57\">",
"      Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 1994; 267:C1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/58\">",
"      Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/59\">",
"      Arnal JF, Yamin J, Dockery S, Harrison DG. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol 1994; 267:C1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/60\">",
"      Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med 1997; 3:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/61\">",
"      Sellke FW, Wang SY, Stamler A, et al. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 1996; 271:H713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/62\">",
"      Li J, Brown LF, Hibberd MG, et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270:H1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/63\">",
"      Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94:2036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/64\">",
"      Wu HM, Yuan Y, McCarthy M, Granger HJ. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol 1996; 271:H1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/65\">",
"      Morbidelli L, Chang CH, Douglas JG, et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270:H411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/66\">",
"      Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99:2625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/67\">",
"      Pipili-Synetos E, Papageorgiou A, Sakkoula E, et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995; 116:1829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/68\">",
"      Pipili-Synetos E, Sakkoula E, Haralabopoulos G, et al. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 1994; 111:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/69\">",
"      Ruel M, Laham RJ, Parker JA, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/70\">",
"      Ruel M, Wu GF, Khan TA, et al. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model. Circulation 2003; 108 Suppl 1:II335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/71\">",
"      Voisine P, Bianchi C, Ruel M, et al. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery 2004; 136:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/72\">",
"      Sodha NR, Clements RT, Boodhwani M, et al. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 2009; 296:H428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/73\">",
"      Boodhwani M, Nakai Y, Mieno S, et al. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 2006; 81:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/74\">",
"      Voisine P, Bianchi C, Khan TA, et al. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction. J Thorac Cardiovasc Surg 2005; 129:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/75\">",
"      Ruel M, Song J, Sellke FW. Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia. Mol Cell Biochem 2004; 264:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/76\">",
"      Suuronen EJ, Hazra S, Zhang P, et al. Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. J Thorac Cardiovasc Surg 2010; 139:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/77\">",
"      Boodhwani M, Mieno S, Feng J, et al. Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine. J Thorac Cardiovasc Surg 2008; 135:117.",
"     </a>",
"    </li>",
"    <li>",
"     Marcus  M. The Coronary Circulation in Health and Disease, 1, McGraw-Hill, New York 1983.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/79\">",
"      Marcus ML, Harrison DG, Chilian WM, et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation 1987; 75:I19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/80\">",
"      Rajappan K, Rimoldi OE, Dutka DP, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002; 105:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/81\">",
"      Brooks BA, Franjic B, Ban CR, et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab 2008; 10:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11785/abstract/82\">",
"      Rajappan K, Rimoldi OE, Camici PG, et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 2003; 107:3170.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1538 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-94DAD92080-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11785=[""].join("\n");
var outline_f11_32_11785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ENDOTHELIAL DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Role of endothelin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cardiac syndrome X",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      After coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cyanotic congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiation induced vasculopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6097547\">",
"      Microvascular changes due to smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Vascular reactivity of coronary collaterals",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Effect of angiogenic growth factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ROLE OF ENDOTHELIAL FACTORS IN THE RESPONSE TO INJURY AND VASCULAR GROWTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Angiogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      STRUCTURAL CHANGES IN THE CORONARY MICROCIRCULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1538\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1538|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/33/41494\" title=\"picture 1\">",
"      Small vessel disease in HCM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5802?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19864?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries: Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=related_link\">",
"      Clinical use of coronary artery pressure and Doppler flow measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8216?source=related_link\">",
"      Coronary collateral circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/11/18617?source=related_link\">",
"      Genetic and cellular therapy in heart failure and myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=related_link\">",
"      Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32841?source=related_link\">",
"      Natural history of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12872?source=related_link\">",
"      Nitric oxide, other hormones, cytokines, and chemokines in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=related_link\">",
"      Nutritional antioxidants in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=related_link\">",
"      Pathogenesis of and risk factors for cardiac allograft vasculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27226?source=related_link\">",
"      Prevalence of and risk factors for coronary heart disease in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/4/6216?source=related_link\">",
"      Therapeutic angiogenesis for management of refractory angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_32_11786="Etiology and clinical manifestations of vitamin B12 and folate deficiency";
var content_f11_32_11786=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11786/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11786/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11786/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11786/contributors\">",
"     William C Mentzer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/32/11786/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/32/11786/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/32/11786/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional megaloblastic anemias were characterized over one hundred years ago. This term identifies patients with anemia and macroovalocytic red cells (ie, mean corpuscular volume greater than 100 fL). The bone marrow shows intense erythroid hyperplasia with abnormal (megaloblastic) morphology. The megaloblast, the morphologic hallmark of the syndrome, is a product of impaired DNA formation, which in turn is due to deficiencies of vitamin B12 (cobalamin, Cbl) or folate [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the major causes and clinical manifestations of Cbl and folate deficiency. In this review, the terms B12, Cbl, and cobalamin will be used interchangeably. The terms &ldquo;folate&rdquo; and &ldquo;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    &rdquo; are sometimes used interchangeably; however, the vitamin is found in nature as a folate while folic acid (FA) is the synthetic, therapeutic form.",
"   </p>",
"   <p>",
"    The physiology of these vitamins, how lack of availability leads to a megaloblastic anemia with ineffective erythropoiesis, and the diagnosis and treatment of these disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link\">",
"     \"Physiology of vitamin B12 and folate deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Deficiencies of Cbl and FA may also be present in the elderly and in those with alcohol abuse. These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=see_link&amp;anchor=H24#H24\">",
"     \"Anemia in the older adult\", section on 'Search for treatable disorders'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4710?source=see_link\">",
"     \"Alcohol abuse and hematologic disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2125777\">",
"    <span class=\"h1\">",
"     VITAMIN B12 DEFICIENCY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Dietary intake and absorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal products (meat and dairy products) provide the only dietary source of Cbl for humans. The usual Western diet contains 5 to 7 micrograms of cobalamin per day, while the minimum daily requirement is listed as 6 to 9 micrograms per day [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3\">",
"     3",
"    </a>",
"    ]. Total body stores of Cbl are 2 to 5 milligrams (2000 to 5000 micrograms), approximately one-half of which are in the liver. As a result, it takes years to develop vitamin B12 deficiency after absorption of dietary B12 ceases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dietary Cbl in the presence of acid and pepsin in the stomach is liberated from its binding to protein and then quickly binds to R factors (R binders, R proteins) in saliva and gastric juice. Cobalamin bound to R factors is not absorbed; however, in the alkaline pancreatic enzyme milieu of the duodenum, cobalamin is freed from R proteins by pancreatic proteases and then binds specifically and rapidly to gastric-derived intrinsic factor (IF). IF is a 45 kDa glycoprotein with very high affinity for Cbl. The IF-Cbl complex binds to specific ileal receptors from which it is absorbed in an energy requiring process that is still incompletely understood.",
"   </p>",
"   <p>",
"    Thus, adequate absorption of cobalamin from the diet depends upon five factors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link\">",
"     \"Physiology of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dietary intake",
"     </li>",
"     <li>",
"      Acid-pepsin in the stomach to liberate Cbl from binding to proteins",
"     </li>",
"     <li>",
"      Pancreatic proteases to free Cbl from binding to R factors",
"     </li>",
"     <li>",
"      Secretion of intrinsic factor (IF) by the gastric parietal cells to bind to Cbl",
"     </li>",
"     <li>",
"      An intact ileum with functional Cbl-IF receptors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once taken up by the ileal enterocytes, the Cbl that enters plasma bound to transcobalamin II binds to specific cell surface receptors from which it enters cells by receptor-mediated endocytosis. Cbl in the cells is metabolized into two coenzymes: adenosyl-Cbl; and methyl-Cbl (",
"    <a class=\"graphic graphic_figure graphicRef58245 \" href=\"UTD.htm?13/53/14175\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Adenosyl-CBL is a cofactor, along with methylmalonyl-CoA mutase, converting methylmalonyl-CoA to succinyl-CoA.",
"     </li>",
"     <li>",
"      Methyl-CBL is a cofactor, along with methionine synthase, converting homocysteine to methionine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Causes of vitamin B12 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin B12 deficiency is usually due to inadequate absorption associated with pernicious anemia (PA) or secondary to gastric disease (",
"    <a class=\"graphic graphic_table graphicRef77437 \" href=\"UTD.htm?30/51/31547\">",
"     table 1",
"    </a>",
"    ). In contrast, folate deficiency is generally attributable to an inadequate diet",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alcoholism. The two deficiencies can coexist in some patients with malabsorption, especially in those with tropical sprue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pernicious anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pernicious anemia (PA) is a common cause of Cbl deficiency. It is usually undiagnosed, and is not an uncommon problem in older adult subjects. One series, for example, evaluated 729 subjects who were randomly solicited from the community [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of PA was 4.1 percent in white and black women and 2.1 percent in white and black men; there were no cases in Latin American or Asian American subjects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H11#H11\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Diagnosing pernicious anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h4\">",
"     Autoantibody formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cbl deficiency in PA is thought to result from an autoimmune attack on gastric intrinsic factor (IF) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. Anti-intrinsic factor antibodies are detectable in the serum in up to 70 percent of patients with PA, providing a highly specific (&gt;95 percent) but relatively insensitive (50 to 84 percent) test [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. There are two types of anti-IF antibodies: one that blocks the attachment of Cbl to IF; and one that blocks attachment of the Cbl-IF complex to ileal receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/8\">",
"     8",
"    </a>",
"    ]. The lack of functional IF is one factor that promotes Cbl deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Antibodies to IF'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Chronic atrophic gastritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A second component of PA is chronic atrophic gastritis, which leads to a decline in IF production. The gastritis is associated with autoantibodies directed against the gastric parietal cells. These antibodies are directed against hydrogen-potassium adenosine triphosphatase (H-K-ATPase), which secretes hydrogen ions into the lumen in exchange for potassium [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/6,9\">",
"     6,9",
"    </a>",
"    ]. Parietal cell injury appears to be mediated by pathogenic CD4+ T cells that react with H-K-ATPase. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24185?source=see_link&amp;anchor=H6#H6\">",
"     \"Metaplastic (chronic) atrophic gastritis\", section on 'Autoimmune metaplastic atrophic gastritis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The chronic atrophic gastritis in PA is also associated with an increased risk of intestinal-type gastric cancer and of gastric carcinoid tumors. The latter are presumably due to prolonged achlorhydria resulting from parietal cell loss, compensatory hypergastrinemia, and argyrophilic cell hyperplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=see_link&amp;anchor=H28#H28\">",
"     \"Risk factors for gastric cancer\", section on 'Pernicious anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Gastrectomy and gastritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrectomy and gastritis are other gastric abnormalities that can produce Cbl deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. The absence of gastric acid and pepsin in these disorders results in impaired liberation of Cbl from its binding to food proteins, while the absence of intrinsic factor prevents the normal absorption of food Cbl.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Helicobacter pylori infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study from Turkey has suggested a link between infection with Helicobacter pylori (HP) and low serum B12 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/11\">",
"     11",
"    </a>",
"    ]. Of 138 cobalamin-deficient patients, infection with HP was documented by endoscopy in 77. In all 31 patients in whom the infection was successfully eradicated, the hematocrit, MCV, LDH, and serum B12 levels returned to normal without the addition of vitamin B12 replacement therapy.",
"   </p>",
"   <p>",
"    A potential link between susceptibility to infection with HP, atrophic gastritis, and low serum B12 levels has been suggested, secondary to a common variation in the FUT2 secretor gene, whose product is a mediator of HP attachment to human gastric mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4809?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\", section on 'Bacterial attachment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Older adult subjects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild and usually subclinical cobalamin deficiency appears to occur (or be recognized) with increased frequency (10 to 24 percent) in older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/15-19\">",
"     15-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based cross-sectional analysis of 3511 older adults from the UK, the age-specific prevalence of cobalamin deficiency was approximately 5 and 10 percent in those ages 65 to 74 and those &ge;75 years of age, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/19\">",
"       19",
"      </a>",
"      ]. The prevalence of folate deficiency in this population was similar, although combined cobalamin and folate deficiency was uncommon.",
"     </li>",
"     <li>",
"      In a series of 107 healthy, free living Dutch subjects between the ages of 74 and 80, 24 percent had evidence of mild cobalamin deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/16\">",
"       16",
"      </a>",
"      ]. Inadequate cobalamin intake or severe atrophic gastritis was present in less than 30 percent of the study population, indicating that other mechanisms must contribute to the Cbl deficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, food cobalamin malabsorption was a more important factor in a report from France of older adult patients with proven cobalamin deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Food cobalamin malabsorption, caused primarily by gastric atrophy, accounted for 60 to 70 percent of cases, while pernicious anemia accounted for 15 to 20 percent.",
"   </p>",
"   <p>",
"    Food cobalamin malabsorption is primarily the result of an inability to release cobalamin from dietary proteins, especially in the presence of reduced gastric acid secretion. It has been defined as cobalamin deficiency in the presence of sufficient food cobalamin intake, a normal Schilling test using crystalline cobalamin, and an abnormal Schilling test using protein-bound cobalamin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Schilling test'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Factors that may contribute to food cobalamin malabsorption in older adults include [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gastric atrophy, achlorhydria",
"     </li>",
"     <li>",
"      Helicobacter pylori infection",
"     </li>",
"     <li>",
"      Intestinal bacterial overgrowth secondary to antibiotic treatment",
"     </li>",
"     <li>",
"      Long-term ingestion of biguanides, antacids, H2 receptor antagonists, and proton pump inhibitors",
"     </li>",
"     <li>",
"      Chronic alcoholism",
"     </li>",
"     <li>",
"      Gastric",
"      <span class=\"nowrap\">",
"       surgery/reconstruction",
"      </span>",
"      for obesity (bariatric surgery) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/23-25\">",
"       23-25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pancreatic exocrine failure",
"     </li>",
"     <li>",
"      Sjogren's syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An important clinical issue to remember is that cobalamin deficiency is common in those over 65, although the anemia of cobalamin deficiency is very uncommon, particularly in patients in whom the anemia is not distinctly macrocytic with no increase in hypersegmented neutrophils.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Intestinal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of intestinal disorders can also cause Cbl deficiency. These include severe pancreatic disease and small bowel diseases such as malabsorption, ileal disease (eg, including tuberculous ileitis, lymphoma, amyloid, long-term survivors of pelvic irradiation), extensive resection or bypass, and Crohn's disease. When jejunal blind loops are present, bacterial overgrowth within the loops competes for Cbl, leading to Cbl deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/26\">",
"     26",
"    </a>",
"    ]. Although not as common currently, infestation with the fish tapeworm, Diphyllobothrium latum, was once a classic cause of Cbl deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=see_link\">",
"     \"Gastrointestinal toxicity of radiation therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22570?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of radiation therapy for gynecologic malignancies\", section on 'Treatment-related toxicity'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/6/44136?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of the short bowel syndrome in adults\", section on 'Limited ileal resection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/6/44136?source=see_link&amp;anchor=H16#H16\">",
"     \"Management of the short bowel syndrome in adults\", section on 'Extensive small bowel resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14162046\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged use of proton pump inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/62/26601?source=see_link\">",
"     omeprazole",
"    </a>",
"    ) can result in Cbl deficiency as a consequence of impaired release of Cbl from food in the absence of gastric acid secretion (",
"    <a class=\"graphic graphic_figure graphicRef72051 \" href=\"UTD.htm?22/29/22994\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/27\">",
"     27",
"    </a>",
"    ]. Approximately 10 to 30 percent of patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    have diminished B12 absorption due to calcium-dependent ileal membrane antagonism, an effect that can be reversed with supplemental calcium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Schilling test'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link\">",
"     \"Metformin in the treatment of diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=see_link&amp;anchor=H59976227#H59976227\">",
"     \"Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders\", section on 'Vitamin B12 malabsorption'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Inadequate dietary intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to gastrointestinal disease, cobalamin deficiency can result from inadequate dietary intake in certain settings. Strict vegans, for example, avoid all animal products, and are at risk of developing nutritional Cbl deficiency. In addition, women who are only moderate vegetarians may become Cbl deficient during pregnancy and lactation; their infants may also be Cbl deficient [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/28\">",
"     28",
"    </a>",
"    ]. The Cbl levels in cord blood are twice as high as maternal blood levels, and Cbl needs are increased during lactation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/28\">",
"     28",
"    </a>",
"    ]. Thus, pregnant women who limit animal protein intake may need Cbl assessment and supplementation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36586?source=see_link&amp;anchor=H54#H54\">",
"     \"Vitamin supplementation in disease prevention\", section on 'Special diets'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link&amp;anchor=H19#H19\">",
"     \"Vegetarian diets for children\", section on 'Vitamin B12'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of low serum levels of Cbl in patients infected with HIV has ranged from 10 to 39 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/29\">",
"     29",
"    </a>",
"    ]. Multiple causes have been suggested, including poor nutritional status, diarrhea, ileal dysfunction, and exudative enteropathy. A long-term study has indicated that a serum level of vitamin B12 &lt;125",
"    <span class=\"nowrap\">",
"     pmol/L",
"    </span>",
"    was an independent predictor of poor survival and disease progression in HIV+ subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=see_link&amp;anchor=H10#H10\">",
"     \"Hematologic manifestations of HIV infection: Anemia\", section on 'Nutritional deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2127138\">",
"    <span class=\"h3\">",
"     Nitrous oxide exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     Nitrous oxide",
"    </a>",
"    (N2O) inactivates cobalamin and its use in anesthesia or inhalant abuse may precipitate RAPID hematologic and neuropsychiatric deterioration in Cbl-deficient subjects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Nitrous oxide exposure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=see_link&amp;anchor=H11#H11\">",
"     \"Inhalant abuse in children and adolescents\", section on 'Nitrous oxide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Hereditary causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rare cases, cobalamin deficiency is a hereditary disorder. Examples include production of a qualitatively abnormal intrinsic factor [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/31,32\">",
"     31,32",
"    </a>",
"    ], or decreased uptake of the intrinsic factor-cobalamin complex. The latter condition, called Imerslund-Grasbeck's disease or juvenile megaloblastic anemia, appears to be due to a mutation either in the gene for cubilin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/33,34\">",
"     33,34",
"    </a>",
"    ] or \"amnionless\" (AMN) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/35\">",
"     35",
"    </a>",
"    ]. It has been postulated that the",
"    <span class=\"nowrap\">",
"     cubilin/AMN",
"    </span>",
"    complex is the functional receptor essential for ileal cobalamin uptake as well as renal protein reabsorption (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link\">",
"     \"Physiology of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with Imerslund-Grasbeck's disease also have varying degrees of proteinuria that is resistant to cobalamin supplementation. Cubilin is heavily expressed in the renal proximal tubule and appears to mediate the reabsorption of filtered albumin; thus, diminished reabsorption due to defective cubilin is presumably responsible for the proteinuria in this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/38\">",
"     38",
"    </a>",
"    ]. Cubilin also facilitates the reabsorption of the calcidiol (25-hydroxyvitamin D)-vitamin D binding protein complex; patients with Imerslund-Grasbeck's disease have increased urinary losses of calcidiol and the binding protein [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=see_link\">",
"     \"Metabolism of vitamin D\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other rare causes of cobalamin deficiency include congenital deficiency of transcobalamin, homocystinuria, severe methylenetetrahydrofolate reductase deficiency, several abnormalities of methionine synthesis, and abnormal lysosomal membrane exporters for cobalamin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/40-45\">",
"     40-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2126391\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2127317\">",
"    <span class=\"h3\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of both cobalamin and folate produce megaloblastic anemia, but only B12 deficiency produces neurologic changes. Another important difference between the two deficiencies is the time required for a deficiency to develop. Because Cbl stores are so large in relation to daily intake, years of inadequate Cbl intake or absorption are required before the onset of symptoms. On the other hand, symptoms of folate deficiency can occur within four to five months after intake is diminished, since body stores are smaller (5 to 10 mg) in relation to daily requirements (200 to 400 mcg).",
"   </p>",
"   <p>",
"    Pernicious anemia is most common in Caucasians of northern European ancestry, and occurs as commonly in blacks as in other Caucasian non-northern European groups. It usually affects older patients, possibly because of the superimposition of age-related chronic atrophic gastritis. However, PA can occur under the age of 30 and can be associated with other autoimmune diseases, such as thyroid disease and vitiligo. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=see_link\">",
"     \"Vitiligo\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classic clinical picture of cobalamin deficiency due to PA was that of a prematurely gray person of Northern European descent whose skin was lemon-colored (reflecting the simultaneous presence of both anemia and jaundice), mentally sluggish, had a shiny tongue (atrophic glossitis), and a shuffling broad-based gait. Examination revealed hematologic changes (eg, macrocytic anemia with oval macrocytes and increased neutrophil lobulation) and neurologic abnormalities (eg, loss of vibration sense and a positive Romberg test) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/46\">",
"     46",
"    </a>",
"    ]. This classic picture of PA is now seen less frequently. It has been replaced by more subtle presentations which including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coincident iron deficiency or homozygous alpha thalassemia-2 (in African Americans) can mask the macrocytosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36025?source=see_link\">",
"       \"Pathophysiology of alpha thalassemia\"",
"      </a>",
"      .) Affected patients may not be anemic and the peripheral blood smear may show only hypersegmented neutrophils [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,47\">",
"       1,47",
"      </a>",
"      ]. Hypersegmentation is an alteration of late granulopoiesis whereas anemia, when present, reflects the severe ineffective erythropoiesis or intramedullary destruction of erythroid precursors within the bone marrow.",
"     </li>",
"     <li>",
"      The patient may have hard-to-characterize neuropsychiatric problems consisting of paresthesias, numbness, weakness, loss of dexterity, impaired memory, and personality changes [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cbl deficiency is one of the treatable causes of dementia; screening for Cbl deficiency (and hypothyroidism) is recommended for patients being evaluated for this condition. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link&amp;anchor=H17#H17\">",
"       \"Evaluation of cognitive impairment and dementia\", section on 'Summary and recommendations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one recent series, for example, the diagnosis of Cbl deficiency was made in patients of whom only 29 percent had anemia, and 64 percent had a MCV greater than 100 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1\">",
"     1",
"    </a>",
"    ]. Hypersegmented neutrophils seen on peripheral smear continue to provide a good clue. Because Cbl is required for all rapidly growing cells, including enteric mucosal cells, patients with Cbl deficiency may complain of glossitis, vaginal atrophy, and malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,48\">",
"     1,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2126412\">",
"    <span class=\"h3\">",
"     Neurologic changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic problems, when present, consist of the classic picture of subacute combined degeneration of the dorsal (posterior) and lateral spinal columns [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3,49\">",
"     3,49",
"    </a>",
"    ]. This lesion, specific for Cbl deficiency, is due to a defect in myelin formation of unknown mechanism. The neuropathy is symmetrical and affects the legs more than the arms. It begins with paresthesias and ataxia associated with loss of vibration and position sense, and can progress to severe weakness, spasticity, clonus, paraplegia, and even fecal and urinary incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H20#H20\">",
"     \"Disorders affecting the spinal cord\", section on 'Subacute combined degeneration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other neurologic abnormalities that can be seen include cerebellar ataxia, axonal degeneration of peripheral nerves and central nervous system symptoms including memory loss, irritability, dementia, and extrapyramidal signs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/3,50,51\">",
"     3,50,51",
"    </a>",
"    ]. Patients may present with Lhermitte's syndrome, a shock-like sensation that radiates to the feet during neck flexion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a positive Romberg test. Optic atrophy is a rare complication and may progress to visual failure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/52\">",
"     52",
"    </a>",
"    ]. In addition, cobalamin deficiency may precipitate optic neuropathy in those with Leber&rsquo;s hereditary optic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether cognitive decline in older subjects is associated with subclinical vitamin B12 deficiency is an unanswered question [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation of cognitive impairment and dementia\", section on 'Laboratory testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41369?source=see_link&amp;anchor=H4#H4\">",
"     \"Prevention of dementia\", section on 'Vitamins B6, B12, and folate'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of clinical importance, not all patients with neurologic abnormalities secondary to Cbl deficiency are either anemic or have macrocytic red cell indices. As an example, among 141 consecutive patients with neuropsychiatric abnormalities due to cobalamin deficiency, the hematocrit was normal in 34, the mean red cell volume was normal in 25, and both tests were normal in 19 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A neurologic syndrome similar to subacute combined degeneration can be seen in patients with copper deficiency, and the two conditions (ie, combined Cbl plus copper deficiencies) may coexist. Thus, continued neurologic deterioration in a patient with a history of Cbl deficiency-related myelopathy and normal Cbl levels while receiving Cbl replacement therapy should be evaluated for copper deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11880?source=see_link\">",
"     \"Copper deficiency myeloneuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2126419\">",
"    <span class=\"h3\">",
"     Skeletal changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin B12 deficiency appears to be associated with an increased risk of osteoporosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/58,59\">",
"     58,59",
"    </a>",
"    ], and hip and spine fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/60,61\">",
"     60,61",
"    </a>",
"    ], possibly due to suppression of osteoblast activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even subtle degrees of B12 deficiency may be associated with bone loss [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/64\">",
"     64",
"    </a>",
"    ], although this has not been shown in all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/65\">",
"     65",
"    </a>",
"    ]. Supplementation with vitamin B12 and folate has been shown to reduce hip fractures in a group of older adult Japanese patients with residual hemiplegia after an ischemic stroke. However, there is insufficient data to recommend this therapeutic approach in other populations at high risk for fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link&amp;anchor=H25#H25\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Folate/vitamin B12'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2127027\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major hematologic finding in either Cbl or FA deficiency is a macroovalocytic anemia (",
"    <a class=\"graphic graphic_picture graphicRef74901 \" href=\"UTD.htm?9/45/9942\">",
"     picture 1",
"    </a>",
"    ) with elevated levels of iron, indirect bilirubin, and LDH, and low levels of haptoglobin, reflecting increased red cell breakdown due to both peripheral destruction and ineffective erythropoiesis. The absolute reticulocyte count is normal or clearly low, reflecting the inability of the bone marrow to effectively produce red cells. The peripheral blood smear shows macroovalocytes, occasionally megaloblasts, and hypersegmented neutrophils (greater than 5 percent of neutrophils with five or more lobes or 1 percent with six or more lobes) (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 2",
"    </a>",
"    ). Macrocytosis (mean cell volume &gt;100 fl) is not specific for Cbl or folate deficiency, and hypersegmented neutrophils can also occur in renal failure, iron deficiency, or as a familial trait. However, the combination of macrocytosis and hypersegmented neutrophils is pathognomonic of megaloblastic anemia (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link\">",
"     \"Macrocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When the anemia is severe, there may also be thrombocytopenia and neutropenia (ie, pancytopenia), suggesting diagnoses such as the myelodysplastic",
"      <span class=\"nowrap\">",
"       syndrome/acute",
"      </span>",
"      myeloid leukemia",
"      <span class=\"nowrap\">",
"       (MDS/AML),",
"      </span>",
"      or aplastic anemia, all of which may present with macrocytosis, reduced reticulocyte count, and pancytopenia. Careful examination of the peripheral blood smear and bone marrow for dysplastic (eg, hyposegmented neutrophils) or leukemic white blood cell changes is diagnostic in",
"      <span class=\"nowrap\">",
"       MDS/AML,",
"      </span>",
"      while the marrow in aplastic anemia shows markedly reduced cellularity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H37#H37\">",
"       \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=see_link&amp;anchor=H16#H16\">",
"       \"Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bone marrow aspiration and biopsy reveals a very hypercellular marrow with megaloblastic erythroid hyperplasia, giant metamyelocytes, and many mitoses (",
"      <a class=\"graphic graphic_picture graphicRef68005 \" href=\"UTD.htm?23/25/23955\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Assays of serum or red cell folate, serum B12, methylmalonate, and homocysteine are required to confirm the diagnosis of folate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vitamin B12 deficiency. These tests and the strategy for making these diagnoses are described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Initial diagnostic strategy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2127469\">",
"    <span class=\"h3\">",
"     Hyperhomocysteinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both Cbl and folate are required for the metabolism of homocysteine to methionine (",
"    <a class=\"graphic graphic_figure graphicRef72986 \" href=\"UTD.htm?7/40/7814\">",
"     figure 3",
"    </a>",
"    ). As a result, deficiencies in these vitamins can lead to elevations in plasma homocysteine levels, a risk factor for the development of atherosclerosis and venous thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/10,66\">",
"     10,66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link\">",
"     \"Overview of homocysteine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of vitamin deficiency in the pathogenesis of hyperhomocysteinemia has been evaluated in a cohort of 1041 older adult subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/66\">",
"     66",
"    </a>",
"    ]. Two-thirds of those with elevated homocysteine levels had a subnormal plasma concentration of folate, vitamin B12, or pyridoxal-5-phosphate (the coenzyme form of vitamin B6). In this report, homocysteine levels were inversely related to folate consumption, reaching a stable baseline level when the folate intake exceeded 400",
"    <span class=\"nowrap\">",
"     mcg/day.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2125996\">",
"    <span class=\"h1\">",
"     FOLATE DEFICIENCY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2125925\">",
"    <span class=\"h2\">",
"     Dietary intake and absorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food folates occur in animal products and in leafy vegetables (eg, green leafy vegetables, fruits, cereals and grains, nuts, and meats) in the polyglutamate form [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Normal daily requirements for unstressed individuals are about 200 to 400 microg per day; this increases to 500 to 800 microg per day in pregnancy and lactation.",
"   </p>",
"   <p>",
"    Folate at physiologic levels enters cells by binding to a folate receptor. Once inside the cell, FA is polyglutamated, a form that is biologically active and cannot back diffuse into the plasma (",
"    <a class=\"graphic graphic_figure graphicRef79271 \" href=\"UTD.htm?0/36/576\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/26\">",
"     26",
"    </a>",
"    ]. Polyglutamated tetrahydrofolate participates in purine synthesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2125988\">",
"    <span class=\"h2\">",
"     Causes of folate deficiency",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Poor nutrition and alcoholism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common cause of folate deficiency is nutritional, due to poor diet",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alcoholism (",
"    <a class=\"graphic graphic_table graphicRef55010 \" href=\"UTD.htm?26/43/27323\">",
"     table 2",
"    </a>",
"    ). Although food folates are plentiful in liver, greens, and yeast, they are easily destroyed by heat during cooking. Body stores are small (5 to 10 mg) and individuals on a folate-deficient diet can develop megaloblastosis within four to five months.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Older patients",
"      </strong>",
"      ��� As noted above for cobalamin deficiency, folate deficiency is also common in older adults. In one study the age-specific prevalence of folate deficiency was approximately 5 and 10 percent in those ages 65 to 74 versus those &ge;75 years of age, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/19\">",
"       19",
"      </a>",
"      ]. Combined cobalamin and folate deficiency was uncommon in this population.",
"     </li>",
"     <li>",
"      <strong>",
"       Alcohol abuse",
"      </strong>",
"      ��� Alcohol abuse produces a sharp fall in serum folate within two to four days by impairing its enterohepatic cycle and inhibiting its absorption [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/26\">",
"       26",
"      </a>",
"      ]. Thus, alcoholics on a low folate intake can develop megaloblastosis within 5 to 10 weeks. This period is shorter than the four to five months required in normals in part because alcoholics start with lower stores due to previous dietary habits.",
"     </li>",
"     <li>",
"      <strong>",
"       Goat&rsquo;s milk",
"      </strong>",
"      ��� The folate concentration in goat&rsquo;s milk is markedly less than that in cow&rsquo;s milk (1 versus 12",
"      <span class=\"nowrap\">",
"       mcg/8",
"      </span>",
"      ounces). Accordingly, infants fed goat&rsquo;s milk may develop folate deficiency, especially if other sources of folate have not yet been introduced into the diet. Goat&rsquo;s milk fortified with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      is commercially available to avoid this problem.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Increased requirements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other mechanisms of folate deficiency include increased requirements in pregnancy and in patients with chronic hemolytic anemias, exfoliative skin disease, and drug-induced interference with folate metabolism. Pregnancy and lactation increase the need for FA and the daily requirement increases from 400 mcg to 800 mcg [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/67\">",
"     67",
"    </a>",
"    ]. Since early signs of deficiency may be subtle and intake is inadequate in some socioeconomic groups,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation (0.8 to 1",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    should be given prophylactically to all pregnant women. This regimen also appears to prevent the development of neural tube defects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/68\">",
"     68",
"    </a>",
"    ]. The US Public Health Service recommends that all women of childbearing age capable of becoming pregnant should consume 400 mcg of folic acid daily to help prevent neural tube defects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36586?source=see_link&amp;anchor=H4#H4\">",
"     \"Vitamin supplementation in disease prevention\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In countries such as the United States and Australia where",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    fortification of flour is mandated, the prevalence of folate deficiency has fallen. As an example, a study from Australia showed that between April 2009 and April 2010, the prevalence of folate deficiency measured in over 20,000 blood samples fell by 77 percent from 9.3 percent to 2.1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs interfere with FA metabolism:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"       Trimethoprim",
"      </a>",
"      is a weak inhibitor of dihydrofolate reductase and in high dose has been implicated in megaloblastic pancytopenia.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/51/23350?source=see_link\">",
"       Pyrimethamine",
"      </a>",
"      (Daraprim), an agent used for the treatment of malaria and toxoplasmosis, is an inhibitor of parasitic dihydrofolate reductase, and has been associated with folate deficiency and megaloblastic anemia.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      can also produce folate deficiency. During thymidylate synthesis, folate becomes oxidized to inactive dihydrofolate polyglutamate. Regeneration of active tetrahydrofolate requires the enzyme dihydrofolate reductase, which is inhibited by methotrexate [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/71\">",
"       71",
"      </a>",
"      ]. Treatment usually consists of FA in a dose of 1",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      although up to 5",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      may be required. For reversal of the chemotherapeutic anti-fol effect of larger doses of methotrexate, one uses folinic acid (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"       leucovorin",
"      </a>",
"      ), which bypasses this enzymatic block. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33658?source=see_link&amp;anchor=H31#H31\">",
"       \"Therapeutic use and toxicity of high-dose methotrexate\", section on 'Leucovorin administration'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       Phenytoin",
"      </a>",
"      blocks FA absorption and increases utilization of FA by an unknown mechanism [",
"      <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Hereditary folate malabsorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary folate malabsorption is an extremely rare autosomal recessive cause of folate deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/72\">",
"     72",
"    </a>",
"    ]. It presents early in life with diarrhea, failure to thrive, megaloblastic anemia, and progressive neurologic deterioration (ataxia, seizures, and mental retardation). Family studies have shown this disorder to be due to mutations in a proton-coupled folate transporter (PCFT), resulting in abnormal folate transport across the gastrointestinal tract and the blood-brain barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/73-76\">",
"     73-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment with high-dose oral or parenteral folinic acid is effective, but serum folate levels needed to provide adequate CNS concentrations of the vitamin are not known. Serial neurocognitive developmental examinations during childhood are needed in order to determine adequacy of treatment, since some of the neurologic deficits can otherwise become permanent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Other hereditary causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare causes of folate deficiency include a number of congenital enzyme deficiencies involving the metabolism of folate. These include methylenetetrahydrofolate reductase deficiency, glutamate formiminotransferase deficiency, and functional methionine synthase deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic presentation of folate deficiency is quite different from that of Cbl deficiency. The patient may abuse alcohol or other drugs and have a very poor dietary intake. Older and depressed patients who live alone and avoid cooking foods that contain folate may become deficient, as can patients with the malabsorption syndrome. Increased folate demands occur in patients with chronic severe hemolytic anemia and pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/32/11786/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deficiency of either Cbl or FA produces megaloblastic anemia but only Cbl deficiency produces neurologic changes. The exceptions to this general rule are the rare cases of hereditary folate malabsorption, which are associated with progressive neurologic deterioration early in life. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Hereditary folate malabsorption'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Another important difference between the two deficiencies is the time required for a deficiency to develop. Because Cbl stores are so large in relation to daily intake, years of inadequate Cbl intake or absorption are required before the onset of symptoms. On the other hand, symptoms of folate deficiency can occur within four to five months after intake is diminished, since body stores of folate are relatively small (5 to 10 mg) in relation to daily requirements (200 to 400 mcg).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2127537\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general laboratory and hematologic findings are identical in Cbl and FA deficiency, and hyperhomocysteinemia can occur in both conditions. The two deficiencies can coexist in some patients with malabsorption, especially in those with tropical sprue. (See",
"    <a class=\"local\" href=\"#H2127027\">",
"     'Laboratory findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Assays of serum or red cell folate, serum B12, methylmalonate, and homocysteine are required to distinguish between folate and vitamin B12 deficiency. These tests, and the strategy for making these diagnoses are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Initial diagnostic strategy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/15/6387?source=see_link\">",
"       \"Patient information: Vitamin B12 deficiency and folate (folic acid) deficiency (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/57/7057?source=see_link\">",
"       \"Patient information: Pernicious anemia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2125769\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of either cobalamin (vitamin B12, Cbl) or folate (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    , FA) is classically associated with the presence of megaloblastic anemia with ineffective erythropoiesis, but only Cbl deficiency is associated with neurologic changes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Disease onset",
"      </strong>",
"      :",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Cbl stores (2 to 5 milligrams) are large in relation to the daily requirement for this vitamin (6 to 9",
"      <span class=\"nowrap\">",
"       mcg/day).",
"      </span>",
"      Accordingly, years of inadequate Cbl intake or absorption are required before the onset of symptoms.",
"     </li>",
"     <li>",
"      Symptoms of FA deficiency can occur within four to five months after intake is diminished, since body stores are smaller (5 to 10 mg) in relation to daily requirements (200 to 400 mcg).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Causes",
"      </strong>",
"      : Cbl deficiency is most often due to inadequate absorption of this vitamin (",
"      <a class=\"graphic graphic_table graphicRef77437 \" href=\"UTD.htm?30/51/31547\">",
"       table 1",
"      </a>",
"      ), whereas FA deficiency is generally attributable to an inadequate diet",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alcoholism (",
"      <a class=\"graphic graphic_table graphicRef55010 \" href=\"UTD.htm?26/43/27323\">",
"       table 2",
"      </a>",
"      ). The two deficiencies can coexist in some patients with malabsorption.",
"     </li>",
"     <li>",
"      <strong>",
"       Clinical manifestations",
"      </strong>",
"      : (see",
"      <a class=\"local\" href=\"#H2127317\">",
"       'General considerations'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Symptoms in Cbl deficiency are related to the anemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      neurologic complaints (eg, memory loss, irritability, dementia, and subacute combined degeneration). (See",
"      <a class=\"local\" href=\"#H2126412\">",
"       'Neurologic changes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms in FA deficiency are restricted to those associated with anemia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Laboratory manifestations",
"      </strong>",
"      : The major hematologic findings in either Cbl or FA deficiency are identical and include macroovalocytic anemia (",
"      <a class=\"graphic graphic_picture graphicRef74901 \" href=\"UTD.htm?9/45/9942\">",
"       picture 1",
"      </a>",
"      ), elevated levels of iron, indirect bilirubin, and LDH, low levels of haptoglobin and reticulocytes, and the presence of hypersegmented neutrophils (",
"      <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2127027\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Bone marrow aspiration and biopsy reveals a hypercellular marrow with megaloblastic erythroid hyperplasia, giant metamyelocytes, and many mitoses (",
"      <a class=\"graphic graphic_picture graphicRef68005 \" href=\"UTD.htm?23/25/23955\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Assays of serum or red cell FA, serum Cbl, methylmalonate, and homocysteine are required to distinguish between Cbl and FA deficiency. These tests are described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link&amp;anchor=H2#H2\">",
"       \"Diagnosis and treatment of vitamin B12 and folate deficiency\", section on 'Initial diagnostic strategy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/1\">",
"      Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994; 69:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/2\">",
"      Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 1993; 7:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/3\">",
"      Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995; 45:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/4\">",
"      Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994; 69:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/5\">",
"      Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/6\">",
"      Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997; 337:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/7\">",
"      Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008; 112:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/8\">",
"      Gu&eacute;ant JL, Safi A, Aimone-Gastin I, et al. Autoantibodies in pernicious anemia type I patients recognize sequence 251-256 in human intrinsic factor. Proc Assoc Am Physicians 1997; 109:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/9\">",
"      Karlsson FA, Burman P, L&ouml;&ouml;f L, M&aring;rdh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/10\">",
"      Sumner AE, Chin MM, Abrahm JL, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med 1996; 124:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/11\">",
"      Kaptan K, Beyan C, Ural AU, et al. Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency? Arch Intern Med 2000; 160:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/12\">",
"      Bor&eacute;n T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/13\">",
"      Hazra A, Kraft P, Selhub J, et al. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet 2008; 40:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/14\">",
"      Azevedo M, Eriksson S, Mendes N, et al. Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol 2008; 215:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/15\">",
"      Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/16\">",
"      van Asselt DZ, de Groot LC, van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr 1998; 68:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/17\">",
"      Rajan S, Wallace JI, Beresford SA, et al. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc 2002; 50:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/18\">",
"      Figlin E, Chetrit A, Shahar A, et al. High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel. Br J Haematol 2003; 123:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/19\">",
"      Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/20\">",
"      Andr&egrave;s E, Goichot B, Schlienger JL. Food cobalamin malabsorption: a usual cause of vitamin B12 deficiency. Arch Intern Med 2000; 160:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/21\">",
"      Andr&egrave;s E, Loukili NH, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004; 171:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/22\">",
"      Dali-Youcef N, Andr&egrave;s E. An update on cobalamin deficiency in adults. QJM 2009; 102:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/23\">",
"      Doscherholmen A, Swaim WR. Impaired assimilation of egg Co 57 vitamin B 12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology 1973; 64:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/24\">",
"      Schilling RF, Gohdes PN, Hardie GH. Vitamin B12 deficiency after gastric bypass surgery for obesity. Ann Intern Med 1984; 101:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/25\">",
"      Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 2006; 91:4223.",
"     </a>",
"    </li>",
"    <li>",
"     Anthony CA. Megaloblastic anemias. In: Hematology: Basic Principles and Practice, 2nd ed, Hoffman R, Benz EJ, Shattil SJ, et al. (Eds), Churchill Livingston, New York 1995. p.552.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/27\">",
"      Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 1994; 120:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/28\">",
"      Allen LH. Vitamin B12 metabolism and status during pregnancy, lactation and infancy. Adv Exp Med Biol 1994; 352:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/29\">",
"      Remacha AF, Cadafalch J. Cobalamin deficiency in patients infected with the human immunodeficiency virus. Semin Hematol 1999; 36:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/30\">",
"      Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997; 127:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/31\">",
"      Tanner SM, Li Z, Perko JD, et al. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. Proc Natl Acad Sci U S A 2005; 102:4130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/32\">",
"      Ament AE, Li Z, Sturm AC, et al. Juvenile cobalamin deficiency in individuals of African ancestry is caused by a founder mutation in the intrinsic factor gene GIF. Br J Haematol 2009; 144:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/33\">",
"      Aminoff M, Carter JE, Chadwick RB, et al. Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet 1999; 21:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/34\">",
"      Kristiansen M, Aminoff M, Jacobsen C, et al. Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. Blood 2000; 96:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/35\">",
"      Tanner SM, Aminoff M, Wright FA, et al. Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nat Genet 2003; 33:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/36\">",
"      Fyfe JC, Madsen M, H&oslash;jrup P, et al. The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood 2004; 103:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/37\">",
"      Andersen CB, Madsen M, Storm T, et al. Structural basis for receptor recognition of vitamin-B(12)-intrinsic factor complexes. Nature 2010; 464:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/38\">",
"      Birn H, Fyfe JC, Jacobsen C, et al. Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest 2000; 105:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/39\">",
"      Nykjaer A, Fyfe JC, Kozyraki R, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci U S A 2001; 98:13895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/40\">",
"      Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol 2006; 134:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/41\">",
"      Coelho D, Suormala T, Stucki M, et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med 2008; 358:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/42\">",
"      Rutsch F, Gailus S, Miousse IR, et al. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet 2009; 41:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/43\">",
"      Carmel R, Parker J, Kelman Z. Genomic mutations associated with mild and severe deficiencies of transcobalamin I (haptocorrin) that cause mildly and severely low serum cobalamin levels. Br J Haematol 2009; 147:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/44\">",
"      Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 2010; 148:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/45\">",
"      Coelho D, Kim JC, Miousse IR, et al. Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. Nat Genet 2012; 44:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/46\">",
"      Puig A, Mino-Kenudson M, Dighe AS. Case records of the Massachusetts General Hospital. Case 13-2012. A 62-year-old man with paresthesias, weight loss, jaundice, and anemia. N Engl J Med 2012; 366:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/47\">",
"      Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/48\">",
"      Graells J, Ojeda RM, Muniesa C, et al. Glossitis with linear lesions: an early sign of vitamin B12 deficiency. J Am Acad Dermatol 2009; 60:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/49\">",
"      Hemmer B, Glocker FX, Schumacher M, et al. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998; 65:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/50\">",
"      Kumar S. Vitamin B12 deficiency presenting with an acute reversible extrapyramidal syndrome. Neurol India 2004; 52:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/51\">",
"      Sharrief AZ, Raffel J, Zee DS. Vitamin B(12) deficiency with bilateral globus pallidus abnormalities. Arch Neurol 2012; 69:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/52\">",
"      Larner AJ. Visual failure caused by vitamin B12 deficiency optic neuropathy. Int J Clin Pract 2004; 58:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/53\">",
"      Pott JW, Wong KH. Leber's hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol 2006; 244:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/54\">",
"      Tangney CC, Tang Y, Evans DA, Morris MC. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology 2009; 72:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/55\">",
"      Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/56\">",
"      Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc 2006; 81:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/57\">",
"      Prodan CI, Bottomley SS, Vincent AS, et al. Hypocupremia associated with prior vitamin B12 deficiency. Am J Hematol 2007; 82:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/58\">",
"      Dhonukshe-Rutten RA, Lips M, de Jong N, et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr 2003; 133:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/59\">",
"      Tucker KL, Hannan MT, Qiao N, et al. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res 2005; 20:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/60\">",
"      Goerss JB, Kim CH, Atkinson EJ, et al. Risk of fractures in patients with pernicious anemia. J Bone Miner Res 1992; 7:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/61\">",
"      Merriman NA, Putt ME, Metz DC, Yang YX. Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology 2010; 138:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/62\">",
"      Carmel R, Lau KH, Baylink DJ, et al. Cobalamin and osteoblast-specific proteins. N Engl J Med 1988; 319:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/63\">",
"      Kim GS, Kim CH, Park JY, et al. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996; 45:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/64\">",
"      Stone KL, Bauer DC, Sellmeyer D, Cummings SR. Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab 2004; 89:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/65\">",
"      Cagnacci A, Baldassari F, Rivolta G, et al. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003; 33:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/66\">",
"      Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/67\">",
"      McPartlin J, Halligan A, Scott JM, et al. Accelerated folate breakdown in pregnancy. Lancet 1993; 341:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/68\">",
"      Wald NJ, Bower C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994; 343:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/69\">",
"      Centers for Disease Control (CDC). Locally acquired neurocysticercosis--North Carolina, Massachusetts, and South Carolina, 1989-1991. MMWR Morb Mortal Wkly Rep 1992; 41:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/70\">",
"      Brown RD, Langshaw MR, Uhr EJ, et al. The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population. Med J Aust 2011; 194:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/71\">",
"      Bertino JR. Karnofsky memorial lecture. Ode to methotrexate. J Clin Oncol 1993; 11:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/72\">",
"      Geller J, Kronn D, Jayabose S, Sandoval C. Hereditary folate malabsorption: family report and review of the literature. Medicine (Baltimore) 2002; 81:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/73\">",
"      Qiu A, Jansen M, Sakaris A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006; 127:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/74\">",
"      Zhao R, Min SH, Qiu A, et al. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 2007; 110:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/75\">",
"      Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 2009; 11:e4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/32/11786/abstract/76\">",
"      Salojin KV, Cabrera RM, Sun W, et al. A mouse model of hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate deficiency. Blood 2011; 117:4895.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7154 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.18-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11786=[""].join("\n");
var outline_f11_32_11786=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2125769\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2125777\">",
"      VITAMIN B12 DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Dietary intake and absorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Causes of vitamin B12 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pernicious anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Autoantibody formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chronic atrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Gastrectomy and gastritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Older adult subjects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Intestinal disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14162046\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Inadequate dietary intake",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2127138\">",
"      - Nitrous oxide exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hereditary causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2126391\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2127317\">",
"      - General considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2126412\">",
"      - Neurologic changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2126419\">",
"      - Skeletal changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2127027\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2127469\">",
"      - Hyperhomocysteinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2125996\">",
"      FOLATE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2125925\">",
"      Dietary intake and absorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2125988\">",
"      Causes of folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Poor nutrition and alcoholism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Increased requirements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Hereditary folate malabsorption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Other hereditary causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2127537\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2125769\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7154\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7154|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/53/14175\" title=\"figure 1\">",
"      Actions of cobalamin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/29/22994\" title=\"figure 2\">",
"      The Schilling test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/40/7814\" title=\"figure 3\">",
"      Homocysteine metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/36/576\" title=\"figure 4\">",
"      B12 and folate in DNA synthesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7154|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/45/9942\" title=\"picture 1\">",
"      Macroovalocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/47/4854\" title=\"picture 2\">",
"      Megaloblastic smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/25/23955\" title=\"picture 3\">",
"      Megaloblastic erythropoiesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7154|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/51/31547\" title=\"table 1\">",
"      Causes of B12 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/43/27323\" title=\"table 2\">",
"      Causes of folate deficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4710?source=related_link\">",
"      Alcohol abuse and hematologic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/0/22538?source=related_link\">",
"      Anemia in the older adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/586?source=related_link\">",
"      Aplastic anemia: Pathogenesis; clinical manifestations; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/38/11880?source=related_link\">",
"      Copper deficiency myeloneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=related_link\">",
"      Gastrointestinal toxicity of radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3098?source=related_link\">",
"      Hematologic manifestations of HIV infection: Anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/61/33753?source=related_link\">",
"      Inhalant abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/6/44136?source=related_link\">",
"      Management of the short bowel syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=related_link\">",
"      Metabolism of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24185?source=related_link\">",
"      Metaplastic (chronic) atrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25034?source=related_link\">",
"      Overview and comparison of the proton pump inhibitors for the treatment of acid-related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22570?source=related_link\">",
"      Overview of radiation therapy for gynecologic malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36025?source=related_link\">",
"      Pathophysiology of alpha thalassemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4809?source=related_link\">",
"      Pathophysiology of and immune response to Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/57/7057?source=related_link\">",
"      Patient information: Pernicious anemia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/15/6387?source=related_link\">",
"      Patient information: Vitamin B12 deficiency and folate (folic acid) deficiency (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=related_link\">",
"      Physiology of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41369?source=related_link\">",
"      Prevention of dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33658?source=related_link\">",
"      Therapeutic use and toxicity of high-dose methotrexate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36586?source=related_link\">",
"      Vitamin supplementation in disease prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=related_link\">",
"      Vitiligo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_32_11787="Causes drug induced acne";
var content_f11_32_11787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of drug-induced acne",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lithium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isoniazid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermal growth factor receptor inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iodides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bromides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Androgens",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corticotropin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cyclosporine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disulfiram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoralens",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thiourea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamins B2, B6, and B12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Azathioprine",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11787=[""].join("\n");
var outline_f11_32_11787=null;
var title_f11_32_11788="Secondary prophylaxis for rheumatic fever - Selection of therapy";
var content_f11_32_11788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Secondary prophylaxis for rheumatic fever - Selection of therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Continuous regimen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Adults &gt;27 kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        Children &le;27 kg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin G benzathine intramuscular (Bicillin LA)",
"       </td>",
"       <td>",
"        1.2 million units every 4 weeks*",
"       </td>",
"       <td>",
"        600,000 units every 4 weeks*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Penicillin V oral",
"       </td>",
"       <td>",
"        250 mg orally twice daily",
"       </td>",
"       <td>",
"        250 mg orally twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfadiazine",
"       </td>",
"       <td>",
"        1000 mg orally once daily",
"       </td>",
"       <td>",
"        500 mg orally once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Allergy to penicillin and sulfadiazine:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Azithromycin",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        250 mg orally once daily",
"       </td>",
"       <td class=\"sublist_other\">",
"        5 mg/kg orally once daily (up to 250 mg)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In high-risk situations, administration every three weeks is justified and recommended.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     For small children and infants: 25,000 units per kg intramuscularly every 4 weeks or 3 weeks (high-risk).",
"     <br/>",
"     &Delta; Macrolide susceptibility testing should be pursued prior to use of this drug class. Erythromycin is an acceptable alternative to azithromycin, although the latter has fewer adverse effects and permits once daily dosing. Erythromycin dosing for adults: 250 mg orally twice daily. Dosing for children: 20 mg/kg/day divided twice daily (maximum 500 mg per day).",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis: A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009; 119(11):1541-51. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11788=[""].join("\n");
var outline_f11_32_11788=null;
var title_f11_32_11789="Infections by immune deficit";
var content_f11_32_11789=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Organisms associated with infection in individuals with various immune deficits",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Immune deficit",
"       </td>",
"       <td class=\"subtitle1\">",
"        Common causes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Organisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Neutrophil disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neutropenia",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Chemotherapy",
"        </p>",
"        <p>",
"         Leukemia",
"        </p>",
"        <p>",
"         AIDS",
"        </p>",
"        <p>",
"         Felty's syndrome",
"        </p>",
"        <p>",
"         Viral infections",
"        </p>",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Gram-negative bacilli (enteric and non-enteric)",
"        </p>",
"        <p>",
"         Staphylococcus aureus",
"        </p>",
"        <p>",
"         Coagulase-negative staphylococcus",
"        </p>",
"        <p>",
"         Streptococci",
"        </p>",
"        <p>",
"         Fungi (Aspergillus spp, Candida spp)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neutrophil chemotaxis",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Diabetes mellitus",
"        </p>",
"        <p>",
"         Cirrhosis, alcoholism",
"        </p>",
"        <p>",
"         Uremia",
"        </p>",
"        <p>",
"         Hodgkin's disease",
"        </p>",
"        <p>",
"         Trauma, burns",
"        </p>",
"        <p>",
"         Lazy leukocyte syndrome",
"        </p>",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         S. aureus",
"        </p>",
"        <p>",
"         Candida spp",
"        </p>",
"        <p>",
"         Streptococci",
"        </p>",
"        <p>",
"         Mucorales",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neutrophil killing",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Chronic granulomatous disease",
"        </p>",
"        <p>",
"         Myeloperoxidase deficiency",
"        </p>",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         S. aureus",
"        </p>",
"        <p>",
"         Escherichia coli",
"        </p>",
"        <p>",
"         Fungi (Aspergillus spp, Candida spp)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T lymphocyte deficiency",
"       </td>",
"       <td>",
"        <p>",
"         HIV/AIDS",
"        </p>",
"        <p>",
"         Lymphoma",
"        </p>",
"        <p>",
"         Chemotherapy",
"        </p>",
"        <p>",
"         Transplantation",
"        </p>",
"        <p>",
"         Glucocorticoids",
"        </p>",
"        <p>",
"         Viral infection",
"        </p>",
"        <p>",
"         T cell-depleting antibodies",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Viruses (latent herpesviruses, papillomaviruses, respiratory viruses)",
"        </p>",
"        <p>",
"         Intracellular bacteria (Legionella spp, mycobacteria)",
"        </p>",
"        <p>",
"         Nocardia spp",
"        </p>",
"        <p>",
"         Fungi (Pneumocystis jirovecii, Cryptococcus spp, Histoplasma capsulatum)",
"        </p>",
"        <p>",
"         Parasites (Strongyloides spp, Toxoplasma spp)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B lymphocyte deficiency",
"       </td>",
"       <td>",
"        <p>",
"         Multiple myeloma",
"        </p>",
"        <p>",
"         Acute leukemia",
"        </p>",
"        <p>",
"         Burns",
"        </p>",
"        <p>",
"         Congenital",
"        </p>",
"        <p>",
"         Drugs (anti-B-cell therapies, azathioprine, mycophenylate)",
"        </p>",
"        <p>",
"         Enteropathies",
"        </p>",
"        <p>",
"         Plasmapheresis",
"        </p>",
"        <p>",
"         Glucocorticoids",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Encapsulated bacteria (Pneumococcus, Haemophilus influenzae, Neisseria meningitidis)",
"        </p>",
"        <p>",
"         Salmonella spp",
"        </p>",
"        <p>",
"         Campylobacter",
"        </p>",
"        <p>",
"         Giardia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spleen",
"       </td>",
"       <td>",
"        <p>",
"         Splenectomy",
"        </p>",
"        <p>",
"         Sickle cell disease",
"        </p>",
"        <p>",
"         Cirrhosis",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Encapsulated bacteria (Pneumococcus, H. influenzae, N. meningitidis)",
"        </p>",
"        <p>",
"         Capnocytophaga",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complement",
"       </td>",
"       <td>",
"        Congenital/acquired deficiencies",
"       </td>",
"       <td>",
"        <p>",
"         S. aureus",
"        </p>",
"        <p>",
"         Encapsulated bacteria (Pneumococcus, H. influenzae, N. meningitidis)",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11789=[""].join("\n");
var outline_f11_32_11789=null;
var title_f11_32_11790="Intl cerv cancer screen policies";
var content_f11_32_11790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pap smear screening policies of selected industrialized nations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Country",
"       </td>",
"       <td class=\"subtitle1\">",
"        Starting age",
"        <br/>",
"        (years)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Stopping age",
"        <br/>",
"        (years)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"        <br/>",
"        (years)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number/lifetime",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Australia",
"       </td>",
"       <td class=\"centered\">",
"        18-20",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        27",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Belgium",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        64",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        2, 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Canada",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        70",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        16",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Denmark",
"       </td>",
"       <td class=\"centered\">",
"        23",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        2, 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Finland",
"       </td>",
"       <td class=\"centered\">",
"        30",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td class=\"centered\">",
"        2, 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        France",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        3",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Germany",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td class=\"centered\">",
"        NS",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        50+",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iceland",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td class=\"centered\">",
"        24",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ireland",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        3",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td class=\"centered\">",
"        2, 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Italy",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        64",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Netherlands",
"       </td>",
"       <td class=\"centered\">",
"        30",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        5",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        New Zealand",
"       </td>",
"       <td class=\"centered\">",
"        20",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        3",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        17",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sweden",
"       </td>",
"       <td class=\"centered\">",
"        23",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        UK",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        64",
"       </td>",
"       <td class=\"centered\">",
"        3",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        US",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        21",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td class=\"centered\">",
"        15",
"       </td>",
"       <td class=\"centered\">",
"        (See text)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        WHO",
"       </td>",
"       <td class=\"centered\">",
"        25",
"       </td>",
"       <td class=\"centered\">",
"        64",
"       </td>",
"       <td class=\"centered\">",
"        3*",
"       </td>",
"       <td class=\"centered\">",
"        14",
"       </td>",
"       <td class=\"centered\">",
"        8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NS: not specified.",
"     <br/>",
"     * Screening every 5 years after the age of 50.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     After 2 normal smears at 6-year intervals.",
"     <br/>",
"     &Delta; Policy planned for one region of the country.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Screening every 5 years after the age of 45.",
"     <br/>",
"     &sect; Screening every 10 years after the age of 40.",
"     <br/>",
"     &yen; These policies provide for a specified number of annual repeat Pap smears (generally 1 to 3) upon the commencement of screening, followed by reversion to less frequent screening.",
"     <br/>",
"     &Dagger; Represents amalgam of professional society recommendations, rather than national screening policy.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Department of Health and Ageing. National cervical screening program. Austrailian Government. Available at: www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cervica-about. (Accessed April 20, 2012.)",
"       </li>",
"       <li>",
"        Arbyn M, et al. European guidelines for quality assurance in cervical cancer screening. 2nd edition. Belgium: European Communities, 2008.",
"       </li>",
"       <li>",
"        European Cervical Cancer Association,",
"        <a href=\"file://www.ecca.info/en/cervical-cancer-prevention/cervical-screening/cse1/table-2.html\" target=\"_blank\">",
"         file://www.ecca.info/en/cervical-cancer-prevention/cervical-screening/cse1/table-2.html",
"        </a>",
"        . (Accessed January 10, 2013.)",
"       </li>",
"       <li>",
"        Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. CMAJ 2013; 185:35.",
"       </li>",
"       <li>",
"        Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, Weiderpass E. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer. 2004 Aug 31; 91(5):935-41.",
"       </li>",
"       <li>",
"        Health Council of The Netherlands. Population screening for cervical cancer. The Hague 2011. Available at:",
"        <a href=\"file://www.gezondheidsraad.nl/en/publications/population-screening-cervical-cancer\" target=\"_blank\">",
"         www.gezondheidsraad.nl/en/publications/population-screening-cervical-cancer",
"        </a>",
"        . (Accessed April 20, 2012.)",
"       </li>",
"       <li>",
"        National Screening Unit, Ministry of Health, New Zealand.",
"       </li>",
"       <li>",
"        Comprehensive cervical cancer control: A guide to essential practice. Switzerland, World Health Organization, 2006.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11790=[""].join("\n");
var outline_f11_32_11790=null;
var title_f11_32_11791="Acute silicosis CXR";
var content_f11_32_11791=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute silicosis (silicoproteinosis)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a bilateral alveolar filling process present in both lower lung zones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy Dr. E. L. Petsonk.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_32_11791=[""].join("\n");
var outline_f11_32_11791=null;
